Boqii Holding Limited (BQ) 20-F 27 Jul 22 2022 FY Annual report (foreign) Financial data

Cover Page

Cover Page	12 Months Ended
	Mar. 31, 2022 shares
Document Information [Line Items]
Document Type	20-F
Amendment Flag	false
Document Registration Statement	false
Document Annual Report	true
Document Transition Report	false
Document Shell Company Report	false
Document Period End Date	Mar. 31, 2022
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	FY
Entity File Number	001-39177
Entity Registrant Name	Boqii Holding Ltd
Entity Central Index Key	0001815021
Current Fiscal Year End Date	--03-31
Entity Well-known Seasoned Issuer	No
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Voluntary Filers	No
Entity Interactive Data Current	Yes
Entity Address, Country	CN
ICFR Auditor Attestation Flag	false
Entity Incorporation, State or Country Code	E9
Document Accounting Standard	U.S. GAAP
Entity Address, Address Line One	Building 9, No. 388, Shengrong Road, Pudong
Entity Address, Address Line Two	New District
Entity Address, City or Town	Shanghai
Entity Address, Postal Zip Code	201210
Auditor Name	PricewaterhouseCoopers Zhong Tian LLP
Auditor Firm ID	1424
Auditor Location	Shanghai, the People’s Republic of China
Business Contact [Member]
Document Information [Line Items]
Entity Address, Country	CN
Entity Address, Address Line One	Building 9, No. 388, Shengrong Road, Pudong
Entity Address, Address Line Two	New District
Entity Address, City or Town	Shanghai
Entity Address, Postal Zip Code	201210
Contact Personnel Name	Yingzhi (Lisa) Tang
Contact Personnel Fax Number	180 1851 3366
Ordinary Shares [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding	68,747,320
Class A Ordinary Shares [Member]
Document Information [Line Items]
Title of 12(b) Security	Class A ordinary shares, par value US$0.001 per share
No Trading Symbol Flag	true
Security Exchange Name	NYSE
Entity Common Stock, Shares Outstanding	55,709,591
Class B Ordinary Shares [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding	13,037,729
American Depositary Shares [Member]
Document Information [Line Items]
Title of 12(b) Security	American depositary shares, each ADS represents 4.5 Class A ordinary shares, par value US$0.001 per share
Trading Symbol	BQ
Security Exchange Name	NYSE

Consolidated Balance Sheets

Consolidated Balance Sheets ¥ in Thousands, $ in Thousands	Mar. 31, 2022 USD ($)	Mar. 31, 2022 CNY (¥)	Mar. 31, 2021 CNY (¥)
Current assets:
Cash and cash equivalents	$ 25,690	¥ 162,855	¥ 292,237
Short-term investments	20,205	128,084	168,546
Accounts receivable, net	7,766	49,231	45,732
Inventories, net	17,340	109,921	91,551
Prepayments and other current assets	18,415	116,738	85,261
Amounts due from related parties	1,850	11,726	11,465
Total current assets	91,266	578,555	694,792
Non-current assets:
Property and equipment, net	1,227	7,779	8,386
Intangible assets	4,029	25,544	29,537
Operating lease right-of-use assets	6,084	38,567	29,234
Long-term investments	12,986	82,319	74,330
Goodwill	6,418	40,684	40,184
Other non-current asset	767	4,861	4,111
Total non-current assets	31,511	199,754	185,782
Total assets	122,777	778,309	880,574
Current liabilities
Short-term borrowings (including amounts of the consolidated VIEs and VIEs' subsidiaries without recourse to the Company of RMB3,484 and RMB872 as of March 31, 2021 and 2022, respectively)	25,417	161,126	85,566
Accounts payable (including accounts payable of the consolidated VIEs and VIEs' subsidiaries without recourse to the Company of RMB29,940 and RMB55,144 as of March 31, 2021 and 2022, respectively, and intra-group payables due to the Group's entities of RMB409,939 and RMB605,803 as of March 31, 2021 and 2022, respectively)	14,863	94,224	71,848
Salary and welfare payable (including amounts of the consolidated VIEs and VIEs' subsidiaries without recourse to the Company of RMB4,851 and RMB5,597 as of March 31, 2021 and 2022, respectively)	1,084	6,871	6,309
Accrued liabilities and other current liabilities (including amounts of the consolidated VIEs and VIEs' subsidiaries without recourse to the Company of RMB24,536 and RMB25,786 as of March 31, 2021 and 2022, respectively, and intra-group payables due to the Group's entities of RMB201,173 and RMB340,157 as of March 31, 2021 and 2022, respectively)	4,310	27,324	30,055
Amounts due to related parties, current (including amounts of the consolidated VIEs and VIEs' subsidiaries without recourse to the Company of RMB910 and RMB4 as of March 31, 2021 and 2022, respectively)	35	219	910
Contract liabilities (including amounts of the consolidated VIEs and VIEs' subsidiaries without recourse to the Company of RMB3,706 and RMB7,007 as of March 31, 2021 and 2022, respectively)	1,105	7,007	3,866
Operating lease liabilities, current (including amounts of the consolidated VIEs and VIEs' subsidiaries without recourse to the Company of RMB6,058 and RMB7,238 as of March 31, 2021 and 2022, respectively)	1,578	10,001	8,063
Derivative liabilities (including amounts of the consolidated VIEs and VIEs' subsidiaries without recourse to the Company of nil as of March 31, 2021 and 2022, respectively)	1,433	9,086	9,996
Total current liabilities	49,825	315,858	216,613
Non-current liabilities
Deferred tax liabilities (including amounts of the consolidated VIEs and VIEs' subsidiaries without recourse to the Company of RMB1,852 and RMB(1,369) as of March 31, 2021 and 2022, respectively)	765	4,847	8,958
Operating lease liabilities, non-current (including amounts of the consolidated VIEs and VIEs' subsidiaries without recourse to the Company of RMB19,997 and RMB28,197 as of March 31, 2021 and 2022, respectively)	4,448	28,197	19,997
Long-term borrowings (including amounts of the consolidated VIEs and VIEs' subsidiaries without recourse to the Company of RMB872 and nil as of March 31, 2021 and 2022, respectively)			68,075
Other debts, non-current (including amounts of the consolidated VIEs and VIEs' subsidiaries without recourse to the Company of RMB415,122 and RMB157,874 as of March 31, 2021 and 2022, respectively)	28,562	181,062	433,292
Total non-current liabilities	33,775	214,106	530,322
Total liabilities	83,600	529,964	746,935
Commitments and contingencies (Note 29)
Mezzanine equity:
Redeemable non-controlling interests	1,029	6,522	5,946
Total mezzanine equity	1,029	6,522	5,946
Shareholders' equity:
Additional paid-in capital	519,826	3,295,336	3,272,612
Statutory reserves	542	3,433	3,047
Accumulated other comprehensive loss	(7,267)	(46,069)	(20,172)
Accumulated deficit	(455,765)	(2,889,233)	(2,759,882)
Receivable for issuance of ordinary shares	(25,988)	(164,700)	(413,377)
Total Boqii Holding Limited shareholders' equity	31,420	199,175	82,674
Non-controlling interests	6,728	42,648	45,019
Total shareholders' equity	38,148	241,823	127,693
Total liabilities, mezzanine equity and shareholders' equity	122,777	778,309	880,574
Class A Ordinary Shares [Member]
Shareholders' equity:
Common Stock Value	59	372	364
Class B Ordinary Shares [Member]
Shareholders' equity:
Common Stock Value	$ 13	¥ 82	¥ 82

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) ¥ in Thousands, $ in Thousands	Mar. 31, 2022 USD ($) $ / shares shares	Mar. 31, 2022 CNY (¥) shares	Mar. 31, 2021 USD ($) $ / shares shares	Mar. 31, 2021 CNY (¥) shares
Short-term borrowings	$ 25,417	¥ 161,126		¥ 85,566
Accounts payable	14,863	94,224		71,848
Salary and welfare payable	1,084	6,871		6,309
Accrued liabilities and other current liabilities	4,310	27,324		30,055
Amounts due to related parties, current	35	219		910
Contract liabilities	1,105	7,007		3,866
Operating lease liabilities, current	1,578	10,001		8,063
Derivative liabilities	1,433	9,086		9,996
Operating lease liabilities, non-current	4,448	28,197		19,997
Long-term borrowings				68,075
Other debts, non-current	28,562	181,062		433,292
Nonrecourse [Member] | Variable Interest Entity, Primary Beneficiary [Member]
Short-term borrowings		872		3,484
Accounts payable		55,144		29,940
Intra group payables due to subsidiaries, Current		945,960		611,112
Salary and welfare payable		5,597		4,851
Accrued liabilities and other current liabilities		25,786		24,536
Amounts due to related parties, current		4		910
Contract liabilities		7,007		3,706
Operating lease liabilities, current		7,238		6,058
Derivative liabilities	$ 0	0	$ 0	0
Deferred tax liabilities		(1,369)		1,852
Operating lease liabilities, non-current		28,197		19,997
Long-term borrowings		0		872
Other debts, non-current		157,874		415,122
Nonrecourse [Member] | Variable Interest Entity, Primary Beneficiary [Member] | Accounts Payable Current [Member]
Intra group payables due to subsidiaries, Current		605,803		409,939
Nonrecourse [Member] | Variable Interest Entity, Primary Beneficiary [Member] | Accounts Payable And Other Accrued Liabilities Current [Member]
Intra group payables due to subsidiaries, Current		¥ 340,157		¥ 201,173
Class A Ordinary Shares [Member]
Common Stock, Par or Stated Value Per Share | $ / shares	$ 0.001		$ 0.001
Common Stock, Shares Authorized | shares	129,500,000	129,500,000	129,500,000	129,500,000
Common Stock, Shares, Issued | shares	55,709,591	55,709,591	54,505,108	54,505,108
Common Stock, Shares, Outstanding | shares	55,709,591	55,709,591	54,505,108	54,505,108
Class B Ordinary Shares [Member]
Common Stock, Par or Stated Value Per Share | $ / shares	$ 0.001		$ 0.001
Common Stock, Shares Authorized | shares	15,000,000	15,000,000	15,000,000	15,000,000
Common Stock, Shares, Issued | shares	13,037,729	13,037,729	13,037,729	13,037,729
Common Stock, Shares, Outstanding | shares	13,037,729	13,037,729	13,037,729	13,037,729

Consolidated Statements of Loss

Consolidated Statements of Loss and Comprehensive Loss ¥ in Thousands, $ in Thousands	12 Months Ended
	Mar. 31, 2022 CNY (¥) ¥ / shares shares	Mar. 31, 2022 USD ($) $ / shares shares	Mar. 31, 2021 CNY (¥) ¥ / shares shares	Mar. 31, 2020 CNY (¥) ¥ / shares shares
Net revenues:
Total revenues	¥ 1,186,429	$ 187,154	¥ 1,010,985	¥ 770,237
Total cost of revenue	(943,698)	(148,865)	(823,686)	(611,470)
Gross profit	242,731	38,289	187,299	158,767
Operating expenses:
Fulfillment expenses	(134,026)	(21,142)	(120,188)	(115,887)
Sales and marketing expenses	(170,986)	(26,972)	(160,201)	(128,387)
General and administrative expenses	(76,248)	(12,028)	(113,972)	(54,277)
Other income, net	280	44	1,067	2,398
Loss from operations	(138,249)	(21,809)	(205,995)	(137,386)
Interest income	15,477	2,441	17,553	400
Interest expense	(20,884)	(3,294)	(27,650)	(59,268)
Other gain (losses), net	6,020	950	11,332	6,984
Fair value change of derivative liabilities	2,824	445	11,369	13,345
Loss before income tax expenses	(134,812)	(21,267)	(193,391)	(175,925)
Income tax expenses	1,571	248	871	512
Share of results of equity investees	418	65	(696)	(520)
Net loss	(132,823)	(20,954)	(193,216)	(175,933)
Less: Net income attributable to the non-controlling interest shareholders	(4,433)	(699)	1,228	3,091
Net loss attributable to Boqii Holding Limited	(128,390)	(20,255)	(194,444)	(179,024)
Accretion on convertible redeemable preferred shares to redemption value			120,873	(204,796)
Accretion on redeemable non-controlling interests to redemption value	(575)	(91)	(138)
Deemed dividend to preferred shareholders			(12,547)	(1,142)
Net loss attributable to Boqii Holding Limited's ordinary shareholders	(128,965)	(20,346)	(86,256)	(384,962)
Net loss	(132,823)	(20,954)	(193,216)	(175,933)
Other comprehensive income (loss):
Foreign currency translation adjustment, net of nil tax	(16,529)	(2,606)	(32,148)	2,021
Unrealized securities holding gains/(losses)	(9,368)	(1,478)	772	3,209
Total comprehensive loss	(158,720)	(25,038)	(224,592)	(170,703)
Less: Total comprehensive loss/(income) attributable to non- controlling interests shareholders	(4,433)	(699)	1,228	3,091
Total comprehensive loss attributable to Boqii Holding Limited	¥ (154,287)	$ (24,339)	¥ (225,820)	¥ (173,794)
Net loss per share attributable to Boqii Holding Limited's ordinary shareholders
— basic | (per share)	¥ (1.9)	$ (0.3)	¥ (1.29)	¥ (17.31)
— diluted | (per share)	¥ (1.9)	$ (0.3)	¥ (1.29)	¥ (17.31)
Weighted average number of ordinary shares
— basic | shares	68,006,172	68,006,172	66,953,610	22,238,454
— diluted | shares	68,006,172	68,006,172	66,953,610	22,238,454
Product Sales [Member]
Net revenues:
Total revenues	¥ 1,137,329	$ 179,409	¥ 1,003,197	¥ 767,496
Total cost of revenue | ¥	(930,400)		(820,300)	(610,600)
Online Marketing And Information Services And Other Revenue [Member]
Net revenues:
Total revenues	49,100	$ 7,745	7,788	2,741
Total cost of revenue | ¥	¥ (13,300)		¥ (3,400)	¥ (900)

Consolidated Statements of Chan

Consolidated Statements of Changes in Shareholders' Equity ¥ in Thousands, $ in Thousands	CNY (¥) shares	USD ($) shares	Ordinary Shares [Member] CNY (¥) shares	Ordinary Shares [Member] Common Class A [Member] CNY (¥) shares	Ordinary Shares [Member] Common Class B [Member] CNY (¥) shares	Additional Paid-in Capital [Member] CNY (¥)	Statutory reserves [Member] CNY (¥)	Accumulated other comprehensive income [Member] CNY (¥)	Accumulated deficit [Member] CNY (¥)	Non-controlling interests [Member] CNY (¥)	Receivable for issuance of ordinary shares [Member] CNY (¥)
Beginning Balance , Shares at Mar. 31, 2019 | shares			20,938,500
Beginning Balance at Mar. 31, 2019	¥ (1,618,438)		¥ 130				¥ 1,650	¥ 5,974	¥ (1,630,819)	¥ 4,627
Foreign currency translation adjustment	2,021							2,021
Accretion to redemption value of redeemable convertible preferred shares (Note 20)	(204,796)								(204,796)
Accretion on redeemable non-controlling interests to redemption value
Unrealized securities holding gains (losses), net of tax	3,209							3,209
Acquisition of a subsidiaries	36,023						199		(199)	36,023
Deemed dividend to preferred shareholders (Note 20)	(1,142)								(1,142)
Appropriations to statutory reserves							778		(778)
Share-based compensation , Shares | shares			1,299,954
Share-based compensation			¥ 9								¥ (9)
Net loss	(175,933)								(179,024)	3,091
Ending Balance, Shares at Mar. 31, 2020 | shares			22,238,454
Ending Balance at Mar. 31, 2020	(1,959,056)		¥ 139				2,627	11,204	(2,016,758)	43,741	(9)
Foreign currency translation adjustment	(32,148)							(32,148)
Accretion to redemption value of redeemable convertible preferred shares (Note 20)	120,873								120,873
Accretion on redeemable non-controlling interests to redemption value	(138)								(138)
Unrealized securities holding gains (losses), net of tax	772							772
Deemed dividend to preferred shareholders (Note 20)	(12,547)								(12,547)
Exercise of CMB Warrant (Note 20)	(656,448)								(656,448)
Receivable for issuance of convertible redeemable preferred shares	(413,377)										(413,377)
Conversion of ordinary shares into Class A and Class B ordinary shares , Shares | shares			(22,238,454)	10,033,850	12,204,604
Conversion of ordinary shares into Class A and Class B ordinary shares			¥ (139)	¥ 63	¥ 76
Issuance of Class A ordinary shares upon initial public offering ("IPO"), net of cost of issuance (Note 19) , Shares | shares				5,250,000
Issuance of Class A ordinary shares upon initial public offering ("IPO"), net of cost of issuance (Note 19)	395,071			¥ 36		¥ 395,035
Conversion of Series A convertible redeemable preferred shares upon completion of the IPO , Shares | shares				7,844,137
Conversion of Series A convertible redeemable preferred shares upon completion of the IPO	461,445			¥ 53		461,392
Conversion of Series B convertible redeemable preferred shares upon completion of the IPO , Shares | shares				8,557,980
Conversion of Series B convertible redeemable preferred shares upon completion of the IPO	504,337			¥ 57		504,280
Conversion of Series C convertible redeemable preferred shares upon completion of the IPO , Shares | shares				4,684,976	833,125
Conversion of Series C convertible redeemable preferred shares upon completion of the IPO	331,465			¥ 32	¥ 6	331,427
Conversion of Series C+ convertible redeemable preferred shares upon completion of the IPO , Shares | shares				6,883,520
Conversion of Series C+ convertible redeemable preferred shares upon completion of the IPO	662,808			¥ 47		662,761
Conversion of Series D convertible redeemable preferred shares upon completion of the IPO , Shares | shares				2,526,026
Conversion of Series D convertible redeemable preferred shares upon completion of the IPO	181,004			¥ 17		180,987
Conversion of Series D-1 convertible redeemable preferred shares upon completion of the IPO , Shares | shares				2,178,530
Conversion of Series D-1 convertible redeemable preferred shares upon completion of the IPO	164,859			¥ 15		164,844
Conversion of Series D-2 convertible redeemable preferred shares upon completion of the IPO , Shares | shares				1,182,803
Conversion of Series D-2 convertible redeemable preferred shares upon completion of the IPO	92,314			¥ 8		92,306
Conversion of Series E convertible redeemable preferred shares upon completion of the IPO , Shares | shares				5,885,210
Conversion of Series E convertible redeemable preferred shares upon completion of the IPO	455,980			¥ 40		455,940
Capital contribution from non-controlling interests	50									50
Appropriations to statutory reserves							420		(420)
Repurchase of Ordinary Shares , Shares | shares				(521,924)
Repurchase of Ordinary Shares	(31,386)			¥ (4)		(31,382)
Share-based compensation	55,031					55,022					9
Net loss	(193,216)								(194,444)	1,228
Ending Balance, Shares at Mar. 31, 2021 | shares				54,505,108	13,037,729
Ending Balance at Mar. 31, 2021	127,693			¥ 364	¥ 82	3,272,612	3,047	(20,172)	(2,759,882)	45,019	(413,377)
Foreign currency translation adjustment	(16,529)							(16,529)
Accretion on redeemable non-controlling interests to redemption value	(575)								(575)
Receivable for issuance of ordinary shares (Note 23)	248,631										248,631
Unrealized securities holding gains (losses), net of tax	(9,368)							(9,368)
Acquisition of a subsidiaries	1,817									1,817
Capital contribution from non-controlling interests	¥ 245									245
Appropriations to statutory reserves							386		(386)
Issuance of ordinary shares for the exercise of stock options, Shares | shares	1,204,483	1,204,483		1,204,483
Issuance of ordinary shares for the exercise of stock options	¥ 8,323			¥ 8		8,315
Share-based compensation	14,409					14,409
Net loss	(132,823)	$ (20,954)							(128,390)	(4,433)
Ending Balance, Shares at Mar. 31, 2022 | shares				55,709,591	13,037,729
Ending Balance at Mar. 31, 2022	¥ 241,823	$ 38,148		¥ 372	¥ 82	¥ 3,295,336	¥ 3,433	¥ (46,069)	¥ (2,889,233)	¥ 42,648	¥ (164,746)

Consolidated Statements of Cash

Consolidated Statements of Cash Flows ¥ in Thousands, $ in Thousands	12 Months Ended
	Mar. 31, 2022 CNY (¥)	Mar. 31, 2022 USD ($)	Mar. 31, 2021 CNY (¥)	Mar. 31, 2020 CNY (¥)
Cash flows from operating activities:
Net loss	¥ (132,823)	$ (20,954)	¥ (193,216)	¥ (175,933)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization expense	7,678	1,211	7,083	4,588
Provision for inventories	311	49	(8)	273
Provision for doubtful accounts	213	34	(107)	271
Interest expense of other debts	17,144	2,704	21,611	53,934
Interest receivable for issuance of ordinary shares	(14,239)	(2,246)	(15,394)
Amortization of right-of-use assets	11,705	1,846	11,687	15,708
Interest of lease liabilities	1,949	307	1,596	1,353
Investment income	622	98
Share of results of equity investees	(418)	(66)	131	520
Loss/(gain) on disposal of property and equipment	(104)	(16)	20	31
Gain on disposal of other debts			(6,846)	(10,095)
Gain from the re-measurement of the previously held equity interest to the fair value in the business acquisition	(127)	(20)		(481)
Share-based compensation expense	14,409	2,273	55,022
Fair value change of derivative liabilities	(2,824)	(445)	(11,369)	(13,345)
Deferred tax expense	(989)	(156)	(1,889)	(661)
Changes in operating assets and liabilities, net of effects of businesses acquired:
Accounts receivable	(6,131)	(967)	(880)	(16,010)
Inventories	(23,176)	(3,656)	(38,839)	15,486
Prepayments and other current assets	(35,056)	(5,530)	(48,853)	3,331
Amounts due from related parties	490	77	(2,663)	(1,944)
Operating lease liabilities	(12,849)	(2,027)	(12,850)	(18,183)
Accounts payable	18,106	2,856	(22,029)	(19,535)
Salary and welfare payable	293	46	2,518	355
Accrued liabilities and other current liabilities	1,954	308	667	574
Amounts due to related parties	(808)	(127)	1,062	(105)
Contract liabilities	3,140	495	(5,229)	1,887
Other non-current assets	4,026	635	11,289	(7,931)
Net cash used in operating activities	(147,504)	(23,271)	(247,486)	(165,912)
Cash flows from investing activities:
Loan receivables advanced to a third party	(2,376)	(375)	(49,392)	(37,671)
Repayments on loan receivables from a third party	2,579	407	44,840	12,013
Loan receivables advanced to a related party	(35,995)	(5,678)	(4,814)
Repayments on loan receivables from a related party	35,245	5,560
Acquisition of subsidiaries, net of cash and cash equivalents acquired				1,783
Increase/(decrease) in short-term investments	40,462	6,383	(168,546)
Purchase of intangible assets	(24)	(4)		(2)
Purchase of property and equipment	(3,077)	(485)	(6,509)	(1,204)
Disposal of property and equipment	125	20	4	5
Acquisitions of long-term investments	(15,792)	(2,491)		(50,000)
Disposal of equity investees				20
Net cash generated from/ (used in) investing activities	21,147	3,337	(184,417)	(75,056)
Cash flows from financing activities:
Proceeds from issuance of convertible redeemable preferred shares, net of issuance costs			354,825	41,197
Acquisition of additional interests in subsidiaries from non-controlling interests	245	39
Proceeds from short-term and long-term borrowings	185,614	29,280	87,846	162,501
Repayments of short-term and long-term borrowings	(176,897)	(27,905)	(74,000)	(43,533)
Proceeds from issuance of other debts, net of issuance costs			16,940	134,867
Proceeds from issuance of ordinary shares	262,870	41,467
Repayments of other debts	(270,860)	(42,727)	(130,827)
Proceeds from exercise of share option	1,023	161	9
Proceeds from the initial public offering, net of underwriter discounts and commissions and other offering costs paid			393,698
Net cash flows generated from financing activities	1,995	315	648,491	295,032
Net increase (decrease) in cash, cash equivalents and restricted cash	(124,362)	(19,619)	216,588	54,064
Cash, cash equivalents and restricted cash at beginning of year	292,237	46,099	88,352	27,217
Effects of exchange rate changes on cash, cash equivalents and restricted cash	(5,020)	(790)	(12,703)	7,071
Cash, cash equivalents and restricted cash at end of year	162,855	25,690	292,237	88,352
Supplemental schedule of non-cash investing and financing activities:
Accretion on convertible redeemable preferred shares			120,873	(204,796)
Accretion on redeemable non-controlling interests	(575)	(91)	(138)
Deemed dividend to preferred shareholders			(12,547)	(1,142)
Non-cash consideration paid for business acquisitions				(33,440)
Unpaid cash consideration for business acquisitions	(2,938)	(463)
Additional ASC 842 supplemental disclosure:
Cash paid for fixed operating lease costs included in the measurement of lease obligations in operating activities	12,849	2,027	12,850	18,183
Right-of-use assets obtained in exchange for operating lease obligations	¥ 21,038	$ 3,319	¥ 25,970	¥ 10,051

Organization and principal acti

Organization and principal activities	12 Months Ended
	Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and principal activities	1. Organization and principal activities (a) Principal activities Boqii Holding Limited (“Boqii Holding”), was incorporated under the laws of the Cayman Islands in June 2012, as an exempted company with limited liability. Boqii Holding, its subsidiaries, consolidated variable interest entities (“VIEs”) and VIEs’ subsidiaries (collectively referred as the “Company”), operate as an online one-stop The Company’s consolidated financial statements include the financial statements of the Company, its subsidiaries, consolidated VIEs and VIEs’ subsidiaries. As of March 31, 2022, the Company’s principal subsidiaries, consolidated VIEs and major VIEs’ subsidiaries are as follows: Name of subsidiaries and VIE Place of Date of or acquisition Percentage of direct or indirect Principal activities Subsidiaries: Boqii Corporation Limited (“Boqii Corporation”) Hong Kong July 2012 100 % Investment holding Boqii International Limited Hong Kong August 2016 100 % Investment holding Xingmu International Limited British Virgin Islands August 2019 51 % Investment holding Xingmu HK Limited Hong Kong November 2019 51 % Investment holding Nanjing Xinmu Information Technology Co., Ltd. (“Xingmu WFOE”) Nanjing, the PRC November 2019 51 % Technology development and sales of merchandise Xincheng (Shanghai) Information Technology Co., Ltd. (“Shanghai Xincheng”) Shanghai, the PRC November 2012 100 % Technology development and sales of merchandise Shanghai Yiqin Pets Products Co., Ltd. Shanghai, the PRC February 2013 100 % Technology development and sales of merchandise Consolidated VIEs Guangcheng (Shanghai) Information Technology Co., Ltd. Shanghai, the PRC November 2012 100 % Operates the Company’s own online e-commerce platform Nanjing Xingmu Biotechnology Co., Ltd. (“Nanjing Xingmu”) Nanjing, the PRC November 2019 51 % Biotechnology research and development Suzhou Taicheng Supply Chain Co., Ltd. (“Suzhou Taicheng”) Suzhou, the PRC June 2021 100 % Sales of merchandise Subsidiaries of VIEs Boqii (Shanghai) Information Technology Co., Ltd. Shanghai, the PRC August 2014 90 % Technology development Tianjing Guangcheng Information Technology Co., Ltd. Tianjin, the PRC June 2017 100 % Sales of merchandise Nanjing Cuida Biotechnology Co. Ltd.(“Cuida”) Nanjing, the PRC April 2017 70 % Biotechnology extension services Taizhou Xingmu Biotechnology Co., Ltd. Taizhou, the PRC November 2019 80 % Biotechnology research and development (b) Consolidated variable interest entities In order to comply with the PRC laws and regulations which prohibit or restrict foreign investments into companies involved in restricted businesses, the Company operates online platforms that provide internet information services and engages in other foreign-ownership-restricted businesses through certain PRC domestic companies (the PRC Domestic Companies, or the “VIEs”). The equity interests of the PRC Domestic Companies are held by certain management members of the Company or onshore nominees of certain investors of the Company (“Nominee Shareholders”), who act as nominee equity holders of the PRC Domestic Companies on behalf of Shanghai Xincheng and Xingmu WFOE, the Company’s wholly owned subsidiaries in the PRC (the “WFOEs”). The WFOEs entered into a series of contractual arrangements with the PRC Domestic Companies and their respective Nominee Shareholders (the “Contractual Arrangements”). These Contractual Agreements cannot be unilaterally terminated by the Nominee Shareholders or the PRC Domestic Companies. Through the Contractual Arrangements, the Nominee Shareholders have granted all their legal rights including voting rights and disposition rights of their equity interests in the PRC Domestic Companies to the WFOEs. The Nominee Shareholders do not have the power to direct the activities of the PRC Domestic Companies that most significantly impact their economic performance. The Nominee Shareholders do not have the obligation to absorb losses of the PRC Domestic Companies that could potentially be significant to them or the right to receive benefits from the PRC Domestic Companies that could potentially be significant to them. Accordingly, the PRC Domestic Companies are considered as variable interest entities of the Company, through the WFOEs. In accordance with Accounting Standards Codification (“ASC”) 810-10-25-38A, the Based on the above, the Company, through the WFOEs, is the ultimate primary beneficiary of the VIEs. Accordingly, the financial statements of the VIEs and their subsidiaries are consolidated in the Company’s consolidated financial statements. Loan Agreements Pursuant to the relevant loan agreements, the WFOEs have granted interest-free loans to the relevant Nominee Shareholders of the relevant VIEs with the sole purpose of providing funds necessary for the capital injection to the relevant VIEs. The loans can only be repaid by transfer of the equity interests of the relevant VIEs held by the Nominee Shareholders, and shall be repaid upon the occurrence of, among other events, the WFOEs exercise of their options to purchase the relevant VIEs’ equity interests under the Exclusive Option Agreements (refer to following section for further details). Any proceeds received by the Nominee Shareholders from transfer of the equity interests shall also be repaid to the WFOEs as part of the loan repayments. Other events that will lead to loan repayments include: the Nominee Shareholders receiving a written notice from the relevant PRC subsidiaries requesting loan repayments; the death or loss of capacity for civil conduct of the Nominee Shareholders; the Nominee Shareholders no longer acting as shareholders of the relevant VIEs or employees of the relevant VIEs, PRC subsidiaries or their related parties; the Nominee Shareholders being involved in criminal activities; or, any third party making a claim in an amount over RMB 500,000 against the Nominee Shareholders. The loans shall be considered fully repaid when the Nominee Shareholders have transferred all equity interests held by them to the WFOEs or a party designated by the WFOEs. The Loan Agreements shall remain valid until the Nominee Shareholders repaid the relevant loans to the WFOEs. Exclusive Option Agreements The Nominee Shareholders of the VIEs have granted the WFOEs the exclusive and irrevocable right to purchase or to designate one or more person(s) at their discretion to purchase part or all of the equity interests in the VIEs from the Nominee Shareholders for a purchase price at any time, subject to the lowest price permitted by PRC laws and regulations. The VIEs and their Nominee Shareholders have agreed that without prior written consent of the WFOEs, their respective Nominee Shareholders cannot sell, transfer, pledge or dispose their equity interests, and the VIEs cannot sell, transfer, pledge or dispose, but not limit to, the equity interests, significant assets, significant revenue and significant business. Also as agreed, the VIEs cannot declare any dividend or change capitalization structure of the VIEs and cannot enter into any loan or investment agreements. Furthermore, the Nominee Shareholders have agreed that any proceeds but not limited to the sales of the Nominee Shareholders’ equity interest in relevant VIEs should be gratuitously paid to the WOFEs or one or more person(s) at their discretion. The Exclusive Option Agreement will remain effective until all equity options in VIEs held by such Nominee Shareholders are transferred or assigned to the WFOEs or their designated representatives. Proxy Agreement and Power of Attorney Pursuant to the irrevocable power of attorney, each of the Nominee Shareholders appointed the WFOEs as their attorney-in-fact Exclusive Consultation and Service Agreements Pursuant to the Exclusive Consultation Service Agreements, the WFOEs have agreed to provide to the VIEs services, including, but not limited to, design and maintenance of the E-Commerce Intellectual Property License Agreements Pursuant to the intellectual property license agreements, the WFOEs have granted a non-exclusive non-transferable Equity Interest Pledge Agreements Pursuant to the relevant equity interest pledge agreements, the Nominee Shareholders of the VIEs have pledged 100% equity interests in relevant VIEs to the WFOEs to guarantee performance by the Nominee Shareholders of their obligations under the Exclusive Option Agreements, the Proxy Agreement and Power of Attorney and the Loan Agreements, as well as the performance by the VIEs of their obligations under the Exclusive Option Agreements, the Exclusive Consultation and Service Agreements and Intellectual Property License Agreements. In the event of a breach by the VIEs or any of their Nominee Shareholders of contractual obligations under the Contractual Agreements, as the case may be, the WFOEs, as pledgee, will have the right to dispose of the pledged equity interests in the relevant VIEs and will have priority in receiving the proceeds from such disposal. The Nominee Shareholders of the VIEs also covenant that, without the prior written consent of the WFOEs, they will not dispose of, create or allow any encumbrance on the pledged equity interests. The Equity Interest Pledge Agreements will remain in effect so long as any of the Loan Agreements, the Exclusive Consultation Service Agreements, the Exclusive Option Agreements, the Proxy Agreement and Power of Attorney, or the Intellectual Property License Agreements, as mentioned above, remains in effect or any guaranteed obligations of the VIEs, or, to the extent applicable, its Nominee Shareholders, remains outstanding under the Contractual Agreements. The pledge was registered with the relevant local administration and will remain binding until the VIEs and their Nominee Shareholders discharge all their obligations under the Contractual Arrangements. The registration of the equity pledge enables the WFOEs to enforce the equity pledge against third parties who acquire the equity interests of the VIEs in good faith. One set of existing Contractual Agreements were initially entered into in September 2012 by Shanghai Xincheng (one of the Company’s WOFEs), Shanghai Guangcheng (one of the Company’s VIEs) and its nominee shareholders, was subsequently amended and restated on substantially similar terms in September 2017, October 2019 and August 2020, respectively. Another set of existing Contractual Agreements were entered into in September 2019 by Xingmu WFOE (one of the Company’s WOFEs), Nanjing Xingmu (one of the Company’s VIEs) and its Nominee Shareholders. A new set of Contractual Agreements were entered into in June 2021 by Shanghai Xincheng (one of the Company’s WOFEs), Suzhou Taicheng (one of the Company’s VIEs) and its Nominee Shareholders. The Loan Agreements, Exclusive Option Agreements, Proxy Agreement and Power of Attorney, Exclusive Consultation and Service Agreements, Intellectual Property License Agreements and Equity Interest Pledge Agreements were amended to reflect the changes of shareholders’ holding in the VIE in their respective dates. No other material terms or conditions of these agreements were changed or altered. There was no impact to the Group’s effective control over the VIEs and the Group continues to consolidate the VIEs. (c) Risks in relations to the VIE structure Under the Contractual Agreements with the consolidated VIEs, the Company has the power to direct activities of the consolidated VIEs and VIEs’ subsidiaries through the Company’s relevant PRC subsidiaries, and can have assets transferred freely out of the consolidated VIEs and VIEs’ subsidiaries without restrictions. Therefore, the Company considers that there is no asset of the consolidated VIEs that can only be used to settle obligations of the respective consolidated VIEs, except for the registered capital of the consolidated VIEs amounting to RMB52 million and RMB62 million as of March 31, 2021 and 2022. Since the consolidated VIEs and VIEs’ subsidiaries are incorporated as limited liability companies under the PRC Law, creditors of the consolidated VIEs and VIEs’ subsidiaries do not have recourse to the general credit of the Company. The Company believes that the Company’s relevant PRC subsidiaries’ Contractual Arrangements with the consolidated VIEs and the Nominee Shareholders are in compliance with PRC laws and regulations, as applicable, and are legally binding and enforceable. However, uncertainties in the PRC legal system could limit the Company’s ability to enforce these contractual arrangements. In addition, if the current structure or any of the contractual arrangements were found to be in violation of any existing or future PRC law, the Company may be subject to penalties, which may include but not be limited to, the cancellation or revocation of the Company’s business and operating licenses, being required to restructure the Company’s operations or terminate the Company’s operating activities. The imposition of any of these or other penalties may result in a material and adverse effect on the Company’s ability to conduct its operations. In such case, the Company may not be able to operate or control the VIEs, which may result in deconsolidation of the VIEs. The following table set forth the assets, liabilities, results of operations and changes in cash, cash equivalents and restricted cash of the consolidated VIEs and their subsidiaries taken as a whole, which were included in the Company’s consolidated financial statements with intercompany transactions eliminated (RMB in thousands): As of March 31, 2021 2022 RMB RMB Cash and cash equivalents 17,886 20,567 Accounts receivable, net 27,393 31,435 Amounts due from related parties 11,465 11,726 Inventories, net 11,349 16,014 Prepayments and other current assets 33,445 57,107 Intra-Group receivables due from the Group’s entities 47,592 16,535 Property and equipment, net 8,372 6,715 Intangible assets 909 507 Operating lease right-of-use 27,736 35,688 Goodwill 494 994 Long-term investments 74,330 81,649 Other non-current 2,433 3,389 Total assets 263,404 282,326 As of March 31, 2021 2022 RMB RMB Short-term borrowings 3,484 872 Accounts payable 29,940 55,144 Amounts due to related parties, current 910 4 Salary and welfare payable 4,851 5,597 Accrued liabilities and other current liabilities 24,536 25,786 Contract liabilities 3,706 7,007 Operating lease liabilities, current 6,058 7,238 Intra-Group payables due to the Group’s entities 611,112 945,960 Deferred tax liabilities 1,852 (1,369 ) Operating lease liabilities, non-current 19,997 28,197 Long-term borrowings 872 — Other debts, non-current 415,122 157,874 Total liabilities 1,122,440 1,232,310 Year Ended March 31, 2020 2021 2022 RMB RMB RMB Net revenues: Third-party revenues 579,365 735,518 877,380 Intra-Group revenues 92,728 48,374 56,079 Total revenues 672,093 783,892 933,459 Cost of revenues: Third-party cost of revenues (226,958 ) (372,475 ) (160,661 ) Intra-Group cost of revenues (282,210 ) (297,844 ) (550,585 ) Total cost of revenues (509,168 ) (670,319 ) (711,246 ) Gross profit 162,925 113,573 222,213 Operating expenses: Third-party operating expenses (229,658 ) (254,951 ) (288,291 ) Intra-Group operating expenses — (7,257 ) — Total operating expenses (229,658 ) (262,208 ) (288,291 ) Other income, net 1,688 1,011 98 Loss from operations (65,045 ) (147,624 ) (65,980 ) Non-operating income /(expense) 3,236 (18,162 ) (20,680 ) Loss before income tax expenses (61,809 ) (165,786 ) (86,660 ) Income tax benefits/(expenses) 141 (20 ) 681 Share of results of equity investees (137 ) (696 ) 418 Net loss (61,805 ) (166,502 ) (85,561 ) Cash flows from operating activities: Net cash provided by transactions with external parties 126,224 419,767 526,201 Net cash used in transactions with the Group’s entities (104,125 ) (331,064 ) (329,325 ) Net cash generated from operating activities 22,099 88,703 196,876 Cash flows from investing activities: Other investing activities (64,591 ) (31,972 ) (18,482 ) Cash flows of loan funding provided to the Group’s entities, net of repayments received 21,156 (5,242 ) 6,294 Net cash used in investing activities (43,435 ) (37,214 ) (12,188 ) Cash flows from financing activities: Other financing activities 73,626 (112,151 ) (273,906 ) Cash flows of loan funding received from the Group’s entities, net of repayments made (29,398 ) 41,717 91,794 Net cash generated from/ (used in) financing activities 44,228 (70,434 ) (182,112 )

Principal Accounting Policies

Principal Accounting Policies	12 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
Principal Accounting Policies	2. Principal Accounting Policies (a) Basis of preparation The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”). Significant accounting policies followed by the Company in the preparation of the accompanying consolidated financial statements are summarized below. (b) Basis of consolidation The Company’s consolidated financial statements include the financial statements of the Company, its subsidiaries, the consolidated VIEs and VIEs’ subsidiaries for which the Company is the primary beneficiary. A subsidiary is an entity in which the Company, directly or indirectly, controls more than one half of the voting power, has the power to appoint or remove the majority of the members of the board of directors, to cast a majority of votes at the meeting of the board of directors or to govern the financial and operating policies of the investee under a statute or agreement among the shareholders or equity holders. A consolidated VIE is an entity in which the Company, or its subsidiaries, through Contractual Agreements, bears the risks of, and enjoys the rewards normally associated with, ownership of the entity, and therefore the Company or its subsidiaries are the primary beneficiary of the entity. All transactions and balances among the Company, its subsidiaries, the consolidated VIEs and VIEs’ subsidiaries have been eliminated upon consolidation . (c) Business combination and non-controlling The Company accounts for its business combinations using the acquisition method of accounting in accordance with Accounting Standards Codification (“ASC”) 805, Business Combinations non-controlling non-controlling In a business combination achieved in stages, the Company re-measures re-measurement When there is a change in ownership interests or a change in contractual arrangements that results in a loss of control of a subsidiary or consolidated VIE, the Company deconsolidates the subsidiary or consolidated VIE from the date control is lost. Any retained non-controlling For the Company’s consolidated subsidiaries, VIEs and VIEs’ subsidiaries, non-controlling Non-controlling (d) Use of estimates The preparation of the Company’s consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company believes that assessment for impairment of long-lived assets and valuation of available-for-sale Management bases the estimates on historical experience and on various other assumptions as discussed elsewhere to the consolidated financial statements that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. On an ongoing basis, management evaluates its estimates based on information that is currently available. Changes in circumstances, facts and experience may cause the Company to revise its estimates. Changes in estimates are recorded in the period in which they become known. Actual results could materially differ from these estimates. (e) Functional currency and foreign currency translation The Company’s reporting currency is Renminbi (“RMB”). The functional currency of the Company’s entities incorporated in Cayman Islands, British Virgin Islands and Hong Kong is the United States dollars (“US$”). The Company’s PRC subsidiaries, consolidated VIEs and VIEs’ subsidiaries determined their functional currency to be RMB. The determination of the respective functional currency is based on the criteria of ASC 830, Foreign Currency Matters Transactions denominated in other than the functional currencies are translated into the functional currency of the entity at the exchange rates prevailing on the transaction dates. Financial assets and liabilities denominated in other than the functional currency are translated at the balance sheet date exchange rate. The resulting exchange differences are included in the consolidated statements of comprehensive loss as foreign exchange related gains (losses), net. The financial statements of the Company are translated from the functional currency into RMB. Assets and liabilities denominated in foreign currencies are translated into RMB using the applicable exchange rates at the balance sheet date. Equity accounts other than earnings generated in current period are translated into RMB at the appropriate historical rates. Revenues, expenses, gains and losses are translated into RMB using the periodic average exchange rates. The resulting foreign currency translation adjustments are recorded in accumulated other comprehensive income (loss) as a component of shareholders’ equity. The exchange rates used for translation on March 31, 2021 and 2022 were US$1.00= RMB 6.5713 and RMB 6.3482, respectively, representing the index rates stipulated by the People’s Bank of China. (f) Convenience translation Translations of the consolidated balance sheets, the consolidated statements of comprehensive loss and the consolidated statements of cash flows from RMB into US$ as of and for the year ended March 31, 2022 are solely for the convenience of the readers and were calculated at the rate of US$1.00=RMB 6.3393, representing the certificated exchange rate published by the Federal Reserve Board. No representation is made that the RMB amounts could have been, or could be, converted, realized or settled into US$ at that rate on March 31, 2022, or at any other rate. (g) Fair value of financial instruments Accounting guidance defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and it considers assumptions that market participants would use when pricing the asset or liability. The established fair value hierarchy requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The three levels of inputs that may be used to measure fair value: Level 1: Quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2: Observable, market-based inputs, other than quoted prices, in active markets for identical assets or liabilities. Level 3: Unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities. Accounting guidance also describes three main approaches to measuring the fair value of assets and liabilities: (1) market approach; (2) income approach and (3) cost approach. The market approach uses prices and other relevant information generated from market transactions involving identical or comparable assets or liabilities. The income approach uses valuation techniques to convert future amounts to a single present value amount. The measurement is based on the value indicated by current market expectations about those future amounts. The cost approach is based on the amount that would currently be required to replace an asset. Financial assets and liabilities of the Company mainly consist of cash and cash equivalents, short-term investments, accounts receivable, amounts due from related parties, prepayments and other current assets, available-for-sale As of March 31, 2021 and 2022, except for available-for-sale non-current (h) Cash and cash equivalents Cash and cash equivalents include cash on hand and time deposits placed with banks and third party payment processors, which are unrestricted as to withdrawal or use, have original maturities of three months or less at the time of purchase and are readily convertible to known amounts of cash. (i) Short-term investments Short-term investments comprise primarily of (i) cash deposits at fixed rates with original maturities of greater than three months, but less than 12 months and; (ii) the investments issued by commercial banks or other financial institutions with a variable interest rate indexed to the performance of underlying assets within one year. As of March 31, 2022, RMB128 million short-term investments were used as collateral of RMB111 million short-term borrowings. (j) Accounts receivable, net Accounts receivable are presented net of allowance for doubtful accounts. The Company maintains an allowance for doubtful accounts which reflects its best estimate of amounts that potentially will not be collected. The Company determines the allowance for doubtful accounts on general basis taking into consideration various factors including but not limited to historical collection experience and credit-worthiness of the customers as well as the age of the individual receivables balance. Additionally, the Company makes specific bad debt provisions based on any specific knowledge the Company has acquired that might indicate that an account is uncollectible. The facts and circumstances of each account may require the Company to use substantial judgment in assessing its collectability. (k) Inventories Inventories are stated at the lower of cost and net realizable value. Cost elements of our inventories comprise the purchase price of products, vendor rebates, shipping charges to receive products from the suppliers when they are embedded in the purchase price. Cost is determined using the first-in first-out (l) Property and equipment, net Property and equipment are carried at cost less accumulated depreciation and amortization. Depreciation is calculated on a straight-line basis over the following estimated useful lives. The estimated useful lives are as follows: Useful years Warehouse equipment 3 - 5 years Furniture, computer and office equipment 3 - 5 years Vehicles 5 years Software 10 years Leasehold improvements Over the shorter of the expected life of leasehold improvements or the lease term Expenditures for maintenance and repairs are expensed as incurred. The gain or loss on the disposal of property and equipment is the difference between the net sales proceeds and the carrying amount of the relevant assets and is recognized in the consolidated statements of comprehensive loss. (m) Intangible assets, net Intangible assets purchased from third parties are initially recorded at cost. The Company performs valuation of the intangible assets arising from business combination to determine the relative fair value to be assigned to each asset acquired. The intangible assets are amortized using the straight-line method over the estimated useful lives of the assets. The estimated useful lives of intangible assets are as follows: Useful years Trademark 10 years Dealership 10 years License 4.5 years The estimated life of amortized intangibles is reassessed if circumstances occur that indicate the life has changed. (n) Goodwill Goodwill represents the excess of the purchase price over the fair value of the identifiable assets and liabilities acquired in a business combination. Goodwill is not depreciated or amortized but is tested for impairment on an annual basis as of March 31, and in between annual tests when an event occurs or circumstances change that could indicate that the asset might be impaired. In accordance with the FASB guidance on “Testing of Goodwill for Impairment”, a company first has the option to assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If the Company decides, as a result of its qualitative assessment, that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, the quantitative impairment test is mandatory. Otherwise, no further testing is required. The quantitative impairment test consists of a comparison of the fair value of each reporting unit with its carrying amount, including goodwill. If the carrying amount of each reporting unit exceeds its fair value, an impairment loss equal to the difference between the implied fair value of the reporting unit’s goodwill and the carrying amount of goodwill will be recorded. Application of a goodwill impairment test requires significant management judgment, including the identification of reporting units, assigning assets and liabilities to reporting units, assigning goodwill to reporting units, and determining the fair value of each reporting unit. The judgment in estimating the fair value of reporting units includes estimating future cash flows, determining appropriate discount rates and making other assumptions. Changes in these estimates and assumptions could materially affect the determination of fair value for each reporting unit. (o) Long-term investments The Company’s investments include equity method investments, equity securities with readily determinable fair values and available-for-sale The Company applies the equity method of accounting to account for an equity investment, in common stock or in-substance Equity securities with readily determinable fair values are measured and recorded at fair value on a recurring basis with changes in fair value, whether realized or unrealized, recorded through the income statement. Debt securities that the Company has the intent to hold the security for an indefinite period or may sell the security in response to the changes in economic conditions are classified as available-for-sale The Company continually reviews its investments to determine whether a decline in fair value to below the carrying value is other-than-temporary. The primary factors the Company considers in its determination are the duration and severity of the decline in fair value; the financial condition, operating performance and the prospects of the equity investee; and other company specific information such as recent financing rounds. If the decline in fair value is deemed to be other-than-temporary, the carrying value of the investment is written down to fair value. (p) Impairment of long-lived assets other than goodwill Long-lived assets are evaluated for impairment whenever events or changes in circumstances (such as a significant adverse change to market conditions that will impact the future use of the assets) indicate that the carrying amount may not be fully recoverable or that the useful life is shorter than the Company had originally estimated. When these events occur, the Company evaluates the impairment by comparing carrying value of the assets to an estimate of future undiscounted cash flows expected to be generated from the use of the assets and their eventual disposition. If the sum of the expected future undiscounted cash flows is less than the carrying value of the assets, the Company recognizes an impairment loss based on the excess of the carrying value of the assets over the fair value of the assets. (q) Revenue recognition In May 2014, the FASB issued ASU No. 2014-09, 2014-09”) 2014-09 No. 2014-09 The Company adopted ASC 606 for all periods presented. Consistent with the criteria of Topic 606, the Company follows five steps for its revenue recognition: (i) identify the contract(s) with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) the entity satisfies a performance obligation. Revenue arrangements with multiple performance obligations are divided into separate distinct goods or services. The Company allocates the transaction price to each performance obligation based on the relative standalone selling price of the goods or services provided. The Company’s revenues are primarily derived from (i) product sales and (ii) online marketing and information services and other service. When either party to a contract has performed, the Company presents the contract in the statement of financial position as a contract asset or a contract liabilities, depending on the relationship between the entity’s performance and the customer’s payment. A receivable is recorded when the Company has an unconditional right to consideration. A right to consideration is unconditional if only the passage of time is required before payment of that consideration is due. A contract asset is recorded when the Company has transferred products or services to the customer before payment is received or is due, and the Company’s right to consideration is conditional on future performance or other factors in the contract. No contract asset was recorded as of March 31, 2021 and 2022. The Company’s contract liabilities consist of payments received or awards to customers (in the form of Boqii Beans) related to unsatisfied performance obligations at the end of the period. As of April 1, 2020 and 2021, the Company’s total contract liabilities were RMB7.7 million and RMB3.9 million, respectively, of which RMB7.7 million and RMB3.6 million were recognized as revenue for the years ended March 31, 2021 and 2022. The Company’s total unearned revenue was RMB7.0 million as of March 31, 2022. Revenue is recorded net of value-added tax. Revenue recognition policies for each type of revenue steam are as follows: Sales of merchandise The Company primarily sells pet products through online stores to individual online customers. Besides online sales, the Company also sells products through offline channels to its business customers and pet stores across the country. The Company recognizes the product revenues from products sales on a gross basis as the Company is acting as a principal in these transactions. The Company has obtained control of the products before they are transferred to customers. The Company is primarily obligated in these transactions, is subject to inventory risk or has the ability to direct the use of inventory, and has latitude in establishing prices and selecting suppliers. Revenue is recognized when consumers physically accept the products after delivery, which is when the control of products is transferred, and is recorded net of return allowances and rebates to pet stores. The Company also enters into arrangement with its business partners to sell their products on the Company’s online stores. The Company considers the arrangement meet the indicators of consignment arrangement under ASC 606-10-55-80, Online marketing and information services and other revenue The Company provides online marketing and information services to third-party on the Company’s various channels and third-party platforms, including but not limited to advertising placements, organizing online and offline marketing campaigns featuring social media influencers and circulating marketing messages to end consumers. With respect to the Company’s marketing services, length of the periods over which services are provided are generally within months or less, revenue from such arrangements is recognized ratably over the service period, as the third-party simultaneously consumes the benefits when the advertisement is displayed or the campaign is ongoing. The Company also provides warehouse services. The warehouse services include warehousing, packaging, dispatching and other services. Revenue is primarily recognized when the services are rendered. (r) Sales returns The Company offers online consumers an unconditional right of return for a period of seven days upon receipt of products. Return allowances, which reduce revenue and cost of sales, are estimated by categories of return policies offered to online customers, based on historical data the Company has maintained, and subject to adjustments to the extent that actual returns differ or are expected to differ. (s) Sales incentives The Company adopted a customer reward program, under which the Company grants certain units (“Boqii Bean”) to its customers at its discretion in different situations. Boqii Beans are not redeemable for cash and can be used as a coupon for the customer’s future purchase on the Boqii Marketplace and Boqii.com. The value of ten units of Boqii Bean is equivalent to one RMB yuan before taking into account the impact of breakage. For the Boqii Beans that are granted with concurrent revenue transactions, the allocated transaction price based on its relative standalone selling price are recognized as reduction of the revenue and accrued for as contract liabilities. As customers redeem awards, the accrued liability is reduced correspondingly. For the Boqii Beans that are granted without concurrent revenue transactions, they are not accounted for when granted and are recognized as a reduction of revenue when they are applied in future sales. The Company also has a coupon program, through which the Company grants coupons to online customers when they make a successful purchase order, finish first registration on Boqii Marketplace or comment on products. When a coupon is granted concurrent with a revenue transaction, the Company accounts for the estimated cost of future usage of the coupon as reduction of the revenue. When a coupon is not granted concurrent with a revenue transaction, they are not accounted for when they are granted and are recognized as a reduction of revenue when they are applied in future sales. (t) Cost of revenue Cost of revenue consist of cost of product sales of RMB610.6 million, RMB820.3 million and RMB930.4 million for the years ended March 31, 2020, 2021 and 2022, respectively, and cost of services of RMB0.9 million, RMB3.4 million and RMB13.3 million for the years ended March 31, 2020, 2021 and 2022, respectively. Cost of product sales comprise the purchase price of products, vendor rebates and inventory write-downs. Cost of products does not include other direct costs related to cost of product sales such as shipping and handling expense, payroll and benefits of logistic staff, logistic centers rental expenses and depreciation expenses. Cost of service consists of the advertising and promotion costs, employee wages and benefits in connection with the Company’s provision of marketing and information services including the fees that the Company paid to third party for advertising and promotion on various online and offline channels. (u) Vendor rebates The Company periodically receives consideration from certain vendors, representing rebates for products sold over a period of time. The Company accounts for the rebates received from its vendors as a reduction to the price it pays for the products purchased. Rebates are earned based on reaching minimum purchased thresholds for a specified period. When volume rebates can be reasonably estimated based on the Company’s past experience, current forecasts and purchase volume, a portion of the rebate is recognized as the Company makes progress towards the purchase threshold. (v) Fulfillment expenses Fulfillment costs primarily represent warehousing, shipping and handling expenses for dispatching and delivering products to consumers, employee wages and benefits for the relevant personnel, customs clearance expenses and other related transaction costs. (w) Sales and marketing expenses Sales and marketing expenses comprise primarily of advertising expenses, third-party platforms commission fee, employee wages, rental expenses and benefits for sales and marketing staff, depreciation expenses and other daily expenses which are related to the sales and marketing functions. Advertising expenses consist primarily of customer acquisition cost and costs for the promotion of corporate image and product marketing. The Company expenses all advertising costs as incurred and classifies these costs under sales and marketing expenses. For the years ended March 31, 2020, 2021 and 2022, the advertising expenses were RMB69 million, RMB83 million and RMB81 million, respectively. (x) General and administrative expenses General and administrative expenses consist of employee wages and benefits for corporate employees, research and development expenses and other expenses which are related to the general corporate functions, including accounting, finance, tax, legal and human resources, costs associated with use by these functions of facilities and equipment, such as depreciation expenses, rental and other general corporate related expenses. (y) Leases The Company determines if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use non-current ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. When determining the lease term, the Company includes options to extend or terminate the lease when it is reasonably certain that it will exercise that option, if any. As the Company’s leases do not provide an implicit rate, the Company uses its incremental borrowing rate, which it calculates based on the credit quality of the Company and by comparing interest rates available in the market for similar borrowings, and adjusting this amount based on the impact of collateral over the term of each lease. The Company has elected to early adopt the following lease policies in conjunction with the adoption of ASU 2016-02 non-lease non-lease (z) Government grant The Company’s PRC based subsidiaries received government subsidies from certain local governments. The Company’s government subsidies consisted of specific subsidies and other subsidies. Specific subsidies are subsidies that the local government has provided for a specific purpose, such as product development and renewal of production facilities. Other subsidies are the subsidies that the local government has not specified its purpose for and are not tied to future trends or performance of the Company; receipt of such subsidy income is not contingent upon any further actions or performance of the Company and the amounts do not have to be refunded under any circumstances. The Company recorded specific purpose subsidies as advances payable when received. For specific subsidies, upon government acceptance of the related project development or asset acquisition, the specific purpose subsidies are recognized to reduce related cost of asset acquisition. Other subsidies are recognized as other income upon receipt as further performance by the Company is not required. (aa) Income taxes Current income taxes are recorded in accordance with the regulations of the relevant tax jurisdiction. The Company accounts for income taxes under the asset and liability method in accordance with ASC 740, Income Tax Uncertain tax positions The Company recognizes in its consolidated financial statements the benefit of a tax position if the tax position is “more likely than not” to prevail based on the facts and technical merits of the position. Tax positions that meet the “more likely than not” recognition threshold are measured at the largest amount of tax benefit that has a greater than fifty percent likelihood of being realized upon settlement. The Company estimates its liability for unrecognized tax benefits which are periodically assessed and may be affected by changing interpretations of laws, rulings by tax authorities, changes and/or developments with respect to tax audits, and expiration of the statute of limitations. The ultimate outcome for a particular tax position may not be determined with certainty prior to the conclusion of a tax audit and, in some cases, appeal or litigation process. The actual benefits ultimately realized may differ from the Company’s estimates. As each audit is concluded, adjustments, if any, are recorded in the Company’s consolidated financial statements in the period in which the audit is concluded. Additionally, in future periods, changes in facts, circumstances and new information may require the Company to adjust the recognition and measurement estimates with regard to individual tax positions. Changes in recognition and measurement estimates are recognized in the period in which the changes occur. As of March 31, 2021 and 2022, the Company did not have any significant unrecognized uncertain tax positions. (ab) Share-based compensation The Company follows ASC 718 to determine whether a share option should be classified and accounted for as a liability award or equity award. All grants of share-based awards to employees, management and nonemployees classified as equity awards are recognized in the financial statements based on their grant date fair values which are calculated using an option pricing model. Employees’ share-based compensation awards are measured at the grant date fair value of the awards and recognized as expenses (a) immediately at the grant date if no vesting conditions are required; or (b) for share-based awards granted with only service conditions, using the graded vesting method, net of estimated forfeitures, over the vesting period; or (c) for share-based awards granted with service conditions and the occurrence of an initial public offering (“IPO”) as performance condition, cumulative share-based compensation expenses for the options that have satisfied the service condition should be recorded upon the completion of the IPO, using the graded vesting method. Under ASC 718, the Company applies the Binominal option pricing model in determining the fair value of options granted. ASC 718 requires forfeiture rates to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from initial estimates. Share-based compensation expense is recorded net of estimated forfeitures such that expense is recorded only for those share-based awards that are expected to vest. (ac) Net loss per share Basic net loss per share is computed by dividing net loss attributable to holders of ordinary shares by the weighted average number of ordinary shares outstanding during the year using the two-class method. Using the two-class method, net profit/loss is allocated between ordinary shares and other participating securities (i.e. preferred shares) based on their participating rights. Diluted loss per share is calculated by dividing net loss attributable to ordinary shareholders as adjusted for the effect of dilutive ordinary equivalent shares, if any, by the weighted average number of ordinary and dilutive ordinary equivalents shares outstanding during the year/period. Ordinary share equivalents consist of the ordinary shares issuable in connection with the Company’s convertible redeemable preferred shares using the if-converted (ad) Comprehensive loss Comprehensive loss is defined as the changes in shareholders’ equity of the Company during a period transactions and other events and circumstances excluding transactions resulting from investments from shareholders, distributions to shareholders, accretions on convertible redeemable preferred shares and modification and extinguishment of convertible redeemable preferred shares. Comprehensive loss for the periods presented includes net loss and foreign currency translation adjustments. (ae) Segment reporting ASC 280, Segment Reporting Based on the criteria established by ASC 280, the Company’s chief operating decision maker (“CODM”) has been identified as the Chief Executive Officer, who reviews consolidated results when making decisions about allocating resources and assessing performance of the Company. As a whole and hence, the Company has only one reportable segment. The Company does not distinguish between markets or segments for the purpose of internal reporting. As the Company’s long-lived assets are substantially located in the PRC and substantially all the Company’s revenue are derived from within the PRC, no geographical segments are presented. (af) Recent accounting pronouncements The Company qualifies as an “emerging growth company”, or EGC, pursuant to the Jumpstart Our Business Startups Act of 2012, as amended, or the JOBS Act. As an EGC, the Company does not need to comply with any new or revised financial acc

Business combinations

Business combinations	12 Months Ended
	Mar. 31, 2022
Business Combinations [Abstract]
Business combinations	3. Business combinations For the year ended March 31, 2022, the Company has completed the below business combination. The results of the acquired entities’ operations have been included in the Company’s consolidated financial statements since their respective dates of acquisition. (a) Chongni Network Technology (Shanghai) Co., Ltd (“Chongni Network”) In October 2018, the Company acquired 49% equity interest of Chongni Network, an offline trading company incorporated in the PRC. According to the investment agreement, the Company was entitled to appoint a director to Chongni Network (out of total three board seats). The Company accounted this investment using equity method. In May 2021, the Company entered into an agreement with Chongni to purchase additional equity interest of Chongni Network with total cash consideration of RMB2.9 million. Upon the acquisition of additional interests in Chongni Network, on June 30, 2021, the date of acquisition, the Company’s equity interests in Chongni network was increased fr om 49% to 63.65% with the right to appoint 2 out of 3 of Chongni Network’s board of directors, and have obtained control over Chongni Network thereon . The Company accounted for this transaction as a step acquisition with the total purchase consideration of RMB3.2 million, which included the cash consideration of RMB2.9 million, and the fair value of the previously held 49% equity interest of Chongni N loss and comprehensive loss for the year ended March 31, 2022. The fair value of the previously held equity interests was estimated based on the acquisition price of the additional interests of Chongni Network. On the acquisition date, the allocation of the purchase price of the assets acquired and liabilities assumed based on their fair values was as follows: As of June 30, 2021 RMB Total purchase price is comprised of: - fair value of 49% previously held equity interests 245 - cash consideration 2,938 Fair value of total consideration 3,183 Cash and cash equivalents 2 Prepayments and other current assets 4,533 Total assets 4,535 Accrued liabilities and other current liabilities (33 ) Total liabilities (33 ) Net assets acquired 4,502 Goodwill 499 Non-controlling (1,818 ) Total 3,183 The acquired business contributed revenues of nil and loss of RMB million to the Company for the period from June 30, 2021 to March 31, 2022. Pro forma results of operations for the acquisition ha ve not been presented because they are not material to the consolidated statements of comprehensive losses for the year ended March 31, 2021 and 2022.

Risks and Concentration

Risks and Concentration	12 Months Ended
	Mar. 31, 2022
Risks and Uncertainties [Abstract]
Risks and Concentration	4. Risks and Concentration (a) Foreign currency exchange rate risk The Company may experience economic losses and negative impacts on earnings and equity as a result of fluctuations in the exchange rate between the US$ and the RMB. The depreciation of RMB against US$ was approximately 6.3% in 2020. The depreciation of RMB against US$ was approximately 2.3% in 2021. It is difficult to predict how market forces or the PRC or the U.S. government policy may impact the exchange rate between RMB and US$ in the future. (b) Interest rate risk Interest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company’s interest rate risk arises primarily from long-term borrowings. Borrowings issued at variable rates and fixed rates expose the Company to cash flow interest rate risk and fair value interest rate risk respectively. (c) Concentration of credit risk Financial instruments that potentially subject the Company to the concentration of credit risks consist of cash and cash equivalents, short-term investment, accounts receivable and amounts due from related parties. The maximum exposures of such assets to credit risk are their carrying amounts as of the balance sheet dates. The Company deposits its cash and cash equivalents and short-term investment with financial institutions located in jurisdictions where the subsidiaries are located. The Company believes that no significant credit risk exists as these financial institutions have high credit quality. Accounts receivable are typically unsecured and are derived from revenue earned through third-party consumers. The Company conducts credit evaluations of third-party customers and related parties, and generally does not require collateral or other security from its third-party customers and related parties. The Company establishes an allowance for doubtful accounts primarily based upon the age of the receivables and factors surrounding the credit risk of specific third-party customers and related parties. (d) Concentration of customers and suppliers Substantially all revenue was derived from customers located in China. There are no customers from whom revenues individually represent greater than 10% of the total revenues of the Company in any of the periods presented. The information of the supplier with greater than 10% of the total purchases of the Company for the years ended March 31, 2020, 2021 and 2022 was as follows: Year Ended March 31, 2020 Year Ended March 31, 2021 Year Ended March 31, 2022 RMB RMB RMB Royal Canin China Co., Ltd. 24 % 19 % 17 %

Cash and cash equivalents

Cash and cash equivalents	12 Months Ended
	Mar. 31, 2022
Cash and Cash Equivalents [Abstract]
Cash and cash equivalents	5. Cash and cash equivalents Cash and cash equivalents represent cash on hand and demand deposits placed with banks and third party-payment processors, which are unrestricted as to withdrawal or use. Cash and cash equivalents balance as of March 31, 2021 and March 31, 2022 primarily consist of the following currencies: As of March 31, 2021 As of March 31, 2022 RMB RMB Amount equivalent Amount equivalent RMB 121,670 121,670 47,321 47,321 Hong Kong dollars 25 21 39 31 US$ 25,947 170,508 18,133 115,110 EUR 5 38 55 392 NZD — — — 1 Total 292,237 162,855

Accounts receivable, net

Accounts receivable, net	12 Months Ended
	Mar. 31, 2022
Receivables [Abstract]
Accounts receivable, net	6. Accounts receivable, net Accounts receivable consist of the following: As of March 31, As of March 31, 2021 2022 RMB RMB Accounts receivable - Product sales 37,429 42,070 Accounts receivable - Online marketing and information service and other service 8,559 7,630 Allowance of doubtful accounts (256 ) (469 ) Total 45,732 49,231 Movement of allowance of doubtful accounts As of March 31, As of March 31, As of March 31, 2020 2021 2022 RMB RMB RMB At beginning of year 92 363 256 Addition/(reversal) 271 (107 ) 213 At end of year 363 256 469

Inventories, net of inventory r

Inventories, net of inventory reserves	12 Months Ended
	Mar. 31, 2022
Inventory Disclosure [Abstract]
Inventories, net of inventory reserves	7. Inventories, net of inventory reserves Inventories, net of inventory reserves consist of the following: As of March 31, As of March 31, 2021 2022 RMB RMB Products 90,913 109,383 Packaging materials and others 638 538 Total inventories, net of inventory reserves 91,551 109,921 Movement of inventory provision: As of March 31, As of March 31, As of March 31, 2020 2021 2022 RMB RMB RMB At beginning of year 527 273 266 Provision/(reversal) (254 ) (7 ) 311 At end of year 273 266 577 The total amounts charged to the consolidated statements of comprehensive loss for (reversal)/provision of inventory reserves amounted to approximately RMB(0.25) million, RMB(0.007) million and RMB0.31 million for the years ended March 31, 2020, 2021 and 2022, respectively.

Prepayments and other current a

Prepayments and other current assets	12 Months Ended
	Mar. 31, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Prepayments and other current assets	8. Prepayments and other current assets The prepayments and other current assets consist of the following: As of March 31, As of March 31, RMB RMB Prepayments for purchases of products (a) 53,209 52,348 Vendor rebate receivables (b) 8,723 24,462 Value-added tax (“VAT”) deductible (c) 10,672 18,864 Loan receivables (d) 3,957 3,845 Sales return assets 1,244 1,264 Deposits 1,456 1,312 Others 6,000 14,643 Total 85,261 116,738 (a) Prepayments for purchases of products represent cash prepaid to the Company’s third-party brand partners for the procurement of products. (b) Vendor rebate receivables represent the rebates to be received by the Company from its suppliers after certain levels of purchases are achieved. (c) VAT recoverable represents the balances that the Company can utilize to deduct its value-added tax liabilities within the next 12 months. (d) The balance represents loan receivables due from certain third-party companies and individuals. From April 2020 to October 2021, the Company entered into several loan agreements with aggregate principal amount of RMB4.93 million. The repayment terms of the loan agreements were ranged from 12 months and 24 months with due dates from July 2021 to October 2022. The interest rates were ranged from 0% to 4% per annum. As of March 31, 2021 and 2022, the balances of loan receivables were RMB4 million and RMB3.8 million, respectively.

Property and equipment, net

Property and equipment, net	12 Months Ended
	Mar. 31, 2022
Property, Plant and Equipment [Abstract]
Property and equipment, net	9. Property and equipment, net Property and equipment consist of the following: As of March 31, As of March 31, RMB RMB Cost: Warehouse equipment 2,513 2,669 Furniture, computer and office equipment 6,592 7,503 Vehicles 2,891 3,684 Leasehold improvement 10,056 10,209 Software 2,709 2,995 Total cost 24,761 27,060 Less: Accumulated depreciation (16,375 ) (19,281 ) Property and equipment, net 8,386 7,779 The total amounts charged to the consolidated statements of comprehensive loss for depreciation and amortization expenses amounted to approximately RMB2.66 million, RMB3.08 million and RMB3.7 million for the years ended March 31, 2020, 2021 and 2022, respectively.

Intangible assets, net

Intangible assets, net	12 Months Ended
	Mar. 31, 2022
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Intangible assets, net	10. Intangible assets, net Intangible assets of the Company were mainly as follows: As of March 31, As of March 31, RMB RMB Cost: Trademark 447 437 License 3,530 3,530 Dealership 31,717 31,717 Total cost 35,694 35,684 Less: Accumulated amortization (6,157 ) (10,140 ) Intangible assets, net 29,537 25,544 License and dealership resulting from the business combinations completed during the year ended March 31, The total amortization expenses of the intangible assets charged to the consolidated statements of comprehensive loss amounted to approximately RMB1.92 million, RMB4.00 million and RMB4.00 million for the years ended March 31, 2020, 2021 and 2022, respectively. The annual estimated amortization expense for intangible assets subject to amortization for the succeeding five years is as follows: As of March 31, 2023 2024 2025 2026 2027 Amortization expenses 4,000 3,867 3,438 3,207 3,203

Long-Term Investments

Long-Term Investments	12 Months Ended
	Mar. 31, 2022
Long-term Investments and Receivables, Net [Abstract]
Long-term investments	11. Long-term investments The Company’s long-term investments consist of the following: As of March 31, As of March 31, RMB RMB Equity method investments 2,973 6,783 Available-for-sale 71,357 74,866 Equity securities with readily determinable fair values — 670 Total 74,330 82,319 Equity method investments The Company applies equity method in accounting for its investments in entities in which the Company has the ability to exercise significant influence but does not have control. As of March 31, 2021 and 2022, the carrying value of the equity method investments were RMB3.0 million and RMB6.8 million respectively, the change of which primarily relates to the equity gain recognized and the following investment which was accounted for as equity method investment: In May 2021, the Company invested in Weishi (Shanghai) Network Co. Ltd MB RMB0.5 million has been paid, RMB0.5 million will be paid within one year and was recorded in accrued liabilities and other current liabilities, RMB1.5 million will be paid after one year and was recorded in other debt , non-current . As the Company is able to exercise significant influence in the form of ordinary shares of the investee, the Company therefore accounts for this investment under the equity method of accounting. Available-for-sale The following table summarizes the Company’s available-for-sale Cost Gross unrealized gains Gross unrealized losses Fair value Unlisted debt securities 60,000 11,357 — 71,357 The following table summarizes the Company’s available-for-sale Cost Gross unrealized gains Gross unrealized losses Fair value Unlisted debt securities 76,000 — (1,134 ) 74,866 In October 2017, the Company purchased 7.2% shareholding of Qingdao Shuangan Biotechnology Co., Ltd (“Qingdao Shuangan”) with a cash consideration of RMB10 million. According to the investment agreement, the Company is entitled to demand redemption after 48 months from the transaction closing date. As of March 31, 2021 and 2022, based on the valuation results, the Company re-measured In October 2019, the Company purchased 23.64% shareholding of Beijing Petdog Technology Development Co., Ltd. (“Beijing Petdog”) with a cash consideration of RMB50 million. According to the investment agreement, the Company is entitled to demand redemption after 60 months from the transaction closing date. As of March 31, 2021 and 2022, based on the valuation results, the Company re-measured Available-for-sale In July and November 2021, the Company entered into investment agreements with Jiangsu Nanjing Agricultural University Animal Pharmaceutical Co., Ltd. (“Nanjing Animal Pharmaceutical”). The Company provided Nanjing Animal Pharmaceutical one-year re-measured Equity securities with readily determinable fair values The following table summarizes the Company’s equity securities with readily determinable fair values as of March 31, 2022: Cost Gross unrealized gains Gross unrealized losses Fair value L 1,292 — (622 ) 670 In June 2021, the Company purchased 40,000 ordinary shares of Better Choice Company Inc. (“BTTR”), a company registered on NYSE American and engaging in selling pet products with a total cash consideration of US$200,000. The Company measured and recorded the investment at fair value on a recurring basis with changes in fair value, whether realized or unrealized, recorded through the income statement. The change of fair value is reported in other gains (losses), net.

Goodwill

Goodwill	12 Months Ended
	Mar. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	12. Goodwill The goodwill of RMB40 million and RMB41 million as of March 31, 2021 and 2022 represented the goodwill generated from the acquisitions of Cuida, Xingmu and Chongni Network (see Note 3). The businesses of Cuida, Xingmu and Chongni Network were fully integrated into the Company after those acquisitions. As of March 31, 2021 and 2022, the Company performed a qualitative assessment by evaluating relevant events and circumstances that would affect the Company’s single reporting unit and did not note any indicator that it is more likely than not that the fair value of the Company’s reporting unit is less than its carrying amount, and therefore the Company’s goodwill was not impaired. The changes in the carrying amount of goodwill were as follows: Total RMB Balance as of March 31, 2020 Goodwill 40,184 Accumulated impairment loss — 40,184 Balance as of March 31, 2021 Goodwill 40,184 Accumulated impairment loss — 40,184 Transaction during the year Additions (Note 3) 500 Balance as of March 31, 2022 Goodwill 40,684 Accumulated impairment loss — 40,684

Other non-current Assets

Other non-current Assets	12 Months Ended
	Mar. 31, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Other non-current Assets	13. Other non-current As of March 31, As of March 31, RMB RMB Deposits (a) 3,767 3,924 Long-term loan receivables (b) 344 937 4,111 4,861 (a) Deposits mainly consisted of rental deposits and deposit for online stores operated on third party platforms, which will be collected after one year. (b) From December 2019 to December 2021, the Company entered into interest free loan agreements with three third parties for total principal amounts of RMB1.2 million. The repayment terms of the loan agreements were ranged from 24 months to 42 months with due dates from June 2023 to December 2023. As of March 31, 2021 and 2022, the balances of long-term loan receivables were RMB0.3 million and RMB0.9 million, respectively.

Accrued liabilities and other c

Accrued liabilities and other current liabilities	12 Months Ended
	Mar. 31, 2022
Accrued Liabilities and Other Liabilities [Abstract]
Accrued liabilities and other current liabilities	14. Accrued liabilities and other current liabilities Accrued liabilities and other current liabilities consist of the following: As of March 31, As of March 31, RMB RMB Logistics expenses payables 16,594 14,625 Advances from customers 3,534 3,773 Payable for investment (Note (11)) — 2,563 Refund obligation of sales returns 1,543 1,411 Professional service fee accruals 3,449 579 Accrued advertising expenses 228 150 Others 4,707 4,223 Total 30,055 27,324

Leases

Leases	12 Months Ended
	Mar. 31, 2022
Leases [Abstract]
Leases	15. Leases As of March 31, 2021 and 2022, the Company has operating leases recorded on its consolidated balance sheet for certain office spaces and facilities that expire on various dates through 2026. The Company does not plan to cancel the existing lease agreements for its existing facilities prior to their respective expiration dates. When determining the lease term, the Company considers options to extend or terminate the lease when it is reasonably certain that it will exercise or not exercise that option. All of the Company’s leases qualify as operating leases. As of March 31, As of March 31, RMB RMB Assets Operating lease right-of-use 29,234 38,567 Liabilities Operating lease liabilities, current 8,063 10,001 Operating lease liabilities, non-current 19,997 28,197 Total operating lease liabilitie s 28,060 38,198 Weighted average remaining lease term (years) 3.70 3.61 Weighted average discount rate 6.47 % 4.95 % Information related to operating lease activity during the years ended March 31, 2020, 2021 and 2022 are as follows: Year ended March 31, 2020 Year ended March 31, 2021 Year ended March 31, 2022 RMB RMB RMB Operating lease right-of-use 10,051 25,970 21,038 Operating lease related expenses Amortization of right-of-use 15,708 11,687 11,705 Interest of lease liabilities 1,353 1,596 1,949 17,061 13,283 13,654 Year ended March 31, 2020 Year ended March 31, 2021 Year ended March 31, 2022 RMB RMB RMB Operating lease payments (included in measurement of lease liabilities) 18,183 12,850 12,849 Maturities of lease liabilities were as follows: Year ended March 31, 2022 RMB For the year ending March 31, 2023 11,311 2024 10,273 2025 11,051 2026 7,546 2027 1,299 Total lease payments 41,480 Less: imputed interest (3,282 ) Total 38,198

Interest expense

Interest expense	12 Months Ended
	Mar. 31, 2022
Interest and Debt Expense [Abstract]
Interest expense	16. Interest expense Year ended March 31, 2020 Year ended March 31, 2021 Year ended March 31, 2022 RMB RMB RMB Amortization charges on promissory notes 56,290 21,611 17,144 Interest expense on borrowings 2,815 6,039 3,740 Others 163 — — Total 59,268 27,650 20,884

Other gains (losses), net

Other gains (losses), net	12 Months Ended
	Mar. 31, 2022
Other Income and Expenses [Abstract]
Other gains (losses), net	17. Other gains (losses), net Year ended March 31, 2020 Year ended March 31, 2021 Year ended March 31, 2022 RMB RMB RMB Gain from the re-measurement of the previously held equity 481 — 127 Foreign exchange losses, net (3,787 ) (2,867 ) 5,322 Gain on disposal of other debts (Note 22) 10,095 6,846 — Reimbursement from a depositary bank (a) — 6,556 1,482 Investment loss (Note 11) — — (622 ) Others 195 797 (289 ) 6,984 11,332 6,020 (a) The Company received a reimbursement of US$1.0M (equivalent to RMB6.6 million) and US$0.2M (equivalent to RMB1.5 million) from the depository for the establishment and maintenance of the ADS program for the years ended March 31, 2021 and March 31, 2022.

Income taxes

Income taxes	12 Months Ended
	Mar. 31, 2022
Income Tax Disclosure [Abstract]
Income taxes	18. Income taxes Cayman Islands Under the current tax laws of Cayman Islands, the Company and its subsidiaries incorporated in the Cayman Islands are not subject to tax on income or capital gain. Additionally, the Cayman Islands does not impose a withholding tax on payments of dividends to shareholders. Hong Kong Under the current Hong Kong Inland Revenue Ordinance, the Company’s subsidiaries incorporated in Hong Kong are subject to a two-tiered to income tax. China On July 25, 2018, Boqii (Shanghai) Information Technology Co., Ltd. (“Shanghai Boqii”) was entitled to be “Software Enterprises”. According to the Enterprise Income Tax (“EIT”) Law and relevant regulations in the PRC, from the year of 2018 In addition, Shanghai Boqii was also qualified as a “High and New Technology Enterprise (“HNTE”) on August 29, 2019, and is eligible to enjoy a preferential tax rate of from 2019 to 2024 to the extent it has taxable income under the EIT Law, as long as it maintains the HNTE qualification and duly conducts relevant EIT filing procedures with the relevant tax authority. Shanghai Boqii can re-apply for the HNTE certificate when the prior certificate expires. Whilst Shanghai Boqii was entitled to the tax preferential treatments under both “HNTE” and “Software Enterprises”, Shanghai Boqii chose to apply the preferential tax rate of “Software Enterprises”. For the years ended March 31, 2020, 2021 and 2022, Shanghai Boqii was subject to EIT rate at 0%, 12.5% and 12.5%, respectively. The Company’s other subsidiaries, VIEs and VIEs’ subsidiaries established in the PRC are subject to the PRC general income tax rate of Reconciliations of the differences between the income tax expenses of the Company and the PRC statutory EIT rate applicable to losses of the consolidated entities are as follows: Year ended March 31, 2020 Year ended March 31, 2021 Year ended March 31, 2022 RMB RMB RMB Loss before income taxes (175,925 ) (193,391 ) (134,812 ) Income tax computed at respective applicable tax rate s (43,981 ) (48,348 ) (33,702 ) Effect of different tax jurisdiction 19,507 14,272 2,341 Super deduction for research and development expenses (a) (4,719 ) (2,632 ) (1,881 ) Non-deductible 138 140 97 Change in valuation allowance 29,567 37,439 34,716 Total 512 871 1,571 (a) According to the relevant laws and regulations promulgated by the State Administration of Tax of the PRC, from 2018 onwards, enterprises engaging in research and development activities are entitled to claim 175% of their qualified research and development expenses so incurred as tax deductible expenses. The additional deduction of 75% of qualified research and development expenses (the “Super Deduction”) can be directly claimed in the annual EIT filing. For the years end March 31, 2020, 2021 and 2022, the Super Deduction for research and development expenses available to the Company amounted to The provisions for income taxes for the years ended March 31, 2020, 2021 and 2022 differ from the amounts computed by applying the EIT primarily due to change in valuation allowance provided and tax differential from certain subsidiaries with preferential tax rates of the Company. The following table sets forth the effect of tax holiday effect on China operations: Year ended March 31, 2020 Year ended March 31, 2021 Year ended March 31, 2022 RMB RMB RMB Tax holiday effect (5,471 ) 1,074 3,513 Basic and diluted net loss per share effect (0.25 ) 0.02 0.05 Reconciliations between the effective income tax rate and the PRC statutory income tax rates are as follows: Year ended March 31, 2020 Year ended March 31, 2021 Year ended March 31, 2022 RMB RMB RMB PRC statutory income tax rates 25 % 25 % 25 % Tax holiday effec t (3 %) 1 % 3 % Difference in tax rates of subsidiaries outside PRC (8 %) (8 %) (8 %) Super deduction for research and development expenses 3 % 1 % 1 % Non-deductible 0 % 0 % 0 % Change in valuation allowance (17 %) (19 %) (20 %) Effective income tax rate 0 % 0 % 1 % Composition of income tax expenses The current and deferred portions of income tax expenses included in the consolidated statements of comprehensive loss are as follows: Year ended March 31, 2020 Year ended March 31, 2021 Year ended March 31, 2022 RMB RMB RMB Current income tax expense/(benefit) 149 1,018 (582 ) Deferred tax expense/(benefit) (661 ) (1,889 ) (989 ) Income tax credit, net (512 ) (871 ) (1,571 ) Deferred tax assets and deferred tax liabilities Deferred taxes were measured using the enacted tax rates for the periods in which they are expected to be reversed. The tax effects of temporary differences that give rise to the deferred tax asset and liabilities balances as of March 31, 2021 and 2022 are as follows: As of March 31, As of March 31, RMB RMB Deferred tax assets: Net accumulated loss-carry forward 143,426 172,059 Deferred deductible advertising expense 940 2,483 Allowance 130 78 Contract liabilities 413 419 Accruals 5,069 2,208 Less: Valuation allowance (149,978 ) (177,247 ) — — Deferred tax liabilities: Recognition of intangible assets arising from asset acquisition and business combination (6,119 ) (5,130 ) Unrealized fair value change of the available-for-sale (2,839 ) 283 Net deferred tax liabilities (8,958 ) (4,847 ) As of March 31, 2021 and 2022, the PRC entities of the Company had tax loss carryforwards of approximately RMB574 million and RMB688 million respectively, which can be carried forward to offset taxable income. The carryforwards period for net operating losses under the EIT Law is five years. The net operating loss carry forward of the Company will expire in varying amounts between 2023 and 2027. Other than the expiration, there are no other limitations or restrictions upon the Company’s ability to use these operating loss carryforwards. Valuation allowance is provided against deferred tax assets when the Company determines that it is more likely than not that the deferred tax assets will not be utilized in the future. In making such determination, the Company considered factors including future taxable income exclusive of reversing temporary differences and tax loss carry forwards. If events occur in the future that allow the Company to realize part or all of its deferred income tax, an adjustment to the valuation allowances will result in a decrease in tax expense when those events occur. As of March 31, 2021 and 2022, valuation allowances of RMB150.0 million and RMB184.7 million were provided because it was more likely than not that the Company will not be able to utilize these Movement of valuation allowance is as follows: As of March 31, As of March 31, RMB RMB Beginning balance 112,539 149,978 Change of valuation allowance 37,439 27,269 Ending balance 149,978 177,247

Ordinary Share

Ordinary Share	12 Months Ended
	Mar. 31, 2022
Equity [Abstract]
Ordinary Share	19. Ordinary Share As of March 31, 2021, the Company had 54,505,108 Class A ordinary shares and 13,037,729 Class B ordinary shares issued and outstanding, respectively. As of March 31, 2022, the Company had 55,709,591 Class A ordinary shares and 13,037,729 Class B ordinary shares issued and outstanding, respectively. Initial public offering In October 2020, the Company completed its IPO on the New York Stock Exchange of 7,000,000 American Depositary Shares (“ ADSs Upon the completion of the IPO, all series of redeemable convertible preferred shares of the Company were converted and designated as Class A ordinary shares with a par value of US$0.001 each on a one-for-one one-for-one one-for-one one-for-one In respect of all matters subject to shareholders’ vote, each holder of Class A ordinary share is entitled to one and each holder of Class B ordinary share is entitled to twenty votes. In February 2021, the Company repurchased from one of its shareholders , the repurchased shares were cancelled thereafter.

Convertible redeemable preferre

Convertible redeemable preferred shares	12 Months Ended
	Mar. 31, 2022
Statement of Stockholders' Equity [Abstract]
Convertible redeemable preferred shares	20. Convertible redeemable preferred shares Series A convertible redeemable preferred shares (“Series A Preferred Shares”) On October 15, 2012, the Company entered into a shares purchase agreement with certain investors, pursuant to which 3,102,000 and 7,238,000 Series A Preferred Shares were issued on November 19, 2012 and April 3, 2013, respectively, for an aggregated consideration of US$11.0 million. The Company incurred issuance costs of RMB1.7 million (US$0.3 million) in connection with this offering. Series B convertible redeemable preferred shares (“Series B Preferred Shares”) On February 7, 2014, the Company entered into a shares purchase agreement with certain investors, pursuant to which 9,067,384 Series B Preferred Shares were issued on February 24, 2014 for an aggregated consideration of US$19.0 million. The Company incurred issuance costs of RMB1.9 million (US$0.3 million) in connection with this offering. Series C convertible redeemable preferred shares (“Series C Preferred Shares”) On May 3, 2015, the Company entered into a shares purchase agreement with certain investors, pursuant to which 5,518,101 Series C Preferred Shares were issued on May 13, 2015 for an aggregated consideration of US$25.5 million. The Company incurred issuance costs of RMB2.7 million (US$0.4 million) in connection with this offering. On July 7, 2015, the Company cancelled 865,585 Series C Preferred Shares previously issued to other investor for not receiving any consideration for these issued shares. Subsequently, on January 7, 2016, the Company re-issued re-issued re-issuance, Series C+ convertible redeemable preferred shares (“Series C+ Preferred Shares”) On January 26, 2016, the Company entered into a shares purchase agreement with certain investors, pursuant to which 552,005 Series C+ Preferred Shares were issued on January 26, 2016 for an aggregated consideration of US$3.8 million. Subsequently, on March 21, 2016, all 552,005 Series C+ Preferred Shares were cancelled as no consideration for these shares were received. On January 26, 2016, the Company issued a warrant to purchase up to 6,734,459 (as adjusted from time to time pursuant to the provisions of this warrant) Series C+ Preferred Shares to an investor at an exercise price equivalent to the conversion price of the Series C+ Preferred Shares in effect at the time of such exercise, amounting to an aggregate purchase price of up to US$46.2 million (the “CMB Warrant”). This warrant was issued in connection with an investment of RMB303.2 million (equivalent to US$46.2 million) made by the investor to one of the Company’s PRC consolidated VIEs, Guangcheng (Shanghai) Information Technology Co., Ltd. (“Guangcheng”), on January 26, 2016 (the “CMB investment”). The investor can convert the investment into Series C+ Preferred Shares of the Company by exercising the warrant. On March 21, 2016, the Company issued a warrant to purchase up to 552,005 (as adjusted from time to time pursuant to the provisions of this warrant) Series C+ Preferred Shares to an investor at an exercise price per share equal to the conversion price of the Series C+ Preferred Shares in effect at the time of the exercise, amounting to an aggregate purchase price of up to US$3.8 million (equivalent to RMB24.9 million). The investor can convert the investment into Series C+ Preferred Shares of the Company by exercising the warrant. The two warrants to purchase Series C+ Preferred Shares described above are collectively referred to as “Series C+ Warrants”. Each of the Series C+ Warrants is embedded in the respective investment instead of freestanding because it was (1) issued in connection with the investments, and (2) not separately exercisable without terminating the investment. The investment is considered to be accounted for as permanent equity because the Company would not be required to return the investment to the investor regardless of whether the warrant is exercised or not. The warrant, as an equity-linked instrument, is clearly and closely related to the investment which is an equity host, and thus does not need to be bifurcated and separately accounted for. Therefore, the combined instrument (investment and warrant) is accounted for as additional paid-in On March 31, 2020, all parties to the CMB Warrant and the CMB Investment entered into an agreement on the settlement of the CMB Warrant and the CMB Investment. According to this agreement: • The investor shall exercise the CMB Warrant at an exercise price of US$6.86 per share for 6,734,459 Series C+ Preferred Shares. • Guangcheng shall repay the CMB Investment to the investor two years after this agreement is signed. • The investor shall pay the exercise price of the CMB Warrant to the Company immediately after receiving the repayment of the CMB Investment from Guangcheng. On August 19, 2020, the CMB Warrant was exercised at an exercise price of US$6.86 per share for 6,734,459 Series C+ Preferred Share. Therefore, the Company recorded Series C+ Preferred Shares at the exercise date fair value amounting to RMB656.4 million and derecognized the permeant equity of CMB Warrant. The difference between the fair value of Series C+ Preferred Shares and the carrying value of the permeant equity adjust ed paid-in paid-in During the years ended March 31, 2021 and 2022, the Company repaid the principal of Loan from CMB in the amount of RMB10.8 million and RMB235.0 million, respectively. For the years ended March 31, 2021 and 2022, the Company recorded RMB9.3 million and RMB8.9 million interest expenses of Loan from CMB. Series D convertible redeemable preferred shares (“Series D Preferred Shares”) On September 8, 2017, the Company entered into a shares purchase agreement with certain investors, pursuant to which 1,492,652 and 803,735 Series D Preferred Shares were issued on October 25, 2017 and November 13, 2017, respectively, for an aggregated consideration of US$20.0 million. The Company incurred issuance costs of RMB1.1 million (US$0.2 million) in connection with this offering. On January 30, 2018, the Company issued convertible promissory notes that are convertible into Series D Preferred Shares (“Series D Notes”). On August 3, 2018, the Company issued 229,639 Series D Preferred Shares upon the conversion of the Series D Notes. Series D-1 D-1 On June 19, 2018, the Company entered into a shares purchase agreement with certain investors, pursuant to which 1,089,265 Series D-1 D-1 On August 3, 2018, the Company issued a warrant to purchase up to 1,089,265 Series D-1 D-1 D-1 On March 31, 2020, the Company issued 1,089,265 Series D-1 D-1 Series D-2 D-2 On January 16, 2019, the Company issued a warrant to purchase up to 963,139 Series D-2 D-2 D-2 On January 16, 2019, the Company issued convertible promissory notes (“Series D-2 D-2 D-2 On March 23, 2020, the Company issued 219,664 Series D-2 D-2 D-2 On March 31, 2020, the Company issued 963,139 Series D-2 D-2 Series D-3 D-3 On June 16, 2019, the Company issued a warrant to purchase up to 154,395 Series D-3 D-3 D-3 D-3 D-3 D-3 Series E convertible redeemable preferred shares (“Series E Preferred Shares”) On June 17, 2019, the Company entered into a shares purchase agreement with an investor, pursuant to which 290,555 Series E Preferred Shares were issued on June 24, 2019 for an aggregated consideration of US$3 million. The Company incurred issuance costs of RMB0.1 million (US$ 21,244) in connection with this offering. On November 21, 2019, in connection with the step acquisition of Nanjing Xingmu, the Company On February 10, 2020, the Company entered into a shares purchase agreement with an investor, pursuant to which 290,555 Series E Preferred Shares were issued on February 17, 2020 for an aggregated consideration of US$3 million. The consideration is lower than the fair value of the preferred shares as of the date of closing, with the difference of RMB0.4 million being recorded as deemed dividend to Series E preferred shareholders. On March 6, 2020, the Company issued a warrant to purchase up to 205,767 Series E Preferred Shares at an exercise price of US$10.3251 per share (“Series E Warrant” and see Note 22(h)). On June 1, 2020, the Company issued 4,842,587 Series E Preferred Shares to an investor for an aggregated consideration of US$50 million. The consideration is lower than the fair value of the preferred shares as of the date of closing, with the difference of RMB12 million being recorded as deemed dividend to Series E preferred shareholders. The Series A, B, C, C+, D, D-1, D-2, D-3 Conversion rights Each Preferred Share may be converted at any time into ordinary shares at the option of the holders at the then applicable conversion price. The initial conversion ratio is 1:1, subject to adjustment in the event of (i) share splits or combinations, share dividends or distribution, other dividends, recapitalization and similar events, or (ii) issuance of ordinary shares (excluding certain events such as issuance of ordinary shares pursuant to a public offering) at a price per share less than the conversion price in effect immediately prior to such issuance. On May 13, 2015, the conversion prices of Series A and B Preferred Shares were increased from US$1.06 and US$2.10 to US$1.40 and US$2.22, respectively, due to some then-effective conversion price adjustment clauses. Other than these changes, no adjustment to conversion prices of the Preferred Shares issued has occurred so far. Each Preferred Share shall be automatically converted, based on the then applicable conversion price, into ordinary shares immediately upon the closing of an initial public offering of the Company’s ordinary shares with an offering price (net of underwriting commissions and expenses) that implies a market capitalization of the Company immediately prior to such offering of not less than US$800 million, and that results in gross cash proceeds to the Company of at least US$50 million (“Qualified IPO”, the criteria of which have been adjusted a number of times historically). The Company determined that there were no beneficial conversion features (“BCF”) identified for any of the Preferred Shares during any of the periods. In making this determination, the Company compared the fair value of the ordinary shares into which the Preferred Shares are convertible with the respective effective conversion price at the issuance date. In all instances, the effective conversion price was greater than the fair value of the ordinary shares. To the extent a conversion price adjustment occurs, as described above, the Company would reevaluate whether or not BCF should be recognized. Voting rights Each of the Preferred Shares has voting rights equivalent to the number of ordinary shares to which it is convertible at the record date. The Preferred Shares shall vote separately as a class with respect to certain specified matters. Otherwise, the holders of the Preferred Shares and ordinary shares shall vote together as a single class. Dividend rights The holders of the Preferred Shares shall be entitled to receive dividends at the same rate as for the holders of the ordinary shares (calculated on an as converted basis), payable out of funds or assets when and as such funds or assets become legally available therefor on parity with each other and the holders of the Ordinary Shares, when, as, and if declared by the Board of Directors, with preference to Series E Preferred Shares, followed by Series D-3, D-2, D-1, Liquidation preference In the event of any liquidation (including deemed liquidation, such as change in control, etc.), dissolution or winding up of the Company, whether voluntary or involuntary, all assets and funds of the Company legally available for distribution (after satisfaction of all creditors’ claims and claims that may be preferred by law) shall be distributed in the following preference order: (1) Holders of the Series E Preferred Shares shall be entitled to receive a per share amount equal to 110% of the issue price of Series E Preferred Shares, respectively, plus all declared but unpaid dividends. (2) Holders of Series D-3 D-3 (3) Holders of Series D-2 D-2 (4) Holders of the Series D-1 D-1 (5) Holders of the Series D Preferred Shares shall be entitled to receive a per share amount equal to 140% of the issue price of Series D Preferred Shares, plus all declared but unpaid dividends. (6) Holders of the Series C+ Preferred Shares shall be entitled to receive a per share amount equal to 130% of the issue price of Series C+ Preferred Shares, plus all declared but unpaid dividends. (7) Holders of the Series C Preferred Shares shall be entitled to receive a per share amount equal to 140% of the issue price of Series C Preferred Shares, plus all declared but unpaid dividends. (8) Holders of the Series B Preferred Shares shall be entitled to receive a per share amount equal to 180% of the issue price of Series B Preferred Shares, plus all declared but unpaid dividends. (9) Holders of the Series A Preferred Shares shall be entitled to receive a per share amount equal to 180% of the issue price of Series A Preferred Shares, plus all declared but unpaid dividends. After the liquidation amounts of all series of the Preferred Shares have been paid in full, holders of the ordinary shares shall be entitled to receive an amount per share equal to US$0.2882 (as adjusted for any share splits, share dividends, combinations, recapitalizations or similar transactions) plus any declared but unpaid dividends thereon. After the liquidation amounts of all series of the Preferred Shares and ordinary shares have been paid in full, any remaining funds or assets of the Company legally available for distribution to shareholders shall be distributed ratably among the holders of the Preferred Shares, on an as-converted In the event of a deemed liquidation that implies a valuation of the Company of no less than US$653 million, any proceeds resulting from such deemed liquidation shall be distributed ratably among the holders of the Preferred Shares, on an as-converted Redemption right The Company shall redeem all or a portion of the Preferred Shares, at the option of the holders, if the Company triggers any redemption events. One redemption event was that the holders could redeem all or portion of the Preferred Shares, at the option of the holders, after the 5th anniversary of the issuance date of Series E Preferred Shares (“Optional Redemption Date”) if the Company had not achieved a Qualified IPO on or before the Optional Redemption Date. The Optional Redemption Date had been amended for a number of times historically. The price at which each of the Preferred Shares should be redeemed are summarized as follows: • Series A and B Preferred Shares – the higher of (1) the sum of 180% issue price and declared but unpaid dividends, or (2) fair market value of the Preferred Share. • All other series of the Preferred Shares – the higher of (1) the sum of issue price, interest calculated at 8% per year compound annually (calculated from the date specified in memorandum of association and articles of association) and any declared but unpaid dividends, or (2) fair market value of the Preferred Share. Upon redemption, the Company shall pay the redemption price of Series B, C, C+, D, D-1, D-2, D-3 Accounting of the Preferred Shares The Company classified the Preferred Shares in the mezzanine section of the Consolidated Balance Sheets because they were contingently redeemable upon the occurrence of an event outside of the Company’s control (e.g. the Company not achieving a Qualified IPO before the Optional Redemption Date). The Preferred Shares were determined to be mezzanine equity with no embedded feature to be bifurcated and no BCF to be recognized. The Preferred Shares are initially recorded at their respective issuance date fair value, net of issuance cost. Since the Preferred Shares become redeemable at the option of the holder at any time after the Optional Redemption Date, for each reporting period, the Company accreted the carrying amount of the Preferred Shares to the higher of (1) the fair market value of the Preferred Shares on the reporting date, or (2) the result of using effective interest rate method to accrete the Preferred Shares to the redemption prices on the Optional Redemption Date that were calculated with pre-determined RMB-121 million Series A Preferred Series B Preferred Series C Preferred Series C+ Preferred Series D Preferred Series D-1 Series D-2 Series E Preferred Number of Amount Number of Amount Number of Amount Number of Amount Number of Amount Number of Amount Number of Amount Number of Amount Balance as of March 31, 2019 10,340,000 424,930 9,067,384 463,560 5,518,101 370,869 — — 2,526,026 168,415 1,089,265 73,409 — — — — Issuance (Note a) — — — — — — — — — — 1,089,265 82,048 1,182,803 89,447 1,042,623 74,830 Accretion on the Preferred Shares to redemption value — 59,192 — 64,122 — 49,550 — — — 19,768 — 8,825 — 17 — 3,322 Deemed dividend to preferred shareholders (Note b) — — — — — — — — — — — — — — — 401 Balances as of March 31, 2020 10,340,000 484,122 9,067,384 527,682 5,518,101 420,419 — — 2,526,026 188,183 2,178,530 164,282 1,182,803 89,464 1,042,623 78,553 Issuance (Note a) — — — — — — 6,734,459 656,448 — — — — — — 4,842,587 353,893 Accretion on the Preferred Shares to redemption value — (22,677 ) — (23,345 ) — (88,954 ) — 6,360 — (7,179 ) — 577 — 2,850 — 11,495 Deemed dividend to preferred shareholders (Note b) — — — — — — — — — — — — — — — 12,039 Conversion of convertible redeemable preferred shares upon completion of the IPO (10,340,000 ) (461,445 ) (9,067,384 ) (504,337 ) (5,518,101 ) (331,465 ) (6,734,459 ) (662,808 ) (2,526,026 ) (181,004 ) (2,178,530 ) (164,859 ) (1,182,803 ) (92,314 ) (5,885,210 ) (455,980 ) Balances as of March 31, 2021 — — — — — — — — — — — — — — — — Note a: In March 2020 , 112,648 Series D-2 D-2 D-2 D-2 D-1 D-1 D-2 D-2 , 6,734,459 Series C+ Preferred Shares were issued upon conversion of Series C+ CMB Warrant. Please refer to Note 22 for further details. Note b: For the years ended March 31, 2021 and 2022, the deemed dividend attributable to the Preferred Shares was RMB12 million and nil, respectively. The Company issued Series C+ Preferred Shares to be settled by the investor after the investor receiving the repayment of the CMB Investment from Guangcheng. The Company recorded a receivable for issuance of preferred shares in the amount of R MB 303 million (which is the present value of the principal amount of US$ 46 million) in mezzanine equity for the consideration of the Series C+ Preferred Shares not yet received from the investors. After the completion of the IPO in October 2020, the Series C+ Preferred Shares were automatically converted into Class A ordinary shares. The Company accounted for the consideration of such-converted ordinary shares as receivable for issuance of ordinary shares in equity. As of March 31 , 2021 and 2022 , the receivable for issuance of ordinary shares is RMB312.5 million and RMB86.4 million, respectively (Note 23).

Redeemable non-controlling inte

Redeemable non-controlling interests	12 Months Ended
	Mar. 31, 2022
Noncontrolling Interest [Abstract]
Redeemable non-controlling interests	21. Redeemable non-controlling Yoken Holding Limited (“Yoken”), a wholly owned subsidiary of the Company issued 120,000 redeemable preferred shares amounting to million to a third-party investor in October, . The preferred shares are redeemable at the pre-agreed period of time since its issuance with a redemption price measured by % interest per year. The preferred shares are therefore accounted for as redeemable non-controlling For the years ended March 31 2021 and 2022, the Company recognized accretion of RMB0.1 million and RMB0.6 million, respectively, to the respective redemption value of the redeemable non-controlling interest over the period starting from issuance date with a corresponding increase to the accumulated deficit. As of March 31, 2021 and 2022, the redeemable non-controlling interests was RMB5.9 million and RMB6.5 million, respectively.

Borrowings, other debts and der

Borrowings, other debts and derivative liabilities	12 Months Ended
	Mar. 31, 2022
Debt Disclosure [Abstract]
Borrowings, other debts and derivative liabilities	22. Borrowings, other debts and derivative liabilities Short-term borrowings and long-term borrowings The following table presents short-term borrowings from commercial banks, other institutions and individuals as of March 31, 2021 and 2022. Short-term borrowings include borrowings with maturity terms shorter than one year: As of March 31, As of March 31, 2021 2022 RMB RMB Bank borrowings 85,566 134,540 Current portion of long-term bank borrowings — 26,586 Total 85,566 161,126 The following table presents long-term borrowings from commercial banks, other institutions and individuals as of March 31, 2021 and 2022. Long-term borrowings include borrowings with maturity terms greater than one year: As of March 31, As of March 31, 2021 2022 RMB RMB Bank borrowings 68,075 — Total 68,075 — Bank borrowings As of March 31, 2021 and 2022, the Company obtained short-term bank borrowings of RMB85.6 million and RMB161.1 million in aggregate, of which RMB37.8 and RMB 110.5 million were collateralized by short-term investments, respectively. The weighted average interest rate for the outstanding borrowings were approximately 4.52% and 2.63%, respectively. These short-term bank borrowings did not include any restrictive covenants. As of March 31, 2021 and 2022, the unused facility for the short-term borrowing were RMB222.3 million and RMB170.3 million, respectively. As of March 31, 2021, the Company obtained long-term bank borrowings of RMB68.1 million, of which RMB68.1 was collateralized by short-term investments. The weighted average interest rate for the outstanding borrowings was approximately 4.15 %. This Future principal maturities of short-term borrowings and long-term borrowings as of March 31, 2021 and 2022 are as followings: Year ended March 31, 2021 Year ended March 31, 2022 RMB RMB For the year ending March 31, - Within 1 year 85,566 161,126 - Between 1 and 2 years 68,075 — Total 153,641 161,126 Other debts Other debts – non-current As of March 31, As of March 31, 2021 2022 RMB RMB Loan for Series C+ Warrant (Note 20) 312,535 86,373 Loan from Chong Li (a) (b) 100,842 70,001 Loan for Yoken Series A-1 19,915 23,188 Payable for investment (Note 11) — 1,500 Total 433,292 181,062 (a) Series D-1 D-1 On August 3, 2018, the Company issued a warrant to an investor to purchase up to 1,089,265 Series D-1 D-1 D-1 D-1 D-1 D-1 would D-1 D-1 D-1 would D-1 D-1 D-1 D-1 On December 3, 2019, all parties to the Series D-1 D-1 D-1 D-1 D-1 D-1 D-1 D-1 D-1 D-1 D-1 D-2 D-2 (b) Series D-2 D-2 On January 16, 2019, the Company issued a warrant to purchase up to 963,139 Series D-2 D-2 D-2 D-2 D-2 would would D-2 D-2 D-2 D-2 D-2 D-2 D-2 On December 27, 2019, all parties to the Series D-2 D-2 D-2 D-2 D-2 D-2 D-2 D-2 On March 31, 2020, the Company, Superb Origin International Limited (“Superb Origin”, an ordinary shareholder of the Company), Chong Li (the 100% equity owner of Superb Origin) and all parties to the Series D-1 D-1 D-2 D-2 • Series D-1 D-1 D-2 D-2 • The investor of Loan for Series D-1 D-2 D-1 D-1 • The Company entered into share purchase agreements with Superb Origin, pursuant to which 1,089,265 Series D-1 D-2 The Company determined that the above transactions executed on March 31, 2020 effectively converted Loan for Series D-1 D-2 D-1 D-2 D-1 D-2 D-1 D-1 D-2 D-2 D-1 D-2 The Company accounted million (which is the present value of the principal amount of RMB128 million) and subsequently measured at amortized cost. During the years ended March 31, 2021 and 2022, the Company repaid the principal of Loan from Chong Li of nil and RMB million, respectively. For the years ended March 31, 2021 and 2022, the Company recorded interest expenses of RMB6.1 million and RMB5.1 million, respectively. The Company issued Series D-1 Preferred Shares and Series D-2 Preferred Shares to be settled by Superb Origin after Guangcheng repaid the Loan from Chong Li to Superb Origin. The Company recorded a receivable for issuance of preferred shares in the amount of RMB95 million (which is the present value of the principal amount of RMB128 million) in mezzanine equity for the consideration of the Series D-1 D-2 D-1 D-2 (c) Series D-2 On January 16, 2019, the Company issued convertible promissory notes of US$1 million (“Series D-2 D-2 D-2 D-2 D-2 D-2 On March 23, 2020, all principal amount of Series D-2 D-2 (d) Series D-2 On January 16, 2019, the Company issued convertible promissory notes of US$1 million (“Series D-2 D-2 D-2 D-2 D-2 On December 16, 2019, the Company and the investor of the Series D-2 D-2 D-2 On March 23, 2020, all principal amount of Series D-2 D-2 (e) Series D-3 D-3 D-3 On June 16, 2019, the Company issued to an investor (1) a warrant to purchase up to 154,395 Series D-3 D-3 D-3 D-3 D-3 D-3 D-3 D-3 Guangcheng has the right to repay each of the loans with a simple interest of 10% per annum prior to their respective maturity dates (plus a 45-day D-3 In June 2020, the Company early repaid the L D-3 D-3 In July and October 2020, the Company repaid the L D-3 D-3 The difference between the total carrying value of the Loan for Series D-3 Warrant A and Loan for Series D-3 Warrant B, and the fair value of the conversion feature and the repaid amounts, being RMB4.9 million, was recognized as other gain (losses), net (Note 17) for the year ended March 31, 2021. (f) Series D-3 On May 27, 2019, the Company issued convertible promissory notes of US$10 million (“Series D-3 D-3 ied On June 25, 2020, the Company and the investor of the Series D-3 PICC Notes entered into a supplementary agreement upon which the investor selected to redeem the Series D-3 PICC Notes and the Company shall repay the total principal and interests of the Series D-3 PICC Notes to the investor by installment in the period from July 3, 2020 to August 25, 2020. As of December 2020, the Company has repaid all principal and interests of US$ million and US$ million, respectively. The difference between the total carrying value of Series D-3 PICC Notes and the repaid amounts, being RMB million, was recognized as other gain (losses), net (Note 17) for the year ended March 31, 2021. (g) Yoken Series A-1 On March 2, 2020, Yoken Holding Limited (“Yoken”), a wholly owned subsidiary of the Company, entered into a share purchase agreement with three investors (“Yoken Series A-1 A-1 A-1 A-1 A-1 A-1 A-1 A-1 A-1 A-1 A-1 On October 23, 2020, of the s A-1 A-1 A-1 A-1 A-1 Accounting of debt modifications The aforementioned amendments to Loan for Series D-1 Warrant, Loan for Series D-2 Warrant, Series D-2 CW Notes, the Series D-2 DL Notes, Loan for Series D-3 Warrant A and Loan for Series D-3 Warrant B with respects to the terms of the debts, etc. do not meet the requirement of a Troubled Debt Restructuring (“TDR”), as the Company was not experiencing financial difficulties at the time of these amendments. The amendments are all accounted for as modifications rather than an extinguishment because the changes in present value of the remaining cash flows before and after the amendments are not substantial (less than 10%). Derivative liabilities As of March 31, As of March 31, 2021 2022 RMB RMB Conversion feature of Yoken Series A-1 Warrant (a) 9,362 9,086 Series E Warrant (b) 444 — Forward exchange contracts (c) 190 — Total 9,996 9,086 For the initial recognition of each debt instrument that has a bifurcated derivative liability (i.e., embedded warrant or conversion feature), out of the total consideration received, the derivative liability is recognized at fair value and the remaining consideration (net of issuance costs) is then allocated to the host debt instrument. The derivative liability is subsequently carried at fair value with any changes in fair value recognized currently in the income statement. The host debt instrument is subsequently amortized using the effective interest rate method. Upon conversion of the host debt instrument into the Preferred Shares or debt repayment, both the host debt instrument and the respective derivative liability are subject to extinguishment accounting with a gain or loss recognized from the difference between the recoded values of both liabilities and the fair value of consideration given by the Company (i.e., the Preferred Shares or cash). (a) The warrant issued in connection with Yoken Series A-1 Warrant is embedded instead of freestanding because it is (1) issued in connection with the instrument and (2) not separately exercisable without terminating the debt instruments. Therefore, each combined instrument (loan with embedded warrant) is substantially similar to a convertible debt where the embedded warrant is similar to a conversion feature able to convert the debt instrument into the Preferred Shares. The Company assessed the embedded warrant along with the conversion features in Yoken Series A-1 Warrant and concluded that it is required to be bifurcated and accounted for separately as derivative liabilities. This is because (1) the embedded warrant or conversion feature, as an equity-linked feature, is not considered clearly and closely related to its debt host instrument, and (2) the redemption rights of the convertible Preferred Shares could give rise to net settlement of the conversion feature of the Preferred Shares. (b) To exchange the consultant service from a service provider, on March 6, 2020, the Company issued a warrant of Series E Preferred Shares of 205,767 shares at an exercise price of US$10.3251 per share (“Series E Warrant”). The fair value of the Series E Warrant is RMB2.5 million and is recorded as prepayments and other current assets. The exercise period of the Series E Warrant is from the warrant issuance date (i.e. March (c) On March 8, 2021, the Company entered a forward exchange contract with a financial institution. Pursuant to which, the financial institution agreed to purchase US$4 million from the Company in exchange of RMB26.5 million at a fixed foreign exchange rate of 6.6280. Such forward exchange contract would be settled on December 10, 2021. For the year ended March 31, 2021, the fair value loss of the forward exchange contract was RMB0.19 million and was recorded as fair value change of derivative liabilities. In June and December 2021 and March 2022, the Company entered three new forward exchange contracts with a financial institution. Pursuant to which, the financial institution agreed to purchase US$8 million, US$4 million and US$5 million from the Company in exchange of RMB52.4 million, RMB26.1 million and RMB32.1 million at a fixed foreign exchange rate of 6.5452, 6.5128 and 6.4200 on June 2022, December 2022 and March 2023, respectively. The Company settled in advance with amount of US$11 million and recorded the fair value gain in the amount of RMB1.2 million as fair value change of derivative liabilities. For the year ended March 31, 2022, the fair value gain of the rest forward exchange contracts was RMB0.9 million and was recorded as fair value change of derivative liabilities. The carrying value of the remaining forward exchange contracts was RMB0.7 million and was recorded as prepayments and other current assets.

Receivable for issuance of ordi

Receivable for issuance of ordinary shares	12 Months Ended
	Mar. 31, 2022
Equity [Abstract]
Receivable for issuance of ordinary shares	23. Receivable for issuance of ordinary shares The Company issued Series C+ Preferred Shares, Series D-1 Preferred Shares and Series D-2 Preferred Shares to be settled by the investors after Guangcheng repaid the Loan from CMB (Details refer to Note 20) and Loan from Chong Li (Details refer to Note 22(b)) to the investors. The Company recorded a receivable for issuance of preferred shares in the amount of RMB303 million and RMB95 million in mezzanine equity for the consideration of the Series C+ Preferred Shares, Series D-1 Preferred Shares and Series D-2 Preferred Shares not yet received from the investors. After the completion of the IPO in October 2020, the Series C+ Preferred Shares, the Series D-1 Preferred Shares and the Series D-2 Preferred Shares were automatically converted into Class A ordinary shares. The Company accounted for the consideration of such-converted ordinary shares as receivable for issuance of ordinary shares under shareholders’ equity. During the years ended March 31, 2021 and 2022, the Company received nil and RMB262.9 million from the receivable for issuance of ordinary shares. For the years ended March 31, 2021 and 2022, the Company recorded interest income of RMB15.4 million and RMB14.2 million, respectively. As of March 31, 2021 and 2022, the balances of receivable for issuance of ordinary shares were RMB413.4 million and RMB164.7 million, respectively.

Share-based compensation

Share-based compensation	12 Months Ended
	Mar. 31, 2022
Share-based Payment Arrangement [Abstract]
Share-based compensation	24. Share-based compensation On certain of non-employees the Except for share options granted to certain senior management personnel during the years ended March 31, 2015 and 2016, which were immediately fully vested and exercisable once granted, other share options granted to employees and non-employees would For the years ended March 31, 2021 and 2022, 998,000 and 1,282,500 share options were granted to the Participants respectively. The following table sets forth the share options activity for the years ended March 31, 2020 and 2021: Number of shares Weighted exercise Weighted remaining contractual Aggregate intrinsic value Weighted fair value US$ US$ US$ Outstanding as of March 31, 2020 4,856,972 2.26 6.67 39,472 2.72 Exercisable as of March 31, 2020 — — Granted 998,000 4.13 2.49 Forfeited (342,750 ) 3.49 4.00 Outstanding as of March 31, 2021 5,512,222 3.36 6.32 29,360 3.28 Exercisable as of March 31, 2021 — — Granted 1,282,500 2.86 2.27 Exercised (1,204,483 ) 1.09 0.73 Forfeited (358,348 ) 2.86 3.83 Outstanding as of March 31, 2022 5,231,891 2.86 5.25 404 2.36 Exercisable as of March 31, 2022 — — The aggregate intrinsic value is calculated as the difference between the exercise price of the options and the estimated fair value of the underlying shares of US$39,471,589, US$29,359,582 and US$404,409 at March 31, 2020, 2021 and 2022, respectively. As of March 31, years . Options granted to t he Year ended March 31, 2021 Year ended March 31, 2022 Expected volatility 44.41% 42.22%-43.71% Risk-free interest rate 0.94% 1.64%-1.87% Exercise multiple 2.8/2.2 2.8/2.2 Expected dividend yield 0% 0% Contractual term (in years) 10 10 The expected volatility was estimated based on the historical volatility of comparable peer public companies with a time horizon close to the expected term of the Company’s options. The risk-free interest rate was estimated based on the yield to maturity of U.S. treasury bonds denominated in US$ for a term consistent with the expected term of the Company’s options in effect at the option valuation date. The expected exercise multiple was estimated as the average ratio of the stock price to the exercise price of when employees would decide to voluntarily exercise their vested options. As the Company did not have sufficient information of past employee exercise history, it was estimated by referencing to a widely-accepted academic research publication. The expected dividend yield is zero as the Company has never declared or paid any cash dividends on its shares, and the Company does not anticipate any dividend payments in the foreseeable future. The expected term is the contract life of the option. For the Company’s share options granted to the Participants, the completion of a Qualified IPO is considered to be a performance condition of the awards. A Qualified IPO is not considered to be probable until it is completed. Under ASC 718, compensation cost should be accrued if it is probable that the performance condition will be achieved. As a result, no compensation expense will be recognized related to these options until the completion of a Qualified IPO, and hence no share-based compensation expense was recognized for the year ended March 31, 2020. For the year ended March 31, 2021, upon the completion of the IPO in October 2020, the Company recorded RMB55 million of share-based compensation expense. For the year ended March 31, 2022, RMB14.4 million of share-based compensation expense was recorded. The fair value of options granted to the Participants for the years ended March 31, 2021 and 2022 was amounting to US$2.5 million and US$2.9 million, respectively.

Employee benefits

Employee benefits	12 Months Ended
	Mar. 31, 2022
Compensation Related Costs [Abstract]
Employee benefits	2 5 Employee benefits The full-time employees of the Company’s subsidiaries and VIEs that are incorporated in the PRC are entitled to staff welfare benefits including medical insurance, basic pensions, unemployment insurance, work injury insurance, maternity insurance and housing funds. These companies are required to contribute to these benefits based on certain percentages of the employees’ salaries in accordance with the relevant regulations and charge the amount contributed to these benefits to the consolidated statements of comprehensive loss. The Company has no legal obligation for the benefits beyond the contribution made. The PRC government is responsible for the welfare and medical benefits and ultimate pension liability to these employees. The total amounts charged to the consolidated statements of comprehensive loss for such employee benefits amounted to RMB7 million, RMB6 million and RMB7 million for the years ended March 31, 2020, 2021 and 2022, respectively.

Fair value measurements

Fair value measurements	12 Months Ended
	Mar. 31, 2022
Fair Value Disclosures [Abstract]
Fair value measurements	2 6 Fair value measurements The Company measured its short-term investments, available-for-sale available-for-sale available-for-sale The following table summarizes the Company’s financial assets and liabilities measured and recorded at fair value on recurring basis as of March 31, 2021 and 2022: Fair value measurement at reporting date using Description Fair value as of Quoted price in Significant other Significant RMB RMB RMB RMB Assets: Short-term investments 168,546 — 168,546 — Available-for-sale 71,357 — — 71,357 Total assets 239,903 — 168,546 71,357 Liabilities: Derivative liabilities 9,996 — 190 9,806 Fair value measurement at reporting date using Description Fair value as of Quoted price in Significant other Significant RMB RMB RMB RMB Assets: Short-term investments 128,084 — 128,084 — Available-for-sale 74,866 — — 74,866 Equity securities with readily determinable fair values 670 670 — — Total assets 203,620 670 128,084 74,866 Liabilities: Derivative liabilities 9,086 — — 9,086 The roll forward of major Level 3 investments are as following: Derivative liabilities Available-for-sale Fair value of Level 3 investments as at March 31, 2019 35,524 16,050 New addition 13,487 50,000 Conversion of Series D-1 (10,701 ) — Conversion of Series D-2 (10,614 ) — Unrealized fair value change of the derivative liabilities (13,345 ) — Unrealized fair value change of the available-for-sale — 4,278 Fair value of Level 3 investments as at March 31, 2020 14,351 70,328 New addition 9,581 — Disposal of Series D-3 (2,377 ) — Unrealized fair value change of the derivative liabilities (11,559 ) — Unrealized fair value change of the available-for-sale — 1,029 Fair value of Level 3 investments as at March 31, 2021 9,996 71,357 New addition — 16,000 Reclassification of forward exchange contracts 746 — Unrealized fair value change of the derivative liabilities (1,656 ) — Unrealized fair value change of the available-for-sale — (12,491 ) Fair value of Level 3 investments as at March 31, 2022 9,086 74,866 The Company determined the fair value of their investments by using income approach and equity allocation model. The determination of the fair value was based on estimates, judgments and information of other comparable public companies. The significant unobservable inputs adopted in the valuation as of March 31, 2021 and 2022: As of March 31, 2021 As of March 31, 2022 Weighted average cost of capital 15%,16.5% 15%,16.5,18% Lack of marketability discount 17%,23% 17%,23%,29% Risk-free rate 2.88%,2.87% 1.95% , , , Expected volatility 41.79%,42.26% 39.88%,42.17%,42.48%,47.34% Probability Liquidation scenario: 40% Redemption scenario: 40% IPO scenario: 20% Liquidation scenario: 20% Redemption scenario: 40% IPO scenario: 40% The significant unobservable inputs used in the fair value measurement of the fair value of the investments include weighted average cost of capital, lack of marketability discount, risk-free rate, expected volatility and probabilities of different scenarios. Significant increases in weighted average cost of capital, lack of marketability discount and risk-free rate would result in a significantly lower fair value measurement. Significant decreases in expected volatility would result in a significantly lower fair value measurement. If the probabilities of redemption and liquidation scenarios are assumed to keep equal, significant increases in the probability of IPO scenario would result in a significantly lower fair value measurement. The Company determined the fair value of their derivative liabilities by using binominal model. The determination of the fair value was based on estimates, judgments and information of other comparable public companies. The significant unobservable inputs adopted in the valuation as of March 31, 2021 and 2022 are as follows: As of March 31, As of March 31, Spot price (US$) 5.57, 0.44, 6.93 Risk-free rate 0.00%, 1.25%, 2.5% Expected volatility 41.05%, 57.95%, 48.15% Expected expiry years (in years) 0.50, 0.50, 3.56 The significant unobservable inputs used in the fair value measurement of the derivative liabilities include spot price, risk-free rate, expected volatility and expected expiry years. Significant decreases in spot price, risk-free rate, expected volatility and expected expiry years would result in a significantly lower fair value measurement.

Net loss per share

Net loss per share	12 Months Ended
	Mar. 31, 2022
Earnings Per Share [Abstract]
Net Loss per share	2 7 Net loss per share Basic loss per share and diluted loss per share have been calculated in accordance with ASC 260 on computation of earnings per share for the years ended March 31, 2020, 2021 and 2022, respectively, as follows: Year Ended March 31, 2020 Year Ended March 31, 2021 Year Ended March 31, 2022 RMB RMB RMB Numerator: Net loss attributable to Boqii Holding Limited (179,024 ) (194,444 ) (128,390 ) Accretion on the Preferred Shares to redemption value (Note 20) (204,796 ) 120,873 — Accretion on the Redeemable non-controlling — (138 ) (575 ) Deemed dividend to preferred shareholders (1,142 ) (12,547 ) — Net loss attributable to ordinary shareholders (384,962 ) (86,256 ) (128,965 ) Denominator: Weighted average number of ordinary shares used in computing net loss per share, Basic and diluted (Note (a)) 22,238,454 66,953,610 68,006,172 Net loss per share attributable to ordinary shareholders: Basic and diluted (17.31 ) (1.29 ) (1.90 ) Note (a): Options exercisable for a minimal exercise price (the “Penny Stock”) are included in the denominator of basic loss per share calculation once there are no further vesting conditions or contingencies associated with them, as they are considered issuable shares. Basic net loss per share is computed using the weighted average number of ordinary shares outstanding and the Penny Stock during the reporting periods. Diluted net loss per share is computed using the weighted average number of ordinary shares and dilutive potential ordinary shares outstanding and the Penny Stock during the reporting periods. For the years ended March 31, 2020, assumed conversion of the Preferred Shares have not been reflected in the dilutive calculations pursuant to ASC 260, “Earnings Per Share,” due to the anti-dilutive effect. For the years ended March 31, 2021 and 2022, assumed share options have not been reflected in the dilutive calculations pursuant to ASC 260, “Earnings Per Share,” due to the anti-dilutive effect. The following ordinary shares equivalent were excluded from the computation of diluted net loss per ordinary share for the periods presented because including them would have had an anti-dilutive effect: Year Ended March 31, 2020 Year Ended March 31, 2021 Year Ended March 31, 2022 RMB RMB RMB Preferred Shares - weighted average 26,072,893 — — Share options - weighted average — 2,585,103 719,437

Related party transactions

Related party transactions	12 Months Ended
	Mar. 31, 2022
Related Party Transactions [Abstract]
Related party transactions	2 8 Related party transactions The table below sets forth the major related parties and their relationships with the Company as of March 31, 2020, 2021 and 2022: Name of related parties Relationship with the Company Nanjing Xingmu An equity investee of the Company before November 1, 2019 Nanjing Animal Pharmaceutical An equity investee of the Company Wuhan Chunzhijin An equity investee of the Company Weishi Network An equity investee of the Company Beijing Petdog An available-for-sale debt investee that the Company has significant influence Shanghai Guangcheng Information Technology (limited partnership) (“Shanghai Guangcheng Information”) A company with a common director of the Company Yingzhi (Lisa) Tang Senior management of the Company Yan Jiang Senior management of the Company Di (Jackie) Chen Senior management of the Company until July, 2021 Ying (Christina) Zhang Senior management of the Company until February, 2022 Fei Wang Senior management of the Company until April, 2022 Lijun Zhou Senior management of the Company until April, 2022 Details of related party transactions and balances as of March 31, 2020, 2021 and 2022 are as follows: The Company believes that the terms of the agreements with the related parties are comparable to the terms in arm’s-length Transactions with related parties Year Ended March 31, 2020 Year Ended March 31, 2021 Year Ended March 31, 2022 RMB RMB RMB Sales of goods Beijing Petdog 2,316 — — Year Ended March 31, 2020 Year Ended March 31, 2021 Year Ended March 31, 2022 RMB RMB RMB Online marketing and information services Beijing Petdog 315 410 — Weishi Network — — 19 315 410 19 Year Ended March 31, 2020 Year Ended March 31, 2021 Year Ended March 31, 2022 RMB RMB RMB Purchase of merchandise Nanjing Xingmu 751 — — Weishi Network — — 1,582 Nanjing Animal Pharmaceutical 45 250 1,020 796 250 2,602 Year Ended March 31, 2020 Year Ended March 31, 2021 Year Ended March 31, 2022 RMB RMB RMB Loans granted to related parties Shanghai Guangcheng Information (a) — — 33,395 Wuhan Chunzhijin (b) — 5,690 2,600 Yingzhi (Lisa) Tang — — 1,750 Lijun Zhou — — 300 Yan Jiang — 200 70 Nanjing Animal Pharmaceutical (c) 1,000 500 — Ying (Christina) Zhang 152 — — Di (Jackie) Chen 785 — — Fei Wang — 500 — 1,937 6,890 38,115 (a) In April 2021, the Company granted Shanghai Guangcheng Information a short-term loan with a total principal amount of million The loan was fully repaid by March 31, 2022. (b) From April 2020 to January 2021, the Company provided interest free loans to Wuhan Chunzhijin with an aggregate amount of million, (c) In December 2019, Nanjing Xingmu, one of the Company’ subsidiaries, entered into a twelve-month interest free loan agreement with Nanjing Agricultural Pharmaceutical for a principal amount of The loan was repaid in June 2021. Year Ended March 31, 2020 Year Ended March 31, 2021 Year Ended March 31, 2022 RMB RMB RMB Staff advances Yingzhi (Lisa) Tang — 10 — Di (Jackie) Chen 6 — — 6 10 — Advances provided to related parties Nanjing Animal Pharmaceutical — 2,073 — Wuhan Chunzhijin 3,350 — — 3,350 2,073 — Loans granted from related parties Shanghai Guangcheng Information (a) — — 9,961 Yingzhi (Lisa) Tang (b) 1,450 — — Di (Jackie) Chen (c) 1,250 — — Yan Jiang (d) 9,000 — — 11,700 — 9,961 (a) In April 2021, the Company obtained a total loan facility up to USD5 million from Shanghai Guangcheng Information. During the year ended March 31, 2022, the Company drew down a total amount of from the loan facility, with interest bearing at 3.5% per annum. The loan was fully repaid by March 31, 2022. (b) In September 2019, the Company obtained a two-year (c) In October 2019, Di (Jackie) Chen advanced RMB1.25 million to the Company, which was repaid by the Company in the same month. (d) In September 2019, the Company obtained a two-year Amounts due from related parties As of March 31, As of March 31, As of March 31, RMB RMB RMB Trade receivables from related parties Beijing Petdog 1,564 — — Prepayments to related parties Nanjing Animal Pharmaceutical — 2,023 1,650 Weishi Network — — 1,582 — 2,023 3,232 As of March 31, As of March 31, As of March 31, RMB RMB RMB Other receivables from related parties Wuhan Chunzhijin 2,481 7,295 7,594 Loans to related parties Nanjing Animal Pharmaceutical 1,000 500 — Yingzhi (Lisa) Tang — 10 — Yan Jiang — 200 200 Di (Jackie) Chen (a) 785 785 — Ying (Christina) Zhang 152 152 — Fei Wang (b) — 500 500 Lijun Zhou — — 200 1,937 2,147 900 (a) In December 2019, the Company entered into a twelve-month interest free loan agreement with, Di (Jackie) Chen, for a principal amount of RMB0.7 million. In December 2020, the loan contract was renewed to June 2023 and was recorded as other non-current assets as of March 31, 2022. (b) In January 2021, the Company entered into a one-year loan agreement with Fei Wang, for a principal amount of RMB0.5 million, bearing an interest rate of 4% per annum. This l Amounts due to related parties As of March 31, As of March 31, As of March 31, RMB RMB RMB Trade payables to related parties Nanjing Animal Pharmaceutical 45 874 219 As of March 31, As of March 31, As of March 31, RMB RMB RMB Advances from related parties Beijing Petdog — 36 — Long-term loan from related parties Yingzhi (Lisa) Tang (a) 2,521 — — Yan Jiang (b) 9,000 — — 11,521 — — (a) In July 2018, the Company entered into a forty-month loan agreement with Yingzhi (Lisa) Tang, for a principal amount of US$0.15 million (RMB1.0 million), bearing an interest rate of 6% per annum. The loan was early repaid in January 2021. In September 2019, the Company entered into another two-year (b) The balance as of December 31, 2019 represented a two-year

Commitments and contingencies

Commitments and contingencies	12 Months Ended
	Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	29. Commitments and contingencies (a) Capital commitments The Company’s capital commitments primarily relate to commitments on leasehold improvement and purchase of equipment. As of March 31, 2021 and 2022, no capital commitment was related to leasehold improvement and purchase of equipment. (b) Contingencies The Company is subject to legal proceedings and regulatory actions in the ordinary course of business. The results of such proceedings cannot be predicted with certainty, but the Company does not anticipate that the final outcome arising out of any such matter will have a material adverse effect on our consolidated financial position, cash flows or results of operations on an individual basis or in the aggregate. As of March 31, 2021 and 2022, the Company is not a party to any material legal or administrative proceedings.

Subsequent events

Subsequent events	12 Months Ended
	Mar. 31, 2022
Subsequent Events [Abstract]
Subsequent events	30. Subsequent events On May 20, 2022, the Company announced to change the ratio of its ADSs to Class A ordinary shares. Under the revised ratio, the Company changed its ratio from one (1) ADS representing three fourths (0.75) Class A ordinary shares to one (1) ADS representing four and a half (4.5) Class A ordinary shares (the “Revised ADS Ratio Change”). The Revised ADS Ratio Change became effective from June 3, 2022.

Restricted net assets

Restricted net assets	12 Months Ended
	Mar. 31, 2022
Receivables [Abstract]
Restricted net assets	31. Restricted net assets The Company’s ability to pay dividends may depend on the Company receiving distributions of funds from the Company’s subsidiaries and the VIEs incorporated in the PRC. Relevant PRC statutory laws and regulations permit payments of dividends by the Company’s PRC subsidiaries only out of their retained earnings, if any, as determined in accordance with PRC accounting standards and regulations. The results of operations reflected in the consolidated financial statements prepared in accordance with US GAAP differ from those reflected in the statutory financial statements of the Company’s PRC subsidiary. In accordance with the Company law of the PRC, a domestic enterprise is required to provide statutory reserves of at least 10% of its annual after-tax For the years ended March 31, 2020, 2021 and 2022, appropriation to statutory reserves was made because two PRC subsidiaries had generated profits for these periods. As a result of these PRC laws and regulations subject to the limit discussed above that require annual appropriations of 10% of after-tax Foreign exchange and other regulations in the PRC further restrict the Company’s PRC subsidiaries from transferring funds to the Company in the form of dividends, loans and advances. As of March Rules 12-04(a) 4-08(e)(3) S-X S-X Rule4-08

Principal Accounting Policies (

Principal Accounting Policies (Policies)	12 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
Basis of preparation	(a) Basis of preparation The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”). Significant accounting policies followed by the Company in the preparation of the accompanying consolidated financial statements are summarized below.
Basis of consolidation	(b) Basis of consolidation The Company’s consolidated financial statements include the financial statements of the Company, its subsidiaries, the consolidated VIEs and VIEs’ subsidiaries for which the Company is the primary beneficiary. A subsidiary is an entity in which the Company, directly or indirectly, controls more than one half of the voting power, has the power to appoint or remove the majority of the members of the board of directors, to cast a majority of votes at the meeting of the board of directors or to govern the financial and operating policies of the investee under a statute or agreement among the shareholders or equity holders. A consolidated VIE is an entity in which the Company, or its subsidiaries, through Contractual Agreements, bears the risks of, and enjoys the rewards normally associated with, ownership of the entity, and therefore the Company or its subsidiaries are the primary beneficiary of the entity. All transactions and balances among the Company, its subsidiaries, the consolidated VIEs and VIEs’ subsidiaries have been eliminated upon consolidation .
Business combination and non-controlling interests	(c) Business combination and non-controlling The Company accounts for its business combinations using the acquisition method of accounting in accordance with Accounting Standards Codification (“ASC”) 805, Business Combinations non-controlling non-controlling In a business combination achieved in stages, the Company re-measures re-measurement When there is a change in ownership interests or a change in contractual arrangements that results in a loss of control of a subsidiary or consolidated VIE, the Company deconsolidates the subsidiary or consolidated VIE from the date control is lost. Any retained non-controlling For the Company’s consolidated subsidiaries, VIEs and VIEs’ subsidiaries, non-controlling Non-controlling
Use of estimates	(d) Use of estimates The preparation of the Company’s consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company believes that assessment for impairment of long-lived assets and valuation of available-for-sale Management bases the estimates on historical experience and on various other assumptions as discussed elsewhere to the consolidated financial statements that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. On an ongoing basis, management evaluates its estimates based on information that is currently available. Changes in circumstances, facts and experience may cause the Company to revise its estimates. Changes in estimates are recorded in the period in which they become known. Actual results could materially differ from these estimates.
Functional currency and foreign currency translation	(e) Functional currency and foreign currency translation The Company’s reporting currency is Renminbi (“RMB”). The functional currency of the Company’s entities incorporated in Cayman Islands, British Virgin Islands and Hong Kong is the United States dollars (“US$”). The Company’s PRC subsidiaries, consolidated VIEs and VIEs’ subsidiaries determined their functional currency to be RMB. The determination of the respective functional currency is based on the criteria of ASC 830, Foreign Currency Matters Transactions denominated in other than the functional currencies are translated into the functional currency of the entity at the exchange rates prevailing on the transaction dates. Financial assets and liabilities denominated in other than the functional currency are translated at the balance sheet date exchange rate. The resulting exchange differences are included in the consolidated statements of comprehensive loss as foreign exchange related gains (losses), net. The financial statements of the Company are translated from the functional currency into RMB. Assets and liabilities denominated in foreign currencies are translated into RMB using the applicable exchange rates at the balance sheet date. Equity accounts other than earnings generated in current period are translated into RMB at the appropriate historical rates. Revenues, expenses, gains and losses are translated into RMB using the periodic average exchange rates. The resulting foreign currency translation adjustments are recorded in accumulated other comprehensive income (loss) as a component of shareholders’ equity. The exchange rates used for translation on March 31, 2021 and 2022 were US$1.00= RMB 6.5713 and RMB 6.3482, respectively, representing the index rates stipulated by the People’s Bank of China.
Convenience translation	(f) Convenience translation Translations of the consolidated balance sheets, the consolidated statements of comprehensive loss and the consolidated statements of cash flows from RMB into US$ as of and for the year ended March 31, 2022 are solely for the convenience of the readers and were calculated at the rate of US$1.00=RMB 6.3393, representing the certificated exchange rate published by the Federal Reserve Board. No representation is made that the RMB amounts could have been, or could be, converted, realized or settled into US$ at that rate on March 31, 2022, or at any other rate.
Fair value of financial instruments	(g) Fair value of financial instruments Accounting guidance defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and it considers assumptions that market participants would use when pricing the asset or liability. The established fair value hierarchy requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The three levels of inputs that may be used to measure fair value: Level 1: Quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2: Observable, market-based inputs, other than quoted prices, in active markets for identical assets or liabilities. Level 3: Unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities. Accounting guidance also describes three main approaches to measuring the fair value of assets and liabilities: (1) market approach; (2) income approach and (3) cost approach. The market approach uses prices and other relevant information generated from market transactions involving identical or comparable assets or liabilities. The income approach uses valuation techniques to convert future amounts to a single present value amount. The measurement is based on the value indicated by current market expectations about those future amounts. The cost approach is based on the amount that would currently be required to replace an asset. Financial assets and liabilities of the Company mainly consist of cash and cash equivalents, short-term investments, accounts receivable, amounts due from related parties, prepayments and other current assets, available-for-sale As of March 31, 2021 and 2022, except for available-for-sale non-current
Cash and cash equivalents	(h) Cash and cash equivalents Cash and cash equivalents include cash on hand and time deposits placed with banks and third party payment processors, which are unrestricted as to withdrawal or use, have original maturities of three months or less at the time of purchase and are readily convertible to known amounts of cash.
Short-term investments	(i) Short-term investments Short-term investments comprise primarily of (i) cash deposits at fixed rates with original maturities of greater than three months, but less than 12 months and; (ii) the investments issued by commercial banks or other financial institutions with a variable interest rate indexed to the performance of underlying assets within one year. As of March 31, 2022, RMB128 million short-term investments were used as collateral of RMB111 million short-term borrowings.
Accounts receivable, net	(j) Accounts receivable, net Accounts receivable are presented net of allowance for doubtful accounts. The Company maintains an allowance for doubtful accounts which reflects its best estimate of amounts that potentially will not be collected. The Company determines the allowance for doubtful accounts on general basis taking into consideration various factors including but not limited to historical collection experience and credit-worthiness of the customers as well as the age of the individual receivables balance. Additionally, the Company makes specific bad debt provisions based on any specific knowledge the Company has acquired that might indicate that an account is uncollectible. The facts and circumstances of each account may require the Company to use substantial judgment in assessing its collectability.
Inventories	(k) Inventories Inventories are stated at the lower of cost and net realizable value. Cost elements of our inventories comprise the purchase price of products, vendor rebates, shipping charges to receive products from the suppliers when they are embedded in the purchase price. Cost is determined using the first-in first-out
Property and equipment, net	(l) Property and equipment, net Property and equipment are carried at cost less accumulated depreciation and amortization. Depreciation is calculated on a straight-line basis over the following estimated useful lives. The estimated useful lives are as follows: Useful years Warehouse equipment 3 - 5 years Furniture, computer and office equipment 3 - 5 years Vehicles 5 years Software 10 years Leasehold improvements Over the shorter of the expected life of leasehold improvements or the lease term Expenditures for maintenance and repairs are expensed as incurred. The gain or loss on the disposal of property and equipment is the difference between the net sales proceeds and the carrying amount of the relevant assets and is recognized in the consolidated statements of comprehensive loss.
Intangible assets, net	(m) Intangible assets, net Intangible assets purchased from third parties are initially recorded at cost. The Company performs valuation of the intangible assets arising from business combination to determine the relative fair value to be assigned to each asset acquired. The intangible assets are amortized using the straight-line method over the estimated useful lives of the assets. The estimated useful lives of intangible assets are as follows: Useful years Trademark 10 years Dealership 10 years License 4.5 years The estimated life of amortized intangibles is reassessed if circumstances occur that indicate the life has changed.
Goodwill	(n) Goodwill Goodwill represents the excess of the purchase price over the fair value of the identifiable assets and liabilities acquired in a business combination. Goodwill is not depreciated or amortized but is tested for impairment on an annual basis as of March 31, and in between annual tests when an event occurs or circumstances change that could indicate that the asset might be impaired. In accordance with the FASB guidance on “Testing of Goodwill for Impairment”, a company first has the option to assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If the Company decides, as a result of its qualitative assessment, that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, the quantitative impairment test is mandatory. Otherwise, no further testing is required. The quantitative impairment test consists of a comparison of the fair value of each reporting unit with its carrying amount, including goodwill. If the carrying amount of each reporting unit exceeds its fair value, an impairment loss equal to the difference between the implied fair value of the reporting unit’s goodwill and the carrying amount of goodwill will be recorded. Application of a goodwill impairment test requires significant management judgment, including the identification of reporting units, assigning assets and liabilities to reporting units, assigning goodwill to reporting units, and determining the fair value of each reporting unit. The judgment in estimating the fair value of reporting units includes estimating future cash flows, determining appropriate discount rates and making other assumptions. Changes in these estimates and assumptions could materially affect the determination of fair value for each reporting unit.
Long-term investments	(o) Long-term investments The Company’s investments include equity method investments, equity securities with readily determinable fair values and available-for-sale The Company applies the equity method of accounting to account for an equity investment, in common stock or in-substance Equity securities with readily determinable fair values are measured and recorded at fair value on a recurring basis with changes in fair value, whether realized or unrealized, recorded through the income statement. Debt securities that the Company has the intent to hold the security for an indefinite period or may sell the security in response to the changes in economic conditions are classified as available-for-sale The Company continually reviews its investments to determine whether a decline in fair value to below the carrying value is other-than-temporary. The primary factors the Company considers in its determination are the duration and severity of the decline in fair value; the financial condition, operating performance and the prospects of the equity investee; and other company specific information such as recent financing rounds. If the decline in fair value is deemed to be other-than-temporary, the carrying value of the investment is written down to fair value.
Impairment of long-lived assets other than goodwill	(p) Impairment of long-lived assets other than goodwill Long-lived assets are evaluated for impairment whenever events or changes in circumstances (such as a significant adverse change to market conditions that will impact the future use of the assets) indicate that the carrying amount may not be fully recoverable or that the useful life is shorter than the Company had originally estimated. When these events occur, the Company evaluates the impairment by comparing carrying value of the assets to an estimate of future undiscounted cash flows expected to be generated from the use of the assets and their eventual disposition. If the sum of the expected future undiscounted cash flows is less than the carrying value of the assets, the Company recognizes an impairment loss based on the excess of the carrying value of the assets over the fair value of the assets.
Revenue recognition	(q) Revenue recognition In May 2014, the FASB issued ASU No. 2014-09, 2014-09”) 2014-09 No. 2014-09 The Company adopted ASC 606 for all periods presented. Consistent with the criteria of Topic 606, the Company follows five steps for its revenue recognition: (i) identify the contract(s) with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) the entity satisfies a performance obligation. Revenue arrangements with multiple performance obligations are divided into separate distinct goods or services. The Company allocates the transaction price to each performance obligation based on the relative standalone selling price of the goods or services provided. The Company’s revenues are primarily derived from (i) product sales and (ii) online marketing and information services and other service. When either party to a contract has performed, the Company presents the contract in the statement of financial position as a contract asset or a contract liabilities, depending on the relationship between the entity’s performance and the customer’s payment. A receivable is recorded when the Company has an unconditional right to consideration. A right to consideration is unconditional if only the passage of time is required before payment of that consideration is due. A contract asset is recorded when the Company has transferred products or services to the customer before payment is received or is due, and the Company’s right to consideration is conditional on future performance or other factors in the contract. No contract asset was recorded as of March 31, 2021 and 2022. The Company’s contract liabilities consist of payments received or awards to customers (in the form of Boqii Beans) related to unsatisfied performance obligations at the end of the period. As of April 1, 2020 and 2021, the Company’s total contract liabilities were RMB7.7 million and RMB3.9 million, respectively, of which RMB7.7 million and RMB3.6 million were recognized as revenue for the years ended March 31, 2021 and 2022. The Company’s total unearned revenue was RMB7.0 million as of March 31, 2022. Revenue is recorded net of value-added tax. Revenue recognition policies for each type of revenue steam are as follows: Sales of merchandise The Company primarily sells pet products through online stores to individual online customers. Besides online sales, the Company also sells products through offline channels to its business customers and pet stores across the country. The Company recognizes the product revenues from products sales on a gross basis as the Company is acting as a principal in these transactions. The Company has obtained control of the products before they are transferred to customers. The Company is primarily obligated in these transactions, is subject to inventory risk or has the ability to direct the use of inventory, and has latitude in establishing prices and selecting suppliers. Revenue is recognized when consumers physically accept the products after delivery, which is when the control of products is transferred, and is recorded net of return allowances and rebates to pet stores. The Company also enters into arrangement with its business partners to sell their products on the Company’s online stores. The Company considers the arrangement meet the indicators of consignment arrangement under ASC 606-10-55-80, Online marketing and information services and other revenue The Company provides online marketing and information services to third-party on the Company’s various channels and third-party platforms, including but not limited to advertising placements, organizing online and offline marketing campaigns featuring social media influencers and circulating marketing messages to end consumers. With respect to the Company’s marketing services, length of the periods over which services are provided are generally within months or less, revenue from such arrangements is recognized ratably over the service period, as the third-party simultaneously consumes the benefits when the advertisement is displayed or the campaign is ongoing. The Company also provides warehouse services. The warehouse services include warehousing, packaging, dispatching and other services. Revenue is primarily recognized when the services are rendered.
Sales returns	(r) Sales returns The Company offers online consumers an unconditional right of return for a period of seven days upon receipt of products. Return allowances, which reduce revenue and cost of sales, are estimated by categories of return policies offered to online customers, based on historical data the Company has maintained, and subject to adjustments to the extent that actual returns differ or are expected to differ.
Sales incentives	(s) Sales incentives The Company adopted a customer reward program, under which the Company grants certain units (“Boqii Bean”) to its customers at its discretion in different situations. Boqii Beans are not redeemable for cash and can be used as a coupon for the customer’s future purchase on the Boqii Marketplace and Boqii.com. The value of ten units of Boqii Bean is equivalent to one RMB yuan before taking into account the impact of breakage. For the Boqii Beans that are granted with concurrent revenue transactions, the allocated transaction price based on its relative standalone selling price are recognized as reduction of the revenue and accrued for as contract liabilities. As customers redeem awards, the accrued liability is reduced correspondingly. For the Boqii Beans that are granted without concurrent revenue transactions, they are not accounted for when granted and are recognized as a reduction of revenue when they are applied in future sales. The Company also has a coupon program, through which the Company grants coupons to online customers when they make a successful purchase order, finish first registration on Boqii Marketplace or comment on products. When a coupon is granted concurrent with a revenue transaction, the Company accounts for the estimated cost of future usage of the coupon as reduction of the revenue. When a coupon is not granted concurrent with a revenue transaction, they are not accounted for when they are granted and are recognized as a reduction of revenue when they are applied in future sales.
Cost of revenue	(t) Cost of revenue Cost of revenue consist of cost of product sales of RMB610.6 million, RMB820.3 million and RMB930.4 million for the years ended March 31, 2020, 2021 and 2022, respectively, and cost of services of RMB0.9 million, RMB3.4 million and RMB13.3 million for the years ended March 31, 2020, 2021 and 2022, respectively. Cost of product sales comprise the purchase price of products, vendor rebates and inventory write-downs. Cost of products does not include other direct costs related to cost of product sales such as shipping and handling expense, payroll and benefits of logistic staff, logistic centers rental expenses and depreciation expenses. Cost of service consists of the advertising and promotion costs, employee wages and benefits in connection with the Company’s provision of marketing and information services including the fees that the Company paid to third party for advertising and promotion on various online and offline channels.
Vendor rebates	(u) Vendor rebates The Company periodically receives consideration from certain vendors, representing rebates for products sold over a period of time. The Company accounts for the rebates received from its vendors as a reduction to the price it pays for the products purchased. Rebates are earned based on reaching minimum purchased thresholds for a specified period. When volume rebates can be reasonably estimated based on the Company’s past experience, current forecasts and purchase volume, a portion of the rebate is recognized as the Company makes progress towards the purchase threshold.
Fulfillment expenses	(v) Fulfillment expenses Fulfillment costs primarily represent warehousing, shipping and handling expenses for dispatching and delivering products to consumers, employee wages and benefits for the relevant personnel, customs clearance expenses and other related transaction costs.
Sales and marketing expenses	(w) Sales and marketing expenses Sales and marketing expenses comprise primarily of advertising expenses, third-party platforms commission fee, employee wages, rental expenses and benefits for sales and marketing staff, depreciation expenses and other daily expenses which are related to the sales and marketing functions. Advertising expenses consist primarily of customer acquisition cost and costs for the promotion of corporate image and product marketing. The Company expenses all advertising costs as incurred and classifies these costs under sales and marketing expenses. For the years ended March 31, 2020, 2021 and 2022, the advertising expenses were RMB69 million, RMB83 million and RMB81 million, respectively.
General and administrative expenses	(x) General and administrative expenses General and administrative expenses consist of employee wages and benefits for corporate employees, research and development expenses and other expenses which are related to the general corporate functions, including accounting, finance, tax, legal and human resources, costs associated with use by these functions of facilities and equipment, such as depreciation expenses, rental and other general corporate related expenses.
Leases	(y) Leases The Company determines if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use non-current ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. When determining the lease term, the Company includes options to extend or terminate the lease when it is reasonably certain that it will exercise that option, if any. As the Company’s leases do not provide an implicit rate, the Company uses its incremental borrowing rate, which it calculates based on the credit quality of the Company and by comparing interest rates available in the market for similar borrowings, and adjusting this amount based on the impact of collateral over the term of each lease. The Company has elected to early adopt the following lease policies in conjunction with the adoption of ASU 2016-02 non-lease non-lease
Government grant	(z) Government grant The Company’s PRC based subsidiaries received government subsidies from certain local governments. The Company’s government subsidies consisted of specific subsidies and other subsidies. Specific subsidies are subsidies that the local government has provided for a specific purpose, such as product development and renewal of production facilities. Other subsidies are the subsidies that the local government has not specified its purpose for and are not tied to future trends or performance of the Company; receipt of such subsidy income is not contingent upon any further actions or performance of the Company and the amounts do not have to be refunded under any circumstances. The Company recorded specific purpose subsidies as advances payable when received. For specific subsidies, upon government acceptance of the related project development or asset acquisition, the specific purpose subsidies are recognized to reduce related cost of asset acquisition. Other subsidies are recognized as other income upon receipt as further performance by the Company is not required.
Income taxes	(aa) Income taxes Current income taxes are recorded in accordance with the regulations of the relevant tax jurisdiction. The Company accounts for income taxes under the asset and liability method in accordance with ASC 740, Income Tax Uncertain tax positions The Company recognizes in its consolidated financial statements the benefit of a tax position if the tax position is “more likely than not” to prevail based on the facts and technical merits of the position. Tax positions that meet the “more likely than not” recognition threshold are measured at the largest amount of tax benefit that has a greater than fifty percent likelihood of being realized upon settlement. The Company estimates its liability for unrecognized tax benefits which are periodically assessed and may be affected by changing interpretations of laws, rulings by tax authorities, changes and/or developments with respect to tax audits, and expiration of the statute of limitations. The ultimate outcome for a particular tax position may not be determined with certainty prior to the conclusion of a tax audit and, in some cases, appeal or litigation process. The actual benefits ultimately realized may differ from the Company’s estimates. As each audit is concluded, adjustments, if any, are recorded in the Company’s consolidated financial statements in the period in which the audit is concluded. Additionally, in future periods, changes in facts, circumstances and new information may require the Company to adjust the recognition and measurement estimates with regard to individual tax positions. Changes in recognition and measurement estimates are recognized in the period in which the changes occur. As of March 31, 2021 and 2022, the Company did not have any significant unrecognized uncertain tax positions.
Share-based compensation	(ab) Share-based compensation The Company follows ASC 718 to determine whether a share option should be classified and accounted for as a liability award or equity award. All grants of share-based awards to employees, management and nonemployees classified as equity awards are recognized in the financial statements based on their grant date fair values which are calculated using an option pricing model. Employees’ share-based compensation awards are measured at the grant date fair value of the awards and recognized as expenses (a) immediately at the grant date if no vesting conditions are required; or (b) for share-based awards granted with only service conditions, using the graded vesting method, net of estimated forfeitures, over the vesting period; or (c) for share-based awards granted with service conditions and the occurrence of an initial public offering (“IPO”) as performance condition, cumulative share-based compensation expenses for the options that have satisfied the service condition should be recorded upon the completion of the IPO, using the graded vesting method. Under ASC 718, the Company applies the Binominal option pricing model in determining the fair value of options granted. ASC 718 requires forfeiture rates to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from initial estimates. Share-based compensation expense is recorded net of estimated forfeitures such that expense is recorded only for those share-based awards that are expected to vest.
Net loss per share	(ac) Net loss per share Basic net loss per share is computed by dividing net loss attributable to holders of ordinary shares by the weighted average number of ordinary shares outstanding during the year using the two-class method. Using the two-class method, net profit/loss is allocated between ordinary shares and other participating securities (i.e. preferred shares) based on their participating rights. Diluted loss per share is calculated by dividing net loss attributable to ordinary shareholders as adjusted for the effect of dilutive ordinary equivalent shares, if any, by the weighted average number of ordinary and dilutive ordinary equivalents shares outstanding during the year/period. Ordinary share equivalents consist of the ordinary shares issuable in connection with the Company’s convertible redeemable preferred shares using the if-converted
Comprehensive loss	(ad) Comprehensive loss Comprehensive loss is defined as the changes in shareholders’ equity of the Company during a period transactions and other events and circumstances excluding transactions resulting from investments from shareholders, distributions to shareholders, accretions on convertible redeemable preferred shares and modification and extinguishment of convertible redeemable preferred shares. Comprehensive loss for the periods presented includes net loss and foreign currency translation adjustments.
Segment reporting	(ae) Segment reporting ASC 280, Segment Reporting Based on the criteria established by ASC 280, the Company’s chief operating decision maker (“CODM”) has been identified as the Chief Executive Officer, who reviews consolidated results when making decisions about allocating resources and assessing performance of the Company. As a whole and hence, the Company has only one reportable segment. The Company does not distinguish between markets or segments for the purpose of internal reporting. As the Company’s long-lived assets are substantially located in the PRC and substantially all the Company’s revenue are derived from within the PRC, no geographical segments are presented.
Recent accounting pronouncements	(af) Recent accounting pronouncements The Company qualifies as an “emerging growth company”, or EGC, pursuant to the Jumpstart Our Business Startups Act of 2012, as amended, or the JOBS Act. As an EGC, the Company does not need to comply with any new or revised financial accounting standards until such date that a private company is otherwise required to comply with such new or revised accounting standards. The Company adopts the following standards based on extended transition period provided to private companies or early adopts as necessary as permitted by the respective standards. New and Amended Standards Adopted by the Company: In August 2018, the FASB issued ASU 2018-13, Fair In December 2019, the FASB issued ASU 2019-12—Income 2019-12 2019-12 New and amended standards not yet adopted by the Company: In June 2016, the FASB issued ASU 2016-13, 2016-13 2016-13 In August 2020, the FASB issued ASU 2020-06, “Debt (Subtopic 470-20) and (Subtopic 815-40),” which diluted earnings-per-share calculations In October 2021, the FASB issued ASU 2021-08, “Business

Organization and principal ac_2

Organization and principal activities (Tables)	12 Months Ended
	Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Details of the Subsidiaries, VIEs and VIE's Subsidiaries	As of March 31, 2022, the Company’s principal subsidiaries, consolidated VIEs and major VIEs’ subsidiaries are as follows: Name of subsidiaries and VIE Place of Date of or acquisition Percentage of direct or indirect Principal activities Subsidiaries: Boqii Corporation Limited (“Boqii Corporation”) Hong Kong July 2012 100 % Investment holding Boqii International Limited Hong Kong August 2016 100 % Investment holding Xingmu International Limited British Virgin Islands August 2019 51 % Investment holding Xingmu HK Limited Hong Kong November 2019 51 % Investment holding Nanjing Xinmu Information Technology Co., Ltd. (“Xingmu WFOE”) Nanjing, the PRC November 2019 51 % Technology development and sales of merchandise Xincheng (Shanghai) Information Technology Co., Ltd. (“Shanghai Xincheng”) Shanghai, the PRC November 2012 100 % Technology development and sales of merchandise Shanghai Yiqin Pets Products Co., Ltd. Shanghai, the PRC February 2013 100 % Technology development and sales of merchandise Consolidated VIEs Guangcheng (Shanghai) Information Technology Co., Ltd. Shanghai, the PRC November 2012 100 % Operates the Company’s own online e-commerce platform Nanjing Xingmu Biotechnology Co., Ltd. (“Nanjing Xingmu”) Nanjing, the PRC November 2019 51 % Biotechnology research and development Suzhou Taicheng Supply Chain Co., Ltd. (“Suzhou Taicheng”) Suzhou, the PRC June 2021 100 % Sales of merchandise Subsidiaries of VIEs Boqii (Shanghai) Information Technology Co., Ltd. Shanghai, the PRC August 2014 90 % Technology development Tianjing Guangcheng Information Technology Co., Ltd. Tianjin, the PRC June 2017 100 % Sales of merchandise Nanjing Cuida Biotechnology Co. Ltd.(“Cuida”) Nanjing, the PRC April 2017 70 % Biotechnology extension services Taizhou Xingmu Biotechnology Co., Ltd. Taizhou, the PRC November 2019 80 % Biotechnology research and development
Schedule of Variable Interest Entities	The following table set forth the assets, liabilities, results of operations and changes in cash, cash equivalents and restricted cash of the consolidated VIEs and their subsidiaries taken as a whole, which were included in the Company’s consolidated financial statements with intercompany transactions eliminated (RMB in thousands): As of March 31, 2021 2022 RMB RMB Cash and cash equivalents 17,886 20,567 Accounts receivable, net 27,393 31,435 Amounts due from related parties 11,465 11,726 Inventories, net 11,349 16,014 Prepayments and other current assets 33,445 57,107 Intra-Group receivables due from the Group’s entities 47,592 16,535 Property and equipment, net 8,372 6,715 Intangible assets 909 507 Operating lease right-of-use 27,736 35,688 Goodwill 494 994 Long-term investments 74,330 81,649 Other non-current 2,433 3,389 Total assets 263,404 282,326 As of March 31, 2021 2022 RMB RMB Short-term borrowings 3,484 872 Accounts payable 29,940 55,144 Amounts due to related parties, current 910 4 Salary and welfare payable 4,851 5,597 Accrued liabilities and other current liabilities 24,536 25,786 Contract liabilities 3,706 7,007 Operating lease liabilities, current 6,058 7,238 Intra-Group payables due to the Group’s entities 611,112 945,960 Deferred tax liabilities 1,852 (1,369 ) Operating lease liabilities, non-current 19,997 28,197 Long-term borrowings 872 — Other debts, non-current 415,122 157,874 Total liabilities 1,122,440 1,232,310 Year Ended March 31, 2020 2021 2022 RMB RMB RMB Net revenues: Third-party revenues 579,365 735,518 877,380 Intra-Group revenues 92,728 48,374 56,079 Total revenues 672,093 783,892 933,459 Cost of revenues: Third-party cost of revenues (226,958 ) (372,475 ) (160,661 ) Intra-Group cost of revenues (282,210 ) (297,844 ) (550,585 ) Total cost of revenues (509,168 ) (670,319 ) (711,246 ) Gross profit 162,925 113,573 222,213 Operating expenses: Third-party operating expenses (229,658 ) (254,951 ) (288,291 ) Intra-Group operating expenses — (7,257 ) — Total operating expenses (229,658 ) (262,208 ) (288,291 ) Other income, net 1,688 1,011 98 Loss from operations (65,045 ) (147,624 ) (65,980 ) Non-operating income /(expense) 3,236 (18,162 ) (20,680 ) Loss before income tax expenses (61,809 ) (165,786 ) (86,660 ) Income tax benefits/(expenses) 141 (20 ) 681 Share of results of equity investees (137 ) (696 ) 418 Net loss (61,805 ) (166,502 ) (85,561 ) Cash flows from operating activities: Net cash provided by transactions with external parties 126,224 419,767 526,201 Net cash used in transactions with the Group’s entities (104,125 ) (331,064 ) (329,325 ) Net cash generated from operating activities 22,099 88,703 196,876 Cash flows from investing activities: Other investing activities (64,591 ) (31,972 ) (18,482 ) Cash flows of loan funding provided to the Group’s entities, net of repayments received 21,156 (5,242 ) 6,294 Net cash used in investing activities (43,435 ) (37,214 ) (12,188 ) Cash flows from financing activities: Other financing activities 73,626 (112,151 ) (273,906 ) Cash flows of loan funding received from the Group’s entities, net of repayments made (29,398 ) 41,717 91,794 Net cash generated from/ (used in) financing activities 44,228 (70,434 ) (182,112 )

Principal Accounting Policies_2

Principal Accounting Policies (Tables)	12 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
Schedule of Property Plant and Equipment & Useful Lives	The estimated useful lives are as follows: Useful years Warehouse equipment 3 - 5 years Furniture, computer and office equipment 3 - 5 years Vehicles 5 years Software 10 years Leasehold improvements Over the shorter of the expected life of leasehold improvements or the lease term
Schedule of Finite Lived Intangible Assets Useful Lives	The estimated useful lives of intangible assets are as follows: Useful years Trademark 10 years Dealership 10 years License 4.5 years

Business combinations (Tables)

Business combinations (Tables)	12 Months Ended
	Mar. 31, 2022
Chongni network technology Co Ltd [Member]
Business Acquisition [Line Items]
Summary of Identified Assets Acquired and Liabilities Assumed	On the acquisition date, the allocation of the purchase price of the assets acquired and liabilities assumed based on their fair values was as follows: As of June 30, 2021 RMB Total purchase price is comprised of: - fair value of 49% previously held equity interests 245 - cash consideration 2,938 Fair value of total consideration 3,183 Cash and cash equivalents 2 Prepayments and other current assets 4,533 Total assets 4,535 Accrued liabilities and other current liabilities (33 ) Total liabilities (33 ) Net assets acquired 4,502 Goodwill 499 Non-controlling (1,818 ) Total 3,183

Risks and Concentration (Tables

Risks and Concentration (Tables)	12 Months Ended
	Mar. 31, 2022
Risks and Uncertainties [Abstract]
Schedules of Concentration of Risk, By Risk Factor	The information of the supplier with greater than 10% of the total purchases of the Company for the years ended March 31, 2020, 2021 and 2022 was as follows: Year Ended March 31, 2020 Year Ended March 31, 2021 Year Ended March 31, 2022 RMB RMB RMB Royal Canin China Co., Ltd. 24 % 19 % 17 %

Cash and cash equivalents (Tabl

Cash and cash equivalents (Tables)	12 Months Ended
	Mar. 31, 2022
Cash and Cash Equivalents [Abstract]
Schedule of Cash and Cash Equivalents	Cash and cash equivalents represent cash on hand and demand deposits placed with banks and third party-payment processors, which are unrestricted as to withdrawal or use. Cash and cash equivalents balance as of March 31, 2021 and March 31, 2022 primarily consist of the following currencies: As of March 31, 2021 As of March 31, 2022 RMB RMB Amount equivalent Amount equivalent RMB 121,670 121,670 47,321 47,321 Hong Kong dollars 25 21 39 31 US$ 25,947 170,508 18,133 115,110 EUR 5 38 55 392 NZD — — — 1 Total 292,237 162,855

Accounts receivable, net (Table

Accounts receivable, net (Tables)	12 Months Ended
	Mar. 31, 2022
Receivables [Abstract]
Summary of Accounts Receivable Net	Accounts receivable consist of the following: As of March 31, As of March 31, 2021 2022 RMB RMB Accounts receivable - Product sales 37,429 42,070 Accounts receivable - Online marketing and information service and other service 8,559 7,630 Allowance of doubtful accounts (256 ) (469 ) Total 45,732 49,231
Summary of Movement of Allowance of Doubtful Accounts	Movement of allowance of doubtful accounts As of March 31, As of March 31, As of March 31, 2020 2021 2022 RMB RMB RMB At beginning of year 92 363 256 Addition/(reversal) 271 (107 ) 213 At end of year 363 256 469

Inventories, net of inventory_2

Inventories, net of inventory reserves (Tables)	12 Months Ended
	Mar. 31, 2022
Inventory Disclosure [Abstract]
Summary of Inventories, Net of Inventory Reserves	Inventories, net of inventory reserves consist of the following: As of March 31, As of March 31, 2021 2022 RMB RMB Products 90,913 109,383 Packaging materials and others 638 538 Total inventories, net of inventory reserves 91,551 109,921
Summary of Movement of inventory provision	Movement of inventory provision: As of March 31, As of March 31, As of March 31, 2020 2021 2022 RMB RMB RMB At beginning of year 527 273 266 Provision/(reversal) (254 ) (7 ) 311 At end of year 273 266 577

Prepayments and other current_2

Prepayments and other current assets (Tables)	12 Months Ended
	Mar. 31, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Summary of Prepayments and Other Current Assets	The prepayments and other current assets consist of the following: As of March 31, As of March 31, RMB RMB Prepayments for purchases of products (a) 53,209 52,348 Vendor rebate receivables (b) 8,723 24,462 Value-added tax (“VAT”) deductible (c) 10,672 18,864 Loan receivables (d) 3,957 3,845 Sales return assets 1,244 1,264 Deposits 1,456 1,312 Others 6,000 14,643 Total 85,261 116,738 (a) Prepayments for purchases of products represent cash prepaid to the Company’s third-party brand partners for the procurement of products. (b) Vendor rebate receivables represent the rebates to be received by the Company from its suppliers after certain levels of purchases are achieved. (c) VAT recoverable represents the balances that the Company can utilize to deduct its value-added tax liabilities within the next 12 months. (d) The balance represents loan receivables due from certain third-party companies and individuals. From April 2020 to October 2021, the Company entered into several loan agreements with aggregate principal amount of RMB4.93 million. The repayment terms of the loan agreements were ranged from 12 months and 24 months with due dates from July 2021 to October 2022. The interest rates were ranged from 0% to 4% per annum. As of March 31, 2021 and 2022, the balances of loan receivables were RMB4 million and RMB3.8 million, respectively.

Property and equipment, net (T

Property and equipment, net (Tables)	12 Months Ended
	Mar. 31, 2022
Property, Plant and Equipment [Abstract]
Summary of Property, Plant and Equipment's	Property and equipment consist of the following: As of March 31, As of March 31, RMB RMB Cost: Warehouse equipment 2,513 2,669 Furniture, computer and office equipment 6,592 7,503 Vehicles 2,891 3,684 Leasehold improvement 10,056 10,209 Software 2,709 2,995 Total cost 24,761 27,060 Less: Accumulated depreciation (16,375 ) (19,281 ) Property and equipment, net 8,386 7,779

Intangible assets, net (Tables)

Intangible assets, net (Tables)	12 Months Ended
	Mar. 31, 2022
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Schedule of Intangible Assets	Intangible assets of the Company were mainly as follows: As of March 31, As of March 31, RMB RMB Cost: Trademark 447 437 License 3,530 3,530 Dealership 31,717 31,717 Total cost 35,694 35,684 Less: Accumulated amortization (6,157 ) (10,140 ) Intangible assets, net 29,537 25,544
Schedule of Annual Estimated Amortization Expense for Intangible Assets	The annual estimated amortization expense for intangible assets subject to amortization for the succeeding five years is as follows: As of March 31, 2023 2024 2025 2026 2027 Amortization expenses 4,000 3,867 3,438 3,207 3,203

Long-Term Investments (Tables)

Long-Term Investments (Tables)	12 Months Ended
	Mar. 31, 2022
Long-term Investments and Receivables, Net [Abstract]
Summary of Long-Term Investment	The Company’s long-term investments consist of the following: As of March 31, As of March 31, RMB RMB Equity method investments 2,973 6,783 Available-for-sale 71,357 74,866 Equity securities with readily determinable fair values — 670 Total 74,330 82,319
Summary of Available-For-Sale Debt Investments	The following table summarizes the Company’s available-for-sale Cost Gross unrealized gains Gross unrealized losses Fair value Unlisted debt securities 60,000 11,357 — 71,357 The following table summarizes the Company’s available-for-sale Cost Gross unrealized gains Gross unrealized losses Fair value Unlisted debt securities 76,000 — (1,134 ) 74,866
Summary of Equity Securities With Readily Determinable Fair Values	The following table summarizes the Company’s equity securities with readily determinable fair values as of March 31, 2022: Cost Gross unrealized gains Gross unrealized losses Fair value L 1,292 — (622 ) 670

Goodwill (Tables)

Goodwill (Tables)	12 Months Ended
	Mar. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Changes in the Carrying Amount of Goodwill	The changes in the carrying amount of goodwill were as follows: Total RMB Balance as of March 31, 2020 Goodwill 40,184 Accumulated impairment loss — 40,184 Balance as of March 31, 2021 Goodwill 40,184 Accumulated impairment loss — 40,184 Transaction during the year Additions (Note 3) 500 Balance as of March 31, 2022 Goodwill 40,684 Accumulated impairment loss — 40,684

Other non-current Assets (Table

Other non-current Assets (Tables)	12 Months Ended
	Mar. 31, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Schedule of Other Non-current Assets	As of March 31, As of March 31, RMB RMB Deposits (a) 3,767 3,924 Long-term loan receivables (b) 344 937 4,111 4,861 (a) Deposits mainly consisted of rental deposits and deposit for online stores operated on third party platforms, which will be collected after one year. (b) From December 2019 to December 2021, the Company entered into interest free loan agreements with three third parties for total principal amounts of RMB1.2 million. The repayment terms of the loan agreements were ranged from 24 months to 42 months with due dates from June 2023 to December 2023. As of March 31, 2021 and 2022, the balances of long-term loan receivables were RMB0.3 million and RMB0.9 million, respectively.

Accrued liabilities and other_2

Accrued liabilities and other current liabilities (Tables)	12 Months Ended
	Mar. 31, 2022
Accrued Liabilities and Other Liabilities [Abstract]
Schedule of Accrued Liabilities and Other Current Liabilities	Accrued liabilities and other current liabilities consist of the following: As of March 31, As of March 31, RMB RMB Logistics expenses payables 16,594 14,625 Advances from customers 3,534 3,773 Payable for investment (Note (11)) — 2,563 Refund obligation of sales returns 1,543 1,411 Professional service fee accruals 3,449 579 Accrued advertising expenses 228 150 Others 4,707 4,223 Total 30,055 27,324

Leases (Tables)

Leases (Tables)	12 Months Ended
	Mar. 31, 2022
Leases [Abstract]
Summary of Operating Leases	As of March 31, As of March 31, RMB RMB Assets Operating lease right-of-use 29,234 38,567 Liabilities Operating lease liabilities, current 8,063 10,001 Operating lease liabilities, non-current 19,997 28,197 Total operating lease liabilitie s 28,060 38,198 Weighted average remaining lease term (years) 3.70 3.61 Weighted average discount rate 6.47 % 4.95 %
Summary of Operating Lease Activity	Information related to operating lease activity during the years ended March 31, 2020, 2021 and 2022 are as follows: Year ended March 31, 2020 Year ended March 31, 2021 Year ended March 31, 2022 RMB RMB RMB Operating lease right-of-use 10,051 25,970 21,038 Operating lease related expenses Amortization of right-of-use 15,708 11,687 11,705 Interest of lease liabilities 1,353 1,596 1,949 17,061 13,283 13,654 Year ended March 31, 2020 Year ended March 31, 2021 Year ended March 31, 2022 RMB RMB RMB Operating lease payments (included in measurement of lease liabilities) 18,183 12,850 12,849
Summary of Maturities of Lease Liabilities	Maturities of lease liabilities were as follows: Year ended March 31, 2022 RMB For the year ending March 31, 2023 11,311 2024 10,273 2025 11,051 2026 7,546 2027 1,299 Total lease payments 41,480 Less: imputed interest (3,282 ) Total 38,198

Interest expense (Tables)

Interest expense (Tables)	12 Months Ended
	Mar. 31, 2022
Interest and Debt Expense [Abstract]
Summary of Interest Expense	Year ended March 31, 2020 Year ended March 31, 2021 Year ended March 31, 2022 RMB RMB RMB Amortization charges on promissory notes 56,290 21,611 17,144 Interest expense on borrowings 2,815 6,039 3,740 Others 163 — — Total 59,268 27,650 20,884

Other gains (losses), net (Tabl

Other gains (losses), net (Tables)	12 Months Ended
	Mar. 31, 2022
Other Income and Expenses [Abstract]
Summary of Other (Losses), Net	Year ended March 31, 2020 Year ended March 31, 2021 Year ended March 31, 2022 RMB RMB RMB Gain from the re-measurement of the previously held equity 481 — 127 Foreign exchange losses, net (3,787 ) (2,867 ) 5,322 Gain on disposal of other debts (Note 22) 10,095 6,846 — Reimbursement from a depositary bank (a) — 6,556 1,482 Investment loss (Note 11) — — (622 ) Others 195 797 (289 ) 6,984 11,332 6,020 (a) The Company received a reimbursement of US$1.0M (equivalent to RMB6.6 million) and US$0.2M (equivalent to RMB1.5 million) from the depository for the establishment and maintenance of the ADS program for the years ended March 31, 2021 and March 31, 2022.

Income taxes (Tables)

Income taxes (Tables)	12 Months Ended
	Mar. 31, 2022
Income Tax Disclosure [Abstract]
Schedule of Effective Income Tax Rate Reconciliation	Reconciliations of the differences between the income tax expenses of the Company and the PRC statutory EIT rate applicable to losses of the consolidated entities are as follows: Year ended March 31, 2020 Year ended March 31, 2021 Year ended March 31, 2022 RMB RMB RMB Loss before income taxes (175,925 ) (193,391 ) (134,812 ) Income tax computed at respective applicable tax rate s (43,981 ) (48,348 ) (33,702 ) Effect of different tax jurisdiction 19,507 14,272 2,341 Super deduction for research and development expenses (a) (4,719 ) (2,632 ) (1,881 ) Non-deductible 138 140 97 Change in valuation allowance 29,567 37,439 34,716 Total 512 871 1,571 (a) According to the relevant laws and regulations promulgated by the State Administration of Tax of the PRC, from 2018 onwards, enterprises engaging in research and development activities are entitled to claim 175% of their qualified research and development expenses so incurred as tax deductible expenses. The additional deduction of 75% of qualified research and development expenses (the “Super Deduction”) can be directly claimed in the annual EIT filing. For the years end March 31, 2020, 2021 and 2022, the Super Deduction for research and development expenses available to the Company amounted to Reconciliations between the effective income tax rate and the PRC statutory income tax rates are as follows: Year ended March 31, 2020 Year ended March 31, 2021 Year ended March 31, 2022 RMB RMB RMB PRC statutory income tax rates 25 % 25 % 25 % Tax holiday effec t (3 %) 1 % 3 % Difference in tax rates of subsidiaries outside PRC (8 %) (8 %) (8 %) Super deduction for research and development expenses 3 % 1 % 1 % Non-deductible 0 % 0 % 0 % Change in valuation allowance (17 %) (19 %) (20 %) Effective income tax rate 0 % 0 % 1 %
Summary of Income Tax Holiday	The following table sets forth the effect of tax holiday effect on China operations: Year ended March 31, 2020 Year ended March 31, 2021 Year ended March 31, 2022 RMB RMB RMB Tax holiday effect (5,471 ) 1,074 3,513 Basic and diluted net loss per share effect (0.25 ) 0.02 0.05
Schedule of Components of Income Tax Expense (Benefit)	The current and deferred portions of income tax expenses included in the consolidated statements of comprehensive loss are as follows: Year ended March 31, 2020 Year ended March 31, 2021 Year ended March 31, 2022 RMB RMB RMB Current income tax expense/(benefit) 149 1,018 (582 ) Deferred tax expense/(benefit) (661 ) (1,889 ) (989 ) Income tax credit, net (512 ) (871 ) (1,571 )
Schedule of Deferred Tax Assets And Tax Liabilities	Deferred taxes were measured using the enacted tax rates for the periods in which they are expected to be reversed. The tax effects of temporary differences that give rise to the deferred tax asset and liabilities balances as of March 31, 2021 and 2022 are as follows: As of March 31, As of March 31, RMB RMB Deferred tax assets: Net accumulated loss-carry forward 143,426 172,059 Deferred deductible advertising expense 940 2,483 Allowance 130 78 Contract liabilities 413 419 Accruals 5,069 2,208 Less: Valuation allowance (149,978 ) (177,247 ) — — Deferred tax liabilities: Recognition of intangible assets arising from asset acquisition and business combination (6,119 ) (5,130 ) Unrealized fair value change of the available-for-sale (2,839 ) 283 Net deferred tax liabilities (8,958 ) (4,847 )
Summary of Valuation Allowance	Movement of valuation allowance is as follows: As of March 31, As of March 31, RMB RMB Beginning balance 112,539 149,978 Change of valuation allowance 37,439 27,269 Ending balance 149,978 177,247

Convertible redeemable prefer_2

Convertible redeemable preferred shares (Tables)	12 Months Ended
	Mar. 31, 2022
Statement of Stockholders' Equity [Abstract]
Summary of Preferred Shares Activities for the Periods as Summarized	Series A Preferred Series B Preferred Series C Preferred Series C+ Preferred Series D Preferred Series D-1 Series D-2 Series E Preferred Number of Amount Number of Amount Number of Amount Number of Amount Number of Amount Number of Amount Number of Amount Number of Amount Balance as of March 31, 2019 10,340,000 424,930 9,067,384 463,560 5,518,101 370,869 — — 2,526,026 168,415 1,089,265 73,409 — — — — Issuance (Note a) — — — — — — — — — — 1,089,265 82,048 1,182,803 89,447 1,042,623 74,830 Accretion on the Preferred Shares to redemption value — 59,192 — 64,122 — 49,550 — — — 19,768 — 8,825 — 17 — 3,322 Deemed dividend to preferred shareholders (Note b) — — — — — — — — — — — — — — — 401 Balances as of March 31, 2020 10,340,000 484,122 9,067,384 527,682 5,518,101 420,419 — — 2,526,026 188,183 2,178,530 164,282 1,182,803 89,464 1,042,623 78,553 Issuance (Note a) — — — — — — 6,734,459 656,448 — — — — — — 4,842,587 353,893 Accretion on the Preferred Shares to redemption value — (22,677 ) — (23,345 ) — (88,954 ) — 6,360 — (7,179 ) — 577 — 2,850 — 11,495 Deemed dividend to preferred shareholders (Note b) — — — — — — — — — — — — — — — 12,039 Conversion of convertible redeemable preferred shares upon completion of the IPO (10,340,000 ) (461,445 ) (9,067,384 ) (504,337 ) (5,518,101 ) (331,465 ) (6,734,459 ) (662,808 ) (2,526,026 ) (181,004 ) (2,178,530 ) (164,859 ) (1,182,803 ) (92,314 ) (5,885,210 ) (455,980 ) Balances as of March 31, 2021 — — — — — — — — — — — — — — — — Note a: In March 2020 , 112,648 Series D-2 D-2 D-2 D-2 D-1 D-1 D-2 D-2 , 6,734,459 Series C+ Preferred Shares were issued upon conversion of Series C+ CMB Warrant. Please refer to Note 22 for further details.

Borrowings, other debts and d_2

Borrowings, other debts and derivative liabilities (Tables)	12 Months Ended
	Mar. 31, 2022
Debt Disclosure [Abstract]
Summary of Short-term Debt	The following table presents short-term borrowings from commercial banks, other institutions and individuals as of March 31, 2021 and 2022. Short-term borrowings include borrowings with maturity terms shorter than one year: As of March 31, As of March 31, 2021 2022 RMB RMB Bank borrowings 85,566 134,540 Current portion of long-term bank borrowings — 26,586 Total 85,566 161,126
Summary of Long-term Debt Instruments	The following table presents long-term borrowings from commercial banks, other institutions and individuals as of March 31, 2021 and 2022. Long-term borrowings include borrowings with maturity terms greater than one year: As of March 31, As of March 31, 2021 2022 RMB RMB Bank borrowings 68,075 — Total 68,075 —
Summary of Maturities of Long-term Debt	Future principal maturities of short-term borrowings and long-term borrowings as of March 31, 2021 and 2022 are as followings: Year ended March 31, 2021 Year ended March 31, 2022 RMB RMB For the year ending March 31, - Within 1 year 85,566 161,126 - Between 1 and 2 years 68,075 — Total 153,641 161,126
Summary of Other Long Term Debt	Other debts – non-current As of March 31, As of March 31, 2021 2022 RMB RMB Loan for Series C+ Warrant (Note 20) 312,535 86,373 Loan from Chong Li (a) (b) 100,842 70,001 Loan for Yoken Series A-1 19,915 23,188 Payable for investment (Note 11) — 1,500 Total 433,292 181,062
Summary of Fair Value of Derivative Liabilities	As of March 31, As of March 31, 2021 2022 RMB RMB Conversion feature of Yoken Series A-1 Warrant (a) 9,362 9,086 Series E Warrant (b) 444 — Forward exchange contracts (c) 190 — Total 9,996 9,086

Share-based compensation (Table

Share-based compensation (Tables)	12 Months Ended
	Mar. 31, 2022
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]
Summary of Stock Option Activity	The following table sets forth the share options activity for the years ended March 31, 2020 and 2021: Number of shares Weighted exercise Weighted remaining contractual Aggregate intrinsic value Weighted fair value US$ US$ US$ Outstanding as of March 31, 2020 4,856,972 2.26 6.67 39,472 2.72 Exercisable as of March 31, 2020 — — Granted 998,000 4.13 2.49 Forfeited (342,750 ) 3.49 4.00 Outstanding as of March 31, 2021 5,512,222 3.36 6.32 29,360 3.28 Exercisable as of March 31, 2021 — — Granted 1,282,500 2.86 2.27 Exercised (1,204,483 ) 1.09 0.73 Forfeited (358,348 ) 2.86 3.83 Outstanding as of March 31, 2022 5,231,891 2.86 5.25 404 2.36 Exercisable as of March 31, 2022 — —
Summary of Options Measured At Fair Value, Valuation Assumptions	The significant unobservable inputs adopted in the valuation as of March 31, 2021 and 2022 are as follows: As of March 31, As of March 31, Spot price (US$) 5.57, 0.44, 6.93 Risk-free rate 0.00%, 1.25%, 2.5% Expected volatility 41.05%, 57.95%, 48.15% Expected expiry years (in years) 0.50, 0.50, 3.56
Employees and Non Employees [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]
Summary of Options Measured At Fair Value, Valuation Assumptions	Year ended March 31, 2021 Year ended March 31, 2022 Expected volatility 44.41% 42.22%-43.71% Risk-free interest rate 0.94% 1.64%-1.87% Exercise multiple 2.8/2.2 2.8/2.2 Expected dividend yield 0% 0% Contractual term (in years) 10 10

Fair value measurements (Tables

Fair value measurements (Tables)	12 Months Ended
	Mar. 31, 2022
Fair Value Disclosures [Abstract]
Summary of Company's Financial Assets and Liabilities	The following table summarizes the Company’s financial assets and liabilities measured and recorded at fair value on recurring basis as of March 31, 2021 and 2022: Fair value measurement at reporting date using Description Fair value as of Quoted price in Significant other Significant RMB RMB RMB RMB Assets: Short-term investments 168,546 — 168,546 — Available-for-sale 71,357 — — 71,357 Total assets 239,903 — 168,546 71,357 Liabilities: Derivative liabilities 9,996 — 190 9,806 Fair value measurement at reporting date using Description Fair value as of Quoted price in Significant other Significant RMB RMB RMB RMB Assets: Short-term investments 128,084 — 128,084 — Available-for-sale 74,866 — — 74,866 Equity securities with readily determinable fair values 670 670 — — Total assets 203,620 670 128,084 74,866 Liabilities: Derivative liabilities 9,086 — — 9,086
Summary of Roll Forward of Major Level 3 Investments	The roll forward of major Level 3 investments are as following: Derivative liabilities Available-for-sale Fair value of Level 3 investments as at March 31, 2019 35,524 16,050 New addition 13,487 50,000 Conversion of Series D-1 (10,701 ) — Conversion of Series D-2 (10,614 ) — Unrealized fair value change of the derivative liabilities (13,345 ) — Unrealized fair value change of the available-for-sale — 4,278 Fair value of Level 3 investments as at March 31, 2020 14,351 70,328 New addition 9,581 — Disposal of Series D-3 (2,377 ) — Unrealized fair value change of the derivative liabilities (11,559 ) — Unrealized fair value change of the available-for-sale — 1,029 Fair value of Level 3 investments as at March 31, 2021 9,996 71,357 New addition — 16,000 Reclassification of forward exchange contracts 746 — Unrealized fair value change of the derivative liabilities (1,656 ) — Unrealized fair value change of the available-for-sale — (12,491 ) Fair value of Level 3 investments as at March 31, 2022 9,086 74,866
Summary of Significant Unobservable Inputs	The Company determined the fair value of their investments by using income approach and equity allocation model. The determination of the fair value was based on estimates, judgments and information of other comparable public companies. The significant unobservable inputs adopted in the valuation as of March 31, 2021 and 2022: As of March 31, 2021 As of March 31, 2022 Weighted average cost of capital 15%,16.5% 15%,16.5,18% Lack of marketability discount 17%,23% 17%,23%,29% Risk-free rate 2.88%,2.87% 1.95% , , , Expected volatility 41.79%,42.26% 39.88%,42.17%,42.48%,47.34% Probability Liquidation scenario: 40% Redemption scenario: 40% IPO scenario: 20% Liquidation scenario: 20% Redemption scenario: 40% IPO scenario: 40%
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions	The significant unobservable inputs adopted in the valuation as of March 31, 2021 and 2022 are as follows: As of March 31, As of March 31, Spot price (US$) 5.57, 0.44, 6.93 Risk-free rate 0.00%, 1.25%, 2.5% Expected volatility 41.05%, 57.95%, 48.15% Expected expiry years (in years) 0.50, 0.50, 3.56

Net loss per share (Tables)

Net loss per share (Tables)	12 Months Ended
	Mar. 31, 2022
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	Basic loss per share and diluted loss per share have been calculated in accordance with ASC 260 on computation of earnings per share for the years ended March 31, 2020, 2021 and 2022, respectively, as follows: Year Ended March 31, 2020 Year Ended March 31, 2021 Year Ended March 31, 2022 RMB RMB RMB Numerator: Net loss attributable to Boqii Holding Limited (179,024 ) (194,444 ) (128,390 ) Accretion on the Preferred Shares to redemption value (Note 20) (204,796 ) 120,873 — Accretion on the Redeemable non-controlling — (138 ) (575 ) Deemed dividend to preferred shareholders (1,142 ) (12,547 ) — Net loss attributable to ordinary shareholders (384,962 ) (86,256 ) (128,965 ) Denominator: Weighted average number of ordinary shares used in computing net loss per share, Basic and diluted (Note (a)) 22,238,454 66,953,610 68,006,172 Net loss per share attributable to ordinary shareholders: Basic and diluted (17.31 ) (1.29 ) (1.90 )
Schedule of Antidilutive Securities Excluded From Computation Of Earnings Per Share	The following ordinary shares equivalent were excluded from the computation of diluted net loss per ordinary share for the periods presented because including them would have had an anti-dilutive effect: Year Ended March 31, 2020 Year Ended March 31, 2021 Year Ended March 31, 2022 RMB RMB RMB Preferred Shares - weighted average 26,072,893 — — Share options - weighted average — 2,585,103 719,437

Related party transactions (Tab

Related party transactions (Tables)	12 Months Ended
	Mar. 31, 2022
Related Party Transactions [Abstract]
Summary of Major Related Parties And Their Relationships With The Company	The table below sets forth the major related parties and their relationships with the Company as of March 31, 2020, 2021 and 2022: Name of related parties Relationship with the Company Nanjing Xingmu An equity investee of the Company before November 1, 2019 Nanjing Animal Pharmaceutical An equity investee of the Company Wuhan Chunzhijin An equity investee of the Company Weishi Network An equity investee of the Company Beijing Petdog An available-for-sale debt investee that the Company has significant influence Shanghai Guangcheng Information Technology (limited partnership) (“Shanghai Guangcheng Information”) A company with a common director of the Company Yingzhi (Lisa) Tang Senior management of the Company Yan Jiang Senior management of the Company Di (Jackie) Chen Senior management of the Company until July, 2021 Ying (Christina) Zhang Senior management of the Company until February, 2022 Fei Wang Senior management of the Company until April, 2022 Lijun Zhou Senior management of the Company until April, 2022
Summary of Related Party Transactions And Balances	The Company believes that the terms of the agreements with the related parties are comparable to the terms in arm’s-length Transactions with related parties Year Ended March 31, 2020 Year Ended March 31, 2021 Year Ended March 31, 2022 RMB RMB RMB Sales of goods Beijing Petdog 2,316 — — Year Ended March 31, 2020 Year Ended March 31, 2021 Year Ended March 31, 2022 RMB RMB RMB Online marketing and information services Beijing Petdog 315 410 — Weishi Network — — 19 315 410 19 Year Ended March 31, 2020 Year Ended March 31, 2021 Year Ended March 31, 2022 RMB RMB RMB Purchase of merchandise Nanjing Xingmu 751 — — Weishi Network — — 1,582 Nanjing Animal Pharmaceutical 45 250 1,020 796 250 2,602 Year Ended March 31, 2020 Year Ended March 31, 2021 Year Ended March 31, 2022 RMB RMB RMB Loans granted to related parties Shanghai Guangcheng Information (a) — — 33,395 Wuhan Chunzhijin (b) — 5,690 2,600 Yingzhi (Lisa) Tang — — 1,750 Lijun Zhou — — 300 Yan Jiang — 200 70 Nanjing Animal Pharmaceutical (c) 1,000 500 — Ying (Christina) Zhang 152 — — Di (Jackie) Chen 785 — — Fei Wang — 500 — 1,937 6,890 38,115 (a) In April 2021, the Company granted Shanghai Guangcheng Information a short-term loan with a total principal amount of million The loan was fully repaid by March 31, 2022. (b) From April 2020 to January 2021, the Company provided interest free loans to Wuhan Chunzhijin with an aggregate amount of million, (c) In December 2019, Nanjing Xingmu, one of the Company’ subsidiaries, entered into a twelve-month interest free loan agreement with Nanjing Agricultural Pharmaceutical for a principal amount of The loan was repaid in June 2021.
Summary of Related Party Transactions	Year Ended March 31, 2020 Year Ended March 31, 2021 Year Ended March 31, 2022 RMB RMB RMB Staff advances Yingzhi (Lisa) Tang — 10 — Di (Jackie) Chen 6 — — 6 10 — Advances provided to related parties Nanjing Animal Pharmaceutical — 2,073 — Wuhan Chunzhijin 3,350 — — 3,350 2,073 — Loans granted from related parties Shanghai Guangcheng Information (a) — — 9,961 Yingzhi (Lisa) Tang (b) 1,450 — — Di (Jackie) Chen (c) 1,250 — — Yan Jiang (d) 9,000 — — 11,700 — 9,961 (a) In April 2021, the Company obtained a total loan facility up to USD5 million from Shanghai Guangcheng Information. During the year ended March 31, 2022, the Company drew down a total amount of from the loan facility, with interest bearing at 3.5% per annum. The loan was fully repaid by March 31, 2022. (b) In September 2019, the Company obtained a two-year (c) In October 2019, Di (Jackie) Chen advanced RMB1.25 million to the Company, which was repaid by the Company in the same month. (d) In September 2019, the Company obtained a two-year
Summary of Transactions Due From Related Parties	Amounts due from related parties As of March 31, As of March 31, As of March 31, RMB RMB RMB Trade receivables from related parties Beijing Petdog 1,564 — — Prepayments to related parties Nanjing Animal Pharmaceutical — 2,023 1,650 Weishi Network — — 1,582 — 2,023 3,232 As of March 31, As of March 31, As of March 31, RMB RMB RMB Other receivables from related parties Wuhan Chunzhijin 2,481 7,295 7,594 Loans to related parties Nanjing Animal Pharmaceutical 1,000 500 — Yingzhi (Lisa) Tang — 10 — Yan Jiang — 200 200 Di (Jackie) Chen (a) 785 785 — Ying (Christina) Zhang 152 152 — Fei Wang (b) — 500 500 Lijun Zhou — — 200 1,937 2,147 900 (a) In December 2019, the Company entered into a twelve-month interest free loan agreement with, Di (Jackie) Chen, for a principal amount of RMB0.7 million. In December 2020, the loan contract was renewed to June 2023 and was recorded as other non-current assets as of March 31, 2022. (b) In January 2021, the Company entered into a one-year loan agreement with Fei Wang, for a principal amount of RMB0.5 million, bearing an interest rate of 4% per annum. This l
Summary of Transactions Due To related parties	Amounts due to related parties As of March 31, As of March 31, As of March 31, RMB RMB RMB Trade payables to related parties Nanjing Animal Pharmaceutical 45 874 219 As of March 31, As of March 31, As of March 31, RMB RMB RMB Advances from related parties Beijing Petdog — 36 — Long-term loan from related parties Yingzhi (Lisa) Tang (a) 2,521 — — Yan Jiang (b) 9,000 — — 11,521 — — (a) In July 2018, the Company entered into a forty-month loan agreement with Yingzhi (Lisa) Tang, for a principal amount of US$0.15 million (RMB1.0 million), bearing an interest rate of 6% per annum. The loan was early repaid in January 2021. In September 2019, the Company entered into another two-year (b) The balance as of December 31, 2019 represented a two-year

Organization and principal ac_3

Organization and principal activities - Schedule of Details of the Subsidiaries, VIEs and VIE's Subsidiaries (Detail)	12 Months Ended
	Mar. 31, 2022
Guangcheng (Shanghai) Information Technology Co., Ltd. [Member]
Schedule Of Subsidiaries And Variable Interest Entities [Line Items]
Place of incorporation	Shanghai, the PRC
Date of incorporation or acquisition	Nov. 30, 2012
Percentage of direct or indirect	100%
Principal activities	Operates the Company’s own online e-commerce platform
Nanjing Xingmu Biotechnology Co., Ltd. ("Nanjing Xingmu") [Member]
Schedule Of Subsidiaries And Variable Interest Entities [Line Items]
Place of incorporation	Nanjing, the PRC
Date of incorporation or acquisition	Nov. 30, 2019
Percentage of direct or indirect	51%
Principal activities	Biotechnology research and development
Suzhou Taicheng Supply Chain Co Ltd Suzhou Taicheng [Member]
Schedule Of Subsidiaries And Variable Interest Entities [Line Items]
Place of incorporation	Suzhou, the PRC
Date of incorporation or acquisition	Jun. 30, 2021
Percentage of direct or indirect	100%
Principal activities	Sales of merchandise
Boqii (Shanghai) Information Technology Co., Ltd. [Member]
Schedule Of Subsidiaries And Variable Interest Entities [Line Items]
Place of incorporation	Shanghai, the PRC
Date of incorporation or acquisition	Aug. 31, 2014
Percentage of direct or indirect	90%
Principal activities	Technology development
Tianjing Guangcheng Information Technology Co., Ltd. [Member]
Schedule Of Subsidiaries And Variable Interest Entities [Line Items]
Place of incorporation	Tianjin, the PRC
Date of incorporation or acquisition	Jul. 31, 2017
Percentage of direct or indirect	100%
Principal activities	Sales of merchandise
Nanjing Cuida Biotechnology Co. Ltd.("Cuida") [Member]
Schedule Of Subsidiaries And Variable Interest Entities [Line Items]
Place of incorporation	Nanjing, the PRC
Date of incorporation or acquisition	Apr. 30, 2017
Percentage of direct or indirect	70%
Principal activities	Biotechnology extension services
Taizhou Xingmu Biotechnology Co., Ltd. [Member]
Schedule Of Subsidiaries And Variable Interest Entities [Line Items]
Place of incorporation	Taizhou, the PRC
Date of incorporation or acquisition	Nov. 30, 2019
Percentage of direct or indirect	80%
Principal activities	Biotechnology research and development
Boqii Corporation Limited ("Boqii Corporation") [Member]
Schedule Of Subsidiaries And Variable Interest Entities [Line Items]
Place of incorporation	Hong Kong
Date of incorporation or acquisition	Jul. 31, 2012
Percentage of direct or indirect	100%
Principal activities	Investment holding
Boqii International Limited [Member]
Schedule Of Subsidiaries And Variable Interest Entities [Line Items]
Place of incorporation	Hong Kong
Date of incorporation or acquisition	Aug. 31, 2016
Percentage of direct or indirect	100%
Principal activities	Investment holding
Xingmu International Limited [Member]
Schedule Of Subsidiaries And Variable Interest Entities [Line Items]
Place of incorporation	British Virgin Islands
Date of incorporation or acquisition	Aug. 31, 2019
Percentage of direct or indirect	51%
Principal activities	Investment holding
Xingmu HK Limited [Member]
Schedule Of Subsidiaries And Variable Interest Entities [Line Items]
Place of incorporation	Hong Kong
Date of incorporation or acquisition	Nov. 30, 2019
Percentage of direct or indirect	51%
Principal activities	Investment holding
Nanjing Xinmu Information Technology Co., Ltd. ("Xinmu WFOE") [Member]
Schedule Of Subsidiaries And Variable Interest Entities [Line Items]
Place of incorporation	Nanjing, the PRC
Date of incorporation or acquisition	Nov. 30, 2019
Percentage of direct or indirect	51%
Principal activities	Technology development and sales of merchandise
Xincheng (Shanghai) Information Technology Co., Ltd. ("Shanghai Xincheng") [Member]
Schedule Of Subsidiaries And Variable Interest Entities [Line Items]
Place of incorporation	Shanghai, the PRC
Date of incorporation or acquisition	Nov. 30, 2012
Percentage of direct or indirect	100%
Principal activities	Technology development and sales of merchandise
Shanghai Yiqin Pets Products Co., Ltd. [Member]
Schedule Of Subsidiaries And Variable Interest Entities [Line Items]
Place of incorporation	Shanghai, the PRC
Date of incorporation or acquisition	Feb. 28, 2013
Percentage of direct or indirect	100%
Principal activities	Technology development and sales of merchandise

Organization and principal ac_4

Organization and principal activities - Schedule of Variable Interest Entities (Detail) ¥ in Thousands, $ in Thousands	12 Months Ended
	Mar. 31, 2022 CNY (¥)	Mar. 31, 2022 USD ($)	Mar. 31, 2021 CNY (¥)	Mar. 31, 2020 CNY (¥)	Mar. 31, 2022 USD ($)
Variable Interest Entity [Line Items]
Cash and cash equivalents	¥ 162,855		¥ 292,237		$ 25,690
Accounts receivable, net	49,231		45,732		7,766
Amounts due from related parties	11,726		11,465		1,850
Inventories, net	109,921		91,551		17,340
Prepayments and other current assets	116,738		85,261		18,415
Property and equipment, net	7,779		8,386		1,227
Intangible assets	25,544		29,537		4,029
Operating lease right-of-use assets	38,567		29,234		6,084
Goodwill	40,684		40,184	¥ 40,184	6,418
Long-term investments	82,319		74,330		12,986
Other non-current asset	4,861		4,111		767
Total assets	778,309		880,574		122,777
Short-term borrowings	161,126		85,566		25,417
Accounts payable	94,224		71,848		14,863
Amounts due to related parties, current	219		910		35
Salary and welfare payable	6,871		6,309		1,084
Accrued liabilities and other current liabilities	27,324		30,055		4,310
Contract liabilities	7,007		3,866		1,105
Operating lease liabilities, current	38,198		28,060
Operating lease liabilities, non-current	28,197		19,997		4,448
Long-term borrowings			68,075
Other debts, non-current	181,062		433,292		28,562
Total liabilities	529,964		746,935		$ 83,600
Net revenues:
Total Revenues	1,186,429	$ 187,154	1,010,985	770,237
Cost of revenues:
Total cost of revenue	(943,698)	(148,865)	(823,686)	(611,470)
Gross profit	242,731	38,289	187,299	158,767
Other income, net	280	44	1,067	2,398
Loss from operations	(138,249)	(21,809)	(205,995)	(137,386)
Income tax benefits/(expenses)	(1,571)	(248)	(871)	(512)
Share of results of equity investees	418	65	(696)	(520)
Net loss	(132,823)	(20,954)	(193,216)	(175,933)
Cash flows from operating activities:
Net cash generated from operating activities	(147,504)	(23,271)	(247,486)	(165,912)
Cash flows from investing activities:
Net cash generated from/ (used in) investing activities	21,147	3,337	(184,417)	(75,056)
Cash flows from financing activities:
Net cash generated from/ (used in) financing activities	1,995	$ 315	648,491	295,032
Variable Interest Entity, Primary Beneficiary [Member] | Nonrecourse [Member]
Variable Interest Entity [Line Items]
Cash and cash equivalents	20,567		17,886
Accounts receivable, net	31,435		27,393
Amounts due from related parties	11,726		11,465
Inventories, net	16,014		11,349
Prepayments and other current assets	57,107		33,445
Intra-Group receivables due from the Group's entities	16,535		47,592
Property and equipment, net	6,715		8,372
Intangible assets	507		909
Operating lease right-of-use assets	35,688		27,736
Goodwill	994		494
Long-term investments	81,649		74,330
Other non-current asset	3,389		2,433
Total assets	282,326		263,404
Short-term borrowings	872		3,484
Accounts payable	55,144		29,940
Amounts due to related parties, current	4		910
Salary and welfare payable	5,597		4,851
Accrued liabilities and other current liabilities	25,786		24,536
Contract liabilities	7,007		3,706
Operating lease liabilities, current	7,238		6,058
Intra-Group payables due to the Group's entities	945,960		611,112
Deferred tax liabilities	(1,369)		1,852
Operating lease liabilities, non-current	28,197		19,997
Long-term borrowings	0		872
Other debts, non-current	157,874		415,122
Total liabilities	1,232,310		1,122,440
Net revenues:
Total Revenues	933,459		783,892	672,093
Cost of revenues:
Total cost of revenue	(711,246)		(670,319)	(509,168)
Gross profit	222,213		113,573	162,925
Operating Expenses	(288,291)		(262,208)	(229,658)
Other income, net	98		1,011	1,688
Loss from operations	(65,980)		(147,624)	(65,045)
Non-operating income/(expense)	(20,680)		(18,162)	3,236
Loss before income tax expenses	(86,660)		(165,786)	(61,809)
Income tax benefits/(expenses)	681		(20)	141
Share of results of equity investees	418		(696)	(137)
Net loss	(85,561)		(166,502)	(61,805)
Cash flows from operating activities:
Net cash provided by transactions with external parties	526,201		419,767	126,224
Net cash used in transactions with the Group's entities	(329,325)		(331,064)	(104,125)
Net cash generated from operating activities	196,876		88,703	22,099
Cash flows from investing activities:
Other investing activities	(18,482)		(31,972)	(64,591)
Cash flows of loan funding provided to the Group's entities, net of repayments received	6,294		(5,242)	21,156
Net cash generated from/ (used in) investing activities	(12,188)		(37,214)	(43,435)
Cash flows from financing activities:
Other financing activities	(273,906)		(112,151)	73,626
Cash flows of loan funding received from the Group's entities, net of repayments made	91,794		41,717	(29,398)
Net cash generated from/ (used in) financing activities	(182,112)		(70,434)	44,228
Variable Interest Entity, Primary Beneficiary [Member] | Nonrecourse [Member] | Third Party [Member]
Net revenues:
Total Revenues	877,380		735,518	579,365
Cost of revenues:
Total cost of revenue	(160,661)		(372,475)	(226,958)
Third-party operating expenses	(288,291)		(254,951)	(229,658)
Variable Interest Entity, Primary Beneficiary [Member] | Nonrecourse [Member] | Intra Group [Member]
Net revenues:
Total Revenues	56,079		48,374	92,728
Cost of revenues:
Total cost of revenue	¥ (550,585)		(297,844)	¥ (282,210)
Intra-Group operating expenses			¥ (7,257)

Organization and principal ac_5

Organization and principal activities - Additional Information (Detail) - CNY (¥)	Mar. 31, 2022	Mar. 31, 2021
Variable Interest Entity, Primary Beneficiary [Member] | Nonrecourse [Member]
Organization And Principal Activities [Line Items]
Total registered capital	¥ 62,000,000	¥ 52,000,000
Contractual Arrangements [Member]
Organization And Principal Activities [Line Items]
Percentage of Maximum entity interests acquirable In variable Interest Entity Under PRC law	100%
Loan Agreements [Member] | Repayment of Loan [Member]
Organization And Principal Activities [Line Items]
Third party claim against nominee shareholders	¥ 500,000
Intellectual Property License Agreements [Member]
Organization And Principal Activities [Line Items]
Number of Business days in which agreement amount is to paid from relevant quarter	15 days
Term of agreement	10 years
Extended term	10 years
Period of prior written notice required to terminate the agreement	90 days
Equity Interest Pledge Agreements [Member]
Organization And Principal Activities [Line Items]
Percentage of equity interest pledged by nominal shareholders	100%

Principal Accounting Policies -

Principal Accounting Policies - Additional Information (Detail) ¥ in Thousands, $ in Thousands	12 Months Ended
	Mar. 31, 2022 CNY (¥)	Mar. 31, 2022 USD ($)	Mar. 31, 2021 CNY (¥)	Mar. 31, 2020 CNY (¥)	May 31, 2021 CNY (¥)	Apr. 01, 2021 CNY (¥)	Apr. 01, 2020 CNY (¥)
Principal Accounting Policies [Line Items]
Contract with Customer, Asset	¥ 0				¥ 0
Contract with Customer, Liability						¥ 3,900	¥ 7,700
Contract with Customer, Liability, Revenue Recognized	3,600		¥ 7,700
Unearned Revenue	7,000
Cost of Revenue	943,698	$ 148,865	823,686	¥ 611,470
Advertising Expense	81,000		83,000	69,000
Short-term Investments [Member]
Principal Accounting Policies [Line Items]
Short-term investments used as collateral	128,000
Short Term Borrowings Collateralized by Short Term Investments	111,000
Cost of product sales [Member]
Principal Accounting Policies [Line Items]
Cost of Revenue	930,400		820,300	610,600
Cost of services [Member]
Principal Accounting Policies [Line Items]
Cost of Revenue	¥ 13,300		¥ 3,400	¥ 900
CNY [Member]
Principal Accounting Policies [Line Items]
Foreign Currency Exchange Rate	6.3482		6.5713
Convenience translation exchange rate	6.3393

Principal Accounting Policies_3

Principal Accounting Policies - Schedule of Property Plant And Equipment Useful Lives (Detail)	12 Months Ended
	Mar. 31, 2022
Vehicles [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	5 years
Software [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	10 years
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Estimated Useful Lives	Over the shorter of the expected life of leasehold improvements or the lease term
Maximum [Member] | Warehouse Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	5 years
Maximum [Member] | Furniture, Computer And Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	5 years
Minimum [Member] | Warehouse Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	3 years
Minimum [Member] | Furniture, Computer And Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	3 years

Principal Accounting Policies_4

Principal Accounting Policies - Schedule of Finite Lived Intangible Assets Useful Lives (Detail)	12 Months Ended
	Mar. 31, 2022
Trademark [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	10 years
Dealership [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	10 years
License [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	4 years 6 months

Business combinations - Summary

Business combinations - Summary of Identified Assets Acquired and Liabilities Assumed (Detail) - Chongni network technology Co Ltd [Member] - CNY (¥) ¥ in Thousands		12 Months Ended
	Jun. 30, 2021	Mar. 31, 2022
Total purchase price is comprised of:
- fair value of 49% previously held equity interests	¥ 245
- cash consideration	2,938	¥ 2,900
Fair value of total consideration	3,183
Cash and cash equivalents	2
Prepayments and other current assets	4,533
Total assets	4,535
Accrued liabilities and other current liabilities	(33)
Total liabilities	(33)
Net assets acquired	4,502
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net	499
Non-controlling interests	(1,818)
Total	¥ 3,183

Business combinations - Summa_2

Business combinations - Summary of Identified Assets Acquired and Liabilities Assumed (Detail) (Parenthetical)	Jun. 30, 2021
Xingmu Group [Member]
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Line Items]
Business Combination, Step Acquisition, Equity Interest in Acquire, Percentage	49%

Business combinations - Additio

Business combinations - Additional Information (Detail) - CNY (¥) ¥ in Thousands		9 Months Ended	12 Months Ended
	Jun. 30, 2021	Mar. 31, 2022	Mar. 31, 2022	Oct. 31, 2018
Nanjing Cuida Biotechnology Co Ltd [Member]
Business Combination, Pro Forma Information, Earnings or Loss of Acquire since Acquisition Date		¥ (80)
Chongni network technology Co Ltd [Member]
Business Acquisition, Percentage of Voting Interests Acquired	63.65%			49%
Payments to Acquire Businesses, Gross	¥ 2,938		¥ 2,900
Business Combination, Step Acquisition, Equity Interest in Acquire, Percentage				49%
Business Combination, Consideration Transferred	3,183
Business Acquisition, Equity Interest Issued or Issuable, Value Assigned	2,900
Business Combination Purchase Price Information On Acquisition Date	300
Business Combination, Step Acquisition, Equity Interest in Acquire, Re-measurement Gain (Loss), Net	¥ 100

Risks and Concentration - Addit

Risks and Concentration - Additional Information (Detail)	12 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Revenue Benchmark [Member]
Concentration Risk [Line Items]
Number of Customers		0
Revenue Benchmark [Member] | Royal Canin China Co., Ltd [Member] | Supplier Concentration Risk [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage		10%
CNY [Member]
Concentration Risk [Line Items]
Foreign currency decrease percentage	2.30%	6.30%

Risks and Concentration - Sched

Risks and Concentration - Schedules of Concentration of Risk, By Risk Factor (Detail)	12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2020
Royal Canin China Co., Ltd [Member] | Supplier Concentration Risk [Member] | Purchases [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	17%	19%	24%

Cash and cash equivalents - Sch

Cash and cash equivalents - Schedule of Cash And Cash Equivalents (Detail) € in Thousands, ¥ in Thousands, $ in Thousands, $ in Thousands, $ in Thousands	Mar. 31, 2022 CNY (¥)	Mar. 31, 2022 USD ($)	Mar. 31, 2022 HKD ($)	Mar. 31, 2022 EUR (€)	Mar. 31, 2022 NZD ($)	Mar. 31, 2021 CNY (¥)	Mar. 31, 2021 USD ($)	Mar. 31, 2021 HKD ($)	Mar. 31, 2021 EUR (€)	Mar. 31, 2021 NZD ($)
RMB
Cash and cash equivalents	¥ 162,855	$ 25,690				¥ 292,237
Cash Equivalents [Member]
RMB
Cash and cash equivalents | ¥	162,855					292,237
CNY [Member] | Cash [Member]
RMB
Cash and cash equivalents | ¥	47,321					121,670
CNY [Member] | Cash Equivalents [Member]
RMB
Cash and cash equivalents | ¥	¥ 47,321					¥ 121,670
Hong Kong dollars [Member] | Cash [Member]
RMB
Cash and cash equivalents			$ 39					$ 25
Hong Kong dollars [Member] | Cash Equivalents [Member]
RMB
Cash and cash equivalents			$ 31					$ 21
USD [Member] | Cash [Member]
RMB
Cash and cash equivalents		18,133					$ 25,947
USD [Member] | Cash Equivalents [Member]
RMB
Cash and cash equivalents		$ 115,110					$ 170,508
EUR [Member] | Cash [Member]
RMB
Cash and cash equivalents | €				€ 55					€ 5
EUR [Member] | Cash Equivalents [Member]
RMB
Cash and cash equivalents | €				€ 392					€ 38
NZD | Cash [Member]
RMB
Cash and cash equivalents					$ 0					$ 0
NZD | Cash Equivalents [Member]
RMB
Cash and cash equivalents					$ 1					$ 0

Accounts receivable, net - Summ

Accounts receivable, net - Summary of Accounts Receivable Net (Detail) ¥ in Thousands, $ in Thousands	Mar. 31, 2022 CNY (¥)	Mar. 31, 2022 USD ($)	Mar. 31, 2021 CNY (¥)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance of doubtful accounts	¥ (469)		¥ (256)
Total	49,231	$ 7,766	45,732
Product Sales [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts receivable	42,070		37,429
Online Marketing And Information Services And Other Revenue [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts receivable	¥ 7,630		¥ 8,559

Accounts receivable, net - Su_2

Accounts receivable, net - Summary of Movement of Allowance of Doubtful Accounts (Detail) ¥ in Thousands, $ in Thousands	12 Months Ended
	Mar. 31, 2022 CNY (¥)	Mar. 31, 2022 USD ($)	Mar. 31, 2021 CNY (¥)	Mar. 31, 2020 CNY (¥)
Accounts, Notes, Loans and Financing Receivable [Line Items]
At beginning of year	¥ 256		¥ 363	¥ 92
Addition/(reversal)	213	$ 34	(107)	271
At end of year	¥ 469		¥ 256	¥ 363

Inventories, net of inventory_3

Inventories, net of inventory reserves - Summary of Inventories, Net of Inventory Reserves (Detail) ¥ in Thousands, $ in Thousands	Mar. 31, 2022 CNY (¥)	Mar. 31, 2022 USD ($)	Mar. 31, 2021 CNY (¥)
Inventory [Line Items]
Inventory, Net	¥ 109,921	$ 17,340	¥ 91,551
Products [Member]
Inventory [Line Items]
Inventory, Net	109,383		90,913
Packaging materials and others [Member]
Inventory [Line Items]
Inventory, Net	¥ 538		¥ 638

Inventories, net of inventory_4

Inventories, net of inventory reserves - Summary of Movement of Inventory Provision (Detail) - CNY (¥) ¥ in Thousands	12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2020
Inventory Disclosure [Abstract]
At beginning of year	¥ 266	¥ 273	¥ 527
Provision/(reversal)	311	(7)	(254)
At end of year	¥ 577	¥ 266	¥ 273

Inventories, net of inventory_5

Inventories, net of inventory reserves - Additional Information (Detail) - CNY (¥) ¥ in Thousands	12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2020
Inventory Disclosure [Abstract]
(Reversal) Provision of inventory reserves	¥ 310	¥ (7)	¥ (250)

Prepayments and other current_3

Prepayments and other current assets - Summary of Prepayments and Other Current Assets (Detail) ¥ in Thousands, $ in Thousands	Mar. 31, 2022 CNY (¥)	Mar. 31, 2022 USD ($)	Mar. 31, 2021 CNY (¥)
Prepaid Expense and Other Assets, Current [Abstract]
Prepayments for purchases of products	¥ 52,348		¥ 53,209
Vendor rebate receivables	24,462		8,723
Value-added tax ("VAT") deductible	18,864		10,672
Loan receivables	3,845		3,957
Sales return assets	1,264		1,244
Deposits	1,312		1,456
Others	14,643		6,000
Total	¥ 116,738	$ 18,415	¥ 85,261

Prepayments and other current_4

Prepayments and other current assets - Additional Information (Detail) - CNY (¥) ¥ in Thousands	12 Months Ended
	Mar. 31, 2022	Oct. 31, 2021	Mar. 31, 2021
Notes and loans receivable net current
Financing receivable, after allowance for credit loss, current	¥ 3,845		¥ 3,957
Loans Receivable Period Ranging From 12 To 24 Months [Member] | Maximum [Member]
Notes and loans receivable net current
Loan receivable fixed rate of interest percentage	4%
Loans Receivable Period Ranging From 12 To 24 Months [Member] | Minimum [Member]
Notes and loans receivable net current
Loan receivable fixed rate of interest percentage	0%
Loans Receivable Period Ranging From 12 To 24 Months [Member] | From April 2020 To October 2021 [Member]
Notes and loans receivable net current
Loan receivable face or par amount		¥ 4,930
Loans Receivable Period Ranging From 12 To 24 Months [Member] | From April 2020 To October 2021 [Member] | Maximum [Member]
Notes and loans receivable net current
Loans receivable term	24 months
Loans receivable month of maturity	2022-10
Loans Receivable Period Ranging From 12 To 24 Months [Member] | From April 2020 To October 2021 [Member] | Minimum [Member]
Notes and loans receivable net current
Loans receivable term	12 months
Loans receivable month of maturity	2021-07

Property and equipment, net - S

Property and equipment, net - Summary of Property, Plant and Equipment's (Detail) ¥ in Thousands, $ in Thousands	Mar. 31, 2022 CNY (¥)	Mar. 31, 2022 USD ($)	Mar. 31, 2021 CNY (¥)
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	¥ 27,060		¥ 24,761
Less: Accumulated depreciation	(19,281)		(16,375)
Property and equipment, net	7,779	$ 1,227	8,386
Warehouse Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	2,669		2,513
Furniture, Computer And Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	7,503		6,592
Vehicles [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	3,684		2,891
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	10,209		10,056
Software [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	¥ 2,995		¥ 2,709

Property and equipment, net -

Property and equipment, net - Additional Information (Detail) - CNY (¥) ¥ in Thousands	12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2020
Property, Plant and Equipment [Abstract]
Depreciation	¥ 3,700	¥ 3,080	¥ 2,660

Intangible assets, net - Schedu

Intangible assets, net - Schedule of Intangible Assets (Detail) ¥ in Thousands, $ in Thousands	Mar. 31, 2022 CNY (¥)	Mar. 31, 2022 USD ($)	Mar. 31, 2021 CNY (¥)
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	¥ 35,684		¥ 35,694
Less: Accumulated amortization	(10,140)		(6,157)
Intangible assets	25,544	$ 4,029	29,537
Trademark [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	437		447
License [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	3,530		3,530
Dealership [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	¥ 31,717		¥ 31,717

Intangible assets, net - Sche_2

Intangible assets, net - Schedule of Annual Estimated Amortization Expense for Intangible Assets (Detail) ¥ in Thousands	Mar. 31, 2022 CNY (¥)
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
2023	¥ 4,000
2024	3,867
2025	3,438
2026	3,207
2027	¥ 3,203

Intangible assets, net - Additi

Intangible assets, net - Additional Information (Detail) - CNY (¥) ¥ in Thousands	12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2020
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Intangible assets resulting from the business combinations		¥ 29,280
Amortization expenses of the intangible assets	¥ 4,000	¥ 4,000	¥ 1,920

Long-Term Investments - Summary

Long-Term Investments - Summary of Long-Term Investment (Detail) ¥ in Thousands, $ in Thousands	Mar. 31, 2022 CNY (¥)	Mar. 31, 2022 USD ($)	Mar. 31, 2021 CNY (¥)
Long-term Investments [Abstract]
Equity method investments	¥ 6,783		¥ 2,973
Available-for-sale investments	74,866		71,357
Equity securities with readily determinable fair values	670		0
Total	¥ 82,319	$ 12,986	¥ 74,330

Long-Term Investments - Summa_2

Long-Term Investments - Summary of Available-For-Sale Debt Investments (Detail) - CNY (¥) ¥ in Thousands	12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Debt Securities, Available-for-sale [Abstract]
Cost	¥ 76,000	¥ 60,000
Gross unrealized gains	0	11,357
Gross unrealized losses	(1,134)	0
Fair value	¥ 74,866	¥ 71,357

Long-Term Investments - Summa_3

Long-Term Investments - Summary Of Equity Securities With Readily Determinable Fair Values (Detail) ¥ in Thousands	12 Months Ended
	Mar. 31, 2022 CNY (¥)
Equity Securities With Readily Determinable Fair Value [Line Items]
Cost	¥ 1,292
Gross unrealized gains	0
Gross unrealized losses	(622)
Fair value	¥ 670

Long-Term Investments - Additio

Long-Term Investments - Additional Information (Detail) ¥ in Thousands				1 Months Ended		12 Months Ended
	Jul. 31, 2021 CNY (¥)	Jun. 30, 2021 USD ($) shares	May 31, 2021 CNY (¥)	Oct. 31, 2019 CNY (¥)	Oct. 31, 2017 CNY (¥)	Mar. 31, 2022 CNY (¥)	Mar. 31, 2022 USD ($)	Mar. 31, 2021 CNY (¥)	Mar. 31, 2020 CNY (¥)	Mar. 31, 2022 USD ($)
Long term Investments and Receivables Net [Line Items]
Carrying value of equity method investments						¥ 6,783		¥ 2,973
Cash consideration						15,792	$ 2,491,000		¥ 50,000
Unrealized Securities holding gain, Net of tax						710
Accounts Payable and Other Accrued Liabilities, Current						27,324		30,055		$ 4,310,000
Stock Issued During Period, Value, New Issues								395,071
Nanjing Animal Pharmaceutical [Member]
Long term Investments and Receivables Net [Line Items]
Long-term Line of Credit	¥ 16,000
Line of Credit Facility, Interest Rate During Period	8%
Debt Instrument, Convertible, Conversion Ratio	3.33
Debt Securities, Held-to-maturity, Fair Value						16,900
Accrued Liabilities And Other Current Liabilities [Member] | Nanjing Animal Pharmaceutical [Member]
Long term Investments and Receivables Net [Line Items]
Long-term Debt, Gross	¥ 2,000
Qingdao Shuangan Biotechnology Co Ltd [Member]
Long term Investments and Receivables Net [Line Items]
Equity method investment ownership percentage					7.20%
Cash consideration					¥ 10,000
Redemption of investment period					48 months
Investment re-measured at fair value						17,800		17,300
Unrealized Securities holding gain, Net of tax						340		20
Beijing Petdog Technology Development Co Ltd [Member]
Long term Investments and Receivables Net [Line Items]
Equity method investment ownership percentage				23.64%
Cash consideration				¥ 50,000
Redemption of investment period				60 months
Investment re-measured at fair value						40,100		54,000
Unrealized Securities holding gain, Net of tax						¥ (10,400)		¥ 750
Better Choice Company Inc [Member]
Long term Investments and Receivables Net [Line Items]
Stock Issued During Period, Shares, New Issues | shares		40,000
Stock Issued During Period, Value, New Issues | $		$ 200,000
Weishi Network Co Ltd [Member]
Long term Investments and Receivables Net [Line Items]
Equity method investment ownership percentage			20%
Cash consideration			¥ 2,500
Weishi Network Co Ltd [Member] | Accrued Liabilities And Other Current Liabilities [Member]
Long term Investments and Receivables Net [Line Items]
Accounts Payable and Other Accrued Liabilities, Current			500
Weishi Network Co Ltd [Member] | Other Debt Non Current [Member]
Long term Investments and Receivables Net [Line Items]
Other Long-term Debt, Noncurrent			¥ 1,500

Goodwill - Schedule of Changes

Goodwill - Schedule of Changes in the Carrying Amount of Goodwill (Detail) ¥ in Thousands, $ in Thousands	Mar. 31, 2022 CNY (¥)	Mar. 31, 2022 USD ($)	Mar. 31, 2021 CNY (¥)	Mar. 31, 2020 CNY (¥)
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	¥ 40,684		¥ 40,184	¥ 40,184
Accumulated impairment loss	0		0	0
Total	40,684	$ 6,418	¥ 40,184	¥ 40,184
Additions	¥ 500

Goodwill - Additional Informati

Goodwill - Additional Information (Detail) - CNY (¥) ¥ in Millions	12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cuida and Xingmu [Member]
Indefinite-lived Intangible Assets [Line Items]
Goodwill generated from the acquisition	¥ 41	¥ 40

Other non-current Assets - Sche

Other non-current Assets - Schedule of Other Non-current Assets (Detail) ¥ in Thousands, $ in Thousands	Mar. 31, 2022 CNY (¥)	Mar. 31, 2022 USD ($)	Mar. 31, 2021 CNY (¥)
Other Assets, Noncurrent Disclosure [Abstract]
Deposits	¥ 3,924		¥ 3,767
Long-term loans receivable	937		344
Total	¥ 4,861	$ 767	¥ 4,111

Other non-current Assets - Sc_2

Other non-current Assets - Schedule of Other Non-current Assets (Parenthetical) (Detail) - CNY (¥) ¥ in Thousands	15 Months Ended
	Mar. 31, 2021	Mar. 31, 2022
Other Assets Noncurrent Disclosure [Line Items]
Long-term loans receivable	¥ 344	¥ 937
Loan Receivable for the Period 24 to 42 Months [Member]
Other Assets Noncurrent Disclosure [Line Items]
Loan receivable face or par amount	¥ 1,200
Loan Receivable for the Period 24 to 42 Months [Member] | From December 2019 To December 2021 [Member] | Maximum [Member]
Other Assets Noncurrent Disclosure [Line Items]
Loans Receivable Term	42 months
Loans receivable month of maturity	2023-12
Loan Receivable for the Period 24 to 42 Months [Member] | From December 2019 To December 2021 [Member] | Minimum [Member]
Other Assets Noncurrent Disclosure [Line Items]
Loans Receivable Term	24 months
Loans receivable month of maturity	2023-06

Accrued liabilities and other_3

Accrued liabilities and other current liabilities - Schedule of Accrued Liabilities and Other Current Liabilities (Detail) ¥ in Thousands, $ in Thousands	Mar. 31, 2022 CNY (¥)	Mar. 31, 2022 USD ($)	Mar. 31, 2021 CNY (¥)
Accrued Liabilities and Other Liabilities [Abstract]
Logistics expenses payables	¥ 14,625		¥ 16,594
Accrued advertising expenses	150		228
Advances from customers	3,773		3,534
Payable for investment (Note (11))	2,563		0
Refund obligation of sales returns	1,411		1,543
Professional service fee accruals	579		3,449
Others	4,223		4,707
Total	¥ 27,324	$ 4,310	¥ 30,055

Leases - Summary of Operating L

Leases - Summary of Operating Leases (Detail) ¥ in Thousands, $ in Thousands	Mar. 31, 2022 CNY (¥)	Mar. 31, 2022 USD ($)	Mar. 31, 2021 CNY (¥)
Assets
Operating lease right-of-use assets	¥ 38,567	$ 6,084	¥ 29,234
Liabilities
Operating lease liabilities, current	10,001	1,578	8,063
Operating lease liabilities, non-current	28,197	$ 4,448	19,997
Total operating lease liabilities	¥ 38,198		¥ 28,060
Weighted average remaining lease term (years)	3 years 7 months 9 days	3 years 7 months 9 days	3 years 8 months 12 days
Weighted average discount rate	4.95%	4.95%	6.47%

Leases - Summary of Operating_2

Leases - Summary of Operating Lease Activity (Detail) ¥ in Thousands, $ in Thousands	12 Months Ended
	Mar. 31, 2022 CNY (¥)	Mar. 31, 2022 USD ($)	Mar. 31, 2021 CNY (¥)	Mar. 31, 2020 CNY (¥)
Leases [Abstract]
Operating lease right-of-use assets obtained in exchange for lease obligations	¥ 21,038	$ 3,319	¥ 25,970	¥ 10,051
Amortization of right-of-use assets	11,705		11,687	15,708
Interest of lease liabilities	1,949		1,596	1,353
Operating lease, expense	13,654		13,283	17,061
Operating lease payments (included in measurement of lease liabilities)	¥ 12,849		¥ 12,850	¥ 18,183

Leases - Summary of Maturities

Leases - Summary of Maturities of Lease Liabilities (Detail) - CNY (¥) ¥ in Thousands	Mar. 31, 2022	Mar. 31, 2021
Leases [Abstract]
2023	¥ 11,311
2024	10,273
2025	11,051
2026	7,546
2027	1,299
Total lease payments	41,480
Less: imputed interest	(3,282)
Total	¥ 38,198	¥ 28,060

Interest expense - Summary of I

Interest expense - Summary of Interest Expense (Detail) ¥ in Thousands, $ in Thousands	12 Months Ended
	Mar. 31, 2022 CNY (¥)	Mar. 31, 2022 USD ($)	Mar. 31, 2021 CNY (¥)	Mar. 31, 2020 CNY (¥)
Interest and Debt Expense [Abstract]
Amortization charges on promissory notes	¥ 17,144		¥ 21,611	¥ 56,290
Interest expense on borrowings	3,740		6,039	2,815
Others	0		0	163
Total	¥ 20,884	$ 3,294	¥ 27,650	¥ 59,268

Other gains (losses), net - Sum

Other gains (losses), net - Summary of Other (Losses), Net (Detail) - CNY (¥) ¥ in Thousands	12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2020
Other gains (losses), net [Abstract]
Gain from the re-measurement of the previously held equity interests to the fair value in the step acquisitions	¥ 127	¥ 0	¥ 481
Foreign exchange losses, net	5,322	(2,867)	(3,787)
Gain on disposal of other debts	0	6,846	10,095
Reimbursement from a depositary bank	1,482	6,556	0
Investment loss	(622)	0	0
Others	(289)	797	195
Total	¥ 6,020	¥ 11,332	¥ 6,984

Other gains (losses), net - S_2

Other gains (losses), net - Summary of Other (Losses), Net (Parenthetical) (Detail) ¥ in Millions, $ in Millions	12 Months Ended
	Mar. 31, 2022 USD ($)	Mar. 31, 2022 CNY (¥)	Mar. 31, 2021 USD ($)	Mar. 31, 2021 CNY (¥)
Other gains (losses), net [Abstract]
Reimbursement depositary received	$ 0.2	¥ 1.5	$ 1	¥ 6.6

Income taxes - Schedule of Effe

Income taxes - Schedule of Effective Income Tax Rate Reconciliation (Detail) ¥ in Thousands, $ in Thousands	12 Months Ended
	Mar. 31, 2022 CNY (¥)	Mar. 31, 2022 USD ($)	Mar. 31, 2021 CNY (¥)	Mar. 31, 2020 CNY (¥)
Income Tax Disclosure [Abstract]
Loss before income taxes	¥ (134,812)	$ (21,267)	¥ (193,391)	¥ (175,925)
Income tax computed at respective applicable tax rates	(33,702)		(48,348)	(43,981)
Effect of different tax jurisdiction	2,341		14,272	19,507
Super deduction for research and development expenses (a)	(1,881)		(2,632)	(4,719)
Non-deductible expenses	97		140	138
Change in valuation allowance	34,716		37,439	29,567
Total	¥ 1,571	$ 248	¥ 871	¥ 512
PRC statutory income tax rates	25%	25%	25%	25%
Tax holiday effect	3%	3%	1%	(3.00%)
Difference in tax rates of subsidiaries outside PRC	(8.00%)	(8.00%)	(8.00%)	(8.00%)
Super deduction for research and development expenses	1%	1%	1%	3%
Non-deductible expenses	0%	0%	0%	0%
Change in valuation allowance	(20.00%)	(20.00%)	(19.00%)	(17.00%)
Effective income tax rate	1%	1%	0%	0%

Income taxes - Schedule of Ef_2

Income taxes - Schedule of Effective Income Tax Rate Reconciliation (Parenthetical) (Detail) - CNY (¥) ¥ in Thousands	12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2020
Super deduction for research and development expenses	¥ 1,881	¥ 2,632	¥ 4,719
Tax Year 2018 [Member]
Effective income tax rate reconciliation non-deductible expense research and development percentage	175%
Effective income tax rate reconciliation non-deductible expense research and development additional deduction percentage	75%

Income taxes - Summary of Inco

Income taxes - Summary of Income Tax Holiday (Detail) - CNY (¥) ¥ / shares in Units, ¥ in Thousands	12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2020
Income Tax Disclosure [Abstract]
Tax holiday effect	¥ 3,513	¥ 1,074	¥ (5,471)
Basic and diluted net loss per share effect	¥ 0.05	¥ 0.02	¥ (0.25)

Income taxes - Schedule of Comp

Income taxes - Schedule of Components of Income Tax Expenses Benefit (Detail) ¥ in Thousands, $ in Thousands	12 Months Ended
	Mar. 31, 2022 CNY (¥)	Mar. 31, 2022 USD ($)	Mar. 31, 2021 CNY (¥)	Mar. 31, 2020 CNY (¥)
Income Tax Disclosure [Abstract]
Current income tax expense/(benefit)	¥ (582)		¥ 1,018	¥ 149
Deferred tax expense/(benefit)	(989)	$ (156)	(1,889)	(661)
Income tax Credit, net	¥ (1,571)	$ (248)	¥ (871)	¥ (512)

Income taxes - Schedule of Defe

Income taxes - Schedule of Deferred Tax Assets And Tax Liabilities (Detail) - CNY (¥) ¥ in Thousands	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2020
Deferred tax assets:
Net accumulated loss-carry forward	¥ 172,059	¥ 143,426
Deferred deductible advertising expense	2,483	940
Allowance	78	130
Contract liabilities	419	413
Accruals	2,208	5,069
Less: Valuation allowance	(177,247)	(149,978)	¥ (112,539)
Net deferred tax assets	0	0
Deferred tax liabilities:
Recognition of intangible assets arising from asset acquisition and business combination	(5,130)	(6,119)
Unrealized fair value change of the available-for-sale debt investments	283	(2,839)
Net deferred tax liabilities	¥ (4,847)	¥ (8,958)

Income taxes - Summary of Valua

Income taxes - Summary of Valuation Allowance (Detail) - CNY (¥) ¥ in Thousands	12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Income Tax Disclosure [Abstract]
Beginning balance	¥ 149,978	¥ 112,539
Change of valuation allowance	27,269	37,439
Ending balance	¥ 177,247	¥ 149,978

Income taxes - Additional Infor

Income taxes - Additional Information (Detail) - CNY (¥) ¥ in Millions		12 Months Ended
	Jul. 25, 2018	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2020
Income tax rate		25%	25%	25%
Income tax holiday, description	Shanghai Boqii could enjoy a tax holiday of 2-year EIT exemption and subsequently 3-year 12.5% preferential tax rate.
Change of valuation allowance		¥ 184.7	¥ 150
Operating loss carry forwards		¥ 688	¥ 574
Preferential tax rate		12.50%	12.50%	0%
HK [Member] | Maximum [Member]
Income tax rate		16.50%
HK [Member] | Minimum [Member]
Income tax rate		8.25%
CHINA [Member]
Income tax rate		25%
Preferential tax rate		15%

Ordinary Share - Additional Inf

Ordinary Share - Additional Information (Detail) $ / shares in Units, ¥ in Thousands, $ in Millions	1 Months Ended		12 Months Ended
	Feb. 28, 2021 USD ($) shares	Oct. 31, 2020 USD ($) shares $ / shares	Mar. 31, 2022 $ / shares shares	Mar. 31, 2021 CNY (¥) shares	Mar. 31, 2021 $ / shares shares
Number of shares per ADS		0.75
Proceeds from IPO		$ 64		¥ 393,698
Common Class A [Member]
Common Stock, Shares, Issued			55,709,591		54,505,108
Common Stock, Shares, Outstanding			55,709,591		54,505,108
stock issued during period		5,250,000
Common Stock, Par or Stated Value Per Share | $ / shares			$ 0.001		$ 0.001
Common Class B [Member]
Common Stock, Shares, Issued			13,037,729		13,037,729
Common Stock, Shares, Outstanding			13,037,729		13,037,729
Common Stock, Par or Stated Value Per Share | $ / shares		$ 0.001	$ 0.001		$ 0.001
Preferred Stock, Conversion Basis			one-for-one basis
ADS [Member]
Share price | $ / shares		10
Series C Redeemable Convertible Preferred Shares [Member]
Preferred Stock, Conversion Basis			one-for-one basis
Series C Preferred Stock [Member]
stock issued during period				0
IPO [Member] | Common Class A [Member]
Common Stock, Par or Stated Value Per Share | $ / shares		$ 0.001
Stock Repurchased and Retired During Period, Shares	521,924
Stock Repurchased and Retired During Period, Value | $	$ 4.8
IPO [Member] | Common Class B [Member]
Stock Issued During Period, Shares, Conversion of Convertible Securities		12,204,604
IPO [Member] | ADS [Member]
Sale of Stock, Number of Shares Issued in Transaction		7,000,000
IPO [Member] | Series A Redeemable Convertible Preferred Shares [Member]
Convertible Preferred Shares, Outstanding		10,340,000
Stock Issued During Period, Shares, Conversion of Convertible Securities		7,844,137
Preferred Stock, Conversion Basis		1: 0.76
IPO [Member] | Series B Redeemable Convertible Preferred Shares [Member]
Convertible Preferred Shares, Outstanding		9,067,384
Stock Issued During Period, Shares, Conversion of Convertible Securities		8,557,980
Preferred Stock, Conversion Basis		1:0.94
IPO [Member] | Series C Plus Redeemable Convertible Preferred Shares [Member]
Convertible Preferred Shares, Outstanding		6,734,459
Stock Issued During Period, Shares, Conversion of Convertible Securities		6,883,520
Preferred Stock, Conversion Basis		1:1.02
IPO [Member] | Series C Preferred Stock [Member]
Convertible Preferred Shares, Outstanding		833,125
Over-Allotment Option [Member] | ADS [Member]
Sale of Stock, Number of Shares Issued in Transaction		1,050,000

Convertible redeemable prefer_3

Convertible redeemable preferred shares - Summary of Preferred Shares Activities for the Periods (Detail) ¥ in Thousands, $ in Millions	12 Months Ended
	Mar. 31, 2022 CNY (¥) shares	Mar. 31, 2021 CNY (¥) shares	Mar. 31, 2021 USD ($) shares	Mar. 31, 2020 CNY (¥) shares	Mar. 31, 2020 USD ($) shares
Schedule of Preferred Stock by Class [Line Items]
Issuance		¥ 395,071
Accretion on the Preferred Shares to redemption value	¥ 0	(121,000)	$ (18)	¥ 204,800	$ 28.9
Deemed dividend to preferred shareholders	¥ 0	¥ 12,000
Series A Preferred Shares [Member]
Schedule of Preferred Stock by Class [Line Items]
Balance Beginning, (in shares) | shares	0	10,340,000	10,340,000	10,340,000	10,340,000
Balance Beginning	¥ 0	¥ 484,122		¥ 424,930
Issuance, (in shares) | shares		0	0
Accretion on the Preferred Shares to redemption value		¥ (22,677)		59,192
Deemed dividend to preferred shareholders		¥ 0		¥ 0
Conversion of convertible redeemable preferred shares upon completion of the IPO (in shares) | shares		(10,340,000)	(10,340,000)
Conversion of convertible redeemable preferred shares upon completion of the IPO		¥ (461,445)
Balance Ending, (in shares) | shares		0	0	10,340,000	10,340,000
Balance Ending		¥ 0		¥ 484,122
Series B Preferred Shares [Member]
Schedule of Preferred Stock by Class [Line Items]
Balance Beginning, (in shares) | shares	0	9,067,384	9,067,384	9,067,384	9,067,384
Balance Beginning	¥ 0	¥ 527,682		¥ 463,560
Issuance, (in shares) | shares		0	0
Accretion on the Preferred Shares to redemption value		¥ (23,345)		64,122
Deemed dividend to preferred shareholders		¥ 0		¥ 0
Conversion of convertible redeemable preferred shares upon completion of the IPO (in shares) | shares		(9,067,384)	(9,067,384)
Conversion of convertible redeemable preferred shares upon completion of the IPO		¥ (504,337)
Balance Ending, (in shares) | shares		0	0	9,067,384	9,067,384
Balance Ending		¥ 0		¥ 527,682
Series C Preferred Shares [Member]
Schedule of Preferred Stock by Class [Line Items]
Balance Beginning, (in shares) | shares	0	5,518,101	5,518,101	5,518,101	5,518,101
Balance Beginning	¥ 0	¥ 420,419		¥ 370,869
Issuance, (in shares) | shares		0	0
Accretion on the Preferred Shares to redemption value		¥ (88,954)		49,550
Deemed dividend to preferred shareholders		¥ 0		¥ 0
Conversion of convertible redeemable preferred shares upon completion of the IPO (in shares) | shares		(5,518,101)	(5,518,101)
Conversion of convertible redeemable preferred shares upon completion of the IPO		¥ (331,465)
Balance Ending, (in shares) | shares		0	0	5,518,101	5,518,101
Balance Ending		¥ 0		¥ 420,419
Series C+ Preferred Shares [Member]
Schedule of Preferred Stock by Class [Line Items]
Balance Beginning, (in shares) | shares	0	0	0	0	0
Balance Beginning	¥ 0	¥ 0		¥ 0
Issuance, (in shares) | shares		6,734,459	6,734,459
Issuance		¥ 656,448
Accretion on the Preferred Shares to redemption value		6,360		0
Deemed dividend to preferred shareholders		¥ 0		¥ 0
Conversion of convertible redeemable preferred shares upon completion of the IPO (in shares) | shares		(6,734,459)	(6,734,459)
Conversion of convertible redeemable preferred shares upon completion of the IPO		¥ (662,808)
Balance Ending, (in shares) | shares		0	0	0	0
Balance Ending		¥ 0		¥ 0
Series D Preferred Shares [Member]
Schedule of Preferred Stock by Class [Line Items]
Balance Beginning, (in shares) | shares	0	2,526,026	2,526,026	2,526,026	2,526,026
Balance Beginning	¥ 0	¥ 188,183		¥ 168,415
Issuance, (in shares) | shares		0	0
Accretion on the Preferred Shares to redemption value		¥ (7,179)		19,768
Deemed dividend to preferred shareholders		¥ 0		¥ 0
Conversion of convertible redeemable preferred shares upon completion of the IPO (in shares) | shares		(2,526,026)	(2,526,026)
Conversion of convertible redeemable preferred shares upon completion of the IPO		¥ (181,004)
Balance Ending, (in shares) | shares		0	0	2,526,026	2,526,026
Balance Ending		¥ 0		¥ 188,183
Series D-1 Preferred Shares [Member]
Schedule of Preferred Stock by Class [Line Items]
Balance Beginning, (in shares) | shares	0	2,178,530	2,178,530	1,089,265	1,089,265
Balance Beginning	¥ 0	¥ 164,282		¥ 73,409
Issuance, (in shares) | shares		0	0	1,089,265	1,089,265
Issuance				¥ 82,048
Accretion on the Preferred Shares to redemption value		¥ 577		8,825
Deemed dividend to preferred shareholders		¥ 0		¥ 0
Conversion of convertible redeemable preferred shares upon completion of the IPO (in shares) | shares		(2,178,530)	(2,178,530)
Conversion of convertible redeemable preferred shares upon completion of the IPO		¥ (164,859)
Balance Ending, (in shares) | shares		0	0	2,178,530	2,178,530
Balance Ending		¥ 0		¥ 164,282
Series D-2 Preferred Shares [Member]
Schedule of Preferred Stock by Class [Line Items]
Balance Beginning, (in shares) | shares	0	1,182,803	1,182,803	0	0
Balance Beginning	¥ 0	¥ 89,464		¥ 0
Issuance, (in shares) | shares		0	0	1,182,803	1,182,803
Issuance				¥ 89,447
Accretion on the Preferred Shares to redemption value		¥ 2,850		17
Deemed dividend to preferred shareholders		¥ 0		¥ 0
Conversion of convertible redeemable preferred shares upon completion of the IPO (in shares) | shares		(1,182,803)	(1,182,803)
Conversion of convertible redeemable preferred shares upon completion of the IPO		¥ (92,314)
Balance Ending, (in shares) | shares		0	0	1,182,803	1,182,803
Balance Ending		¥ 0		¥ 89,464
Series E Preferred Shares [Member]
Schedule of Preferred Stock by Class [Line Items]
Balance Beginning, (in shares) | shares	0	1,042,623	1,042,623	0	0
Balance Beginning	¥ 0	¥ 78,553		¥ 0
Issuance, (in shares) | shares		4,842,587	4,842,587	1,042,623	1,042,623
Issuance		¥ 353,893		¥ 74,830
Accretion on the Preferred Shares to redemption value		11,495		3,322
Deemed dividend to preferred shareholders		¥ 12,039		¥ 401
Conversion of convertible redeemable preferred shares upon completion of the IPO (in shares) | shares		(5,885,210)	(5,885,210)
Conversion of convertible redeemable preferred shares upon completion of the IPO		¥ (455,980)
Balance Ending, (in shares) | shares		0	0	1,042,623	1,042,623
Balance Ending		¥ 0		¥ 78,553

Convertible redeemable prefer_4

Convertible redeemable preferred shares - Summary of Preferred Shares Activities for the Periods as Follows (Detail) (Parenthetical) - CNY (¥) ¥ in Thousands	1 Months Ended		12 Months Ended
	Aug. 31, 2020	Mar. 31, 2020	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2020
Schedule of Preferred Stock by Class [Line Items]
Dividends, preferred Stock			¥ 0	¥ 12,000
Series C+ Preferred Shares [Member]
Schedule of Preferred Stock by Class [Line Items]
Dividends, preferred Stock				¥ 0	¥ 0
Series D-1 Warrant [Member] | Series D-1 Preferred Shares [Member]
Schedule of Preferred Stock by Class [Line Items]
Debt instrument converted shares issued		1,089,265
Series D-2 Warrant [Member] | Series D-2 Preferred Shares [Member]
Schedule of Preferred Stock by Class [Line Items]
Debt instrument converted shares issued		963,139
Series C+ CMB Warrant [Member] | Series C+ Preferred Shares [Member]
Schedule of Preferred Stock by Class [Line Items]
Debt instrument converted shares issued	6,734,459
Series D-2 CW Notes [Member] | Series D-2 Preferred Shares [Member]
Schedule of Preferred Stock by Class [Line Items]
Debt instrument converted shares issued					112,648
Series D-2 DL Notes [Member] | Series D-2 Preferred Shares [Member]
Schedule of Preferred Stock by Class [Line Items]
Debt instrument converted shares issued		107,016

Convertible redeemable prefer_5

Convertible redeemable preferred shares - Additional Information (Detail) $ / shares in Units, ¥ in Thousands																																					12 Months Ended
	Aug. 19, 2020 CNY (¥) shares	Aug. 19, 2020 USD ($)	Mar. 31, 2020 shares	Mar. 23, 2020 shares	Mar. 06, 2020 $ / shares shares	Feb. 10, 2020 CNY (¥) shares	Feb. 10, 2020 USD ($) shares	Jan. 01, 2020 CNY (¥) shares	Jan. 01, 2020 USD ($) shares	Nov. 21, 2019 USD ($) shares	Jun. 17, 2019 CNY (¥) shares	Jun. 17, 2019 USD ($) shares	Jun. 16, 2019 CNY (¥) shares	Jan. 16, 2019 shares	Aug. 03, 2018 shares	Jun. 19, 2018 CNY (¥) shares	Jun. 19, 2018 USD ($) shares	Nov. 13, 2017 USD ($) shares	Oct. 25, 2017 shares	Sep. 08, 2017 CNY (¥)	Sep. 08, 2017 USD ($)	Mar. 21, 2016 CNY (¥) shares	Mar. 21, 2016 USD ($) shares	Jan. 26, 2016 USD ($) shares	Jan. 07, 2016 CNY (¥)	Jan. 07, 2016 USD ($)	Jul. 07, 2015 shares	May 13, 2015 $ / shares	May 03, 2015 CNY (¥) shares	May 03, 2015 USD ($) shares	Feb. 07, 2014 CNY (¥) shares	Feb. 07, 2014 USD ($) shares	Apr. 03, 2013 shares	Nov. 19, 2012 USD ($) shares	Oct. 15, 2012 CNY (¥)	Oct. 15, 2012 USD ($)	Mar. 31, 2022 CNY (¥) shares	Mar. 31, 2022 USD ($) shares	Mar. 31, 2021 CNY (¥) shares	Mar. 31, 2021 USD ($) shares	Mar. 31, 2020 CNY (¥) shares	Mar. 31, 2020 USD ($) shares	Mar. 31, 2022 USD ($) $ / shares	Aug. 19, 2020 USD ($) $ / shares shares	Jan. 26, 2016 CNY (¥)	Jan. 26, 2016 USD ($)
Stock issued during period, value, new issues | ¥																																							¥ 395,071
Dividends, preferred stock | ¥																																					¥ 0		12,000
Equity method investments | ¥																																					¥ 6,783		2,973
Number of share options exercised during the period.																																					1,204,483	1,204,483
Stockholders' equity note, stock split, conversion ratio																																					1	1
Preferred stock, liquidation preference, percentage																																					140%						140%
Preferred stock, liquidation preference, value | $																																											$ 653,000,000
Debt conversion, converted instrument, terms																																					24 months	24 months
Debt conversion, converted instrument, rate																																					7%	7%
Accretion on the Preferred Shares to redemption value																																					¥ 0		(121,000)	$ (18,000,000)	¥ 204,800	$ 28,900,000
Repayments of other debts																																					270,860	$ 42,727,000	130,827
Receivable from shareholders or affiliates for issuance of capital stock																																					164,700		413,377				$ 25,988,000
Interest expense																																					¥ 20,884	3,294,000	¥ 27,650		59,268
IPO [Member]
Proceeds from issuance of convertible preferred stock | $																																						800,000,000
Proceeds from IPO | $																																						$ 50,000,000
Series E Warrant [Member]
Class of warrants or rights exercise price | $ / shares					$ 10.3251
Preferred Stock [Member]
Preferred stock, liquidation preference, percentage																																					8%						8%
Common Stock [Member]
Conversion of ordinary shares into Class A and Class B ordinary shares , Shares																																							(22,238,454)	(22,238,454)
Shares issued, price per share | $ / shares																																											$ 0.2882
Series A Preferred Shares [Member]
Stock issued during period																																	7,238,000	3,102,000
Stock issued during period, value, new issues | $																																		$ 11,000,000
Payments of stock issuance costs																																			¥ 1,700	$ 300,000
Series B Preferred Shares [Member]
Stock issued during period																															9,067,384	9,067,384
Stock issued during period, value, new issues | $																																$ 19,000,000
Payments of stock issuance costs																															¥ 1,900	$ 300,000
Series C Preferred Shares [Member]
Stock issued during period																													5,518,101	5,518,101
Stock issued during period, value, new issues | $																														$ 25,500,000
Payments of stock issuance costs																													¥ 2,700	$ 400,000
Stock cancelled during period, shares																											865,585
Stock re-issued during period, value | $																										$ 4,000,000
Dividends, preferred stock																									¥ 4,900	$ 700,000
Series C Plus Convertible Redeemable Preferred Shares [Member]
Stock issued during period																								552,005
Stock issued during period, value, new issues | $																								$ 3,800,000
Stock cancelled during period, shares																						552,005	552,005
Class of warrant issued during period , shares																						552,005	552,005	6,734,459
Class of warrant issued during period ,value																						¥ 24,900	$ 3,800,000	$ 46,200,000
Class of warrants or rights exercise price | $ / shares																																												$ 6.86
Number of warrants or rights outstanding.	6,734,459																																											6,734,459
Adjustments to additional paid in capital, fair value | ¥	¥ 656,400
Series C Plus Convertible Redeemable Preferred Shares [Member] | Preferred Stock [Member]
Stock issued during period, value, new issues	303,000	$ 46,000,000
Series C Plus Convertible Redeemable Preferred Shares [Member] | Guangcheng Shanghai Information Technology Co Ltd [Member]
Equity method investments																																													¥ 303,200	$ 46,200,000
Series C Plus Preferred Stock [Member]
Stock issued during period																																							6,734,459	6,734,459
Stock issued during period, value, new issues | ¥																																							¥ 656,448
Dividends, preferred stock | ¥																																							0		0
Preferred stock, liquidation preference, percentage																																					130%						130%
Accretion on the Preferred Shares to redemption value | ¥																																							6,360		0
Series C Plus Preferred Stock [Member] | CMB Investment [Member]
Principal amount of loan	¥ 303,000																																											$ 46,000,000
Series C Plus Preferred Stock [Member] | CMB Investment [Member] | Extension Of Loan Agreement [Member]
Repayments of other debts | ¥																																					¥ 235,000		10,800
Receivable from shareholders or affiliates for issuance of capital stock | ¥																																					86,400		312,500
Interest expense | ¥																																					¥ 8,900		¥ 9,300
Series D Convertible Redeemable Preferred Shares [Member]
Stock issued during period																		803,735	1,492,652
Stock issued during period, value, new issues | $																		$ 20,000,000
Payments of stock issuance costs																				¥ 1,100	$ 200,000
Conversion of ordinary shares into Class A and Class B ordinary shares , Shares															229,639
Series D-1 Convertible Redeemable Preferred Shares [Member]
Stock issued during period																1,089,265	1,089,265
Stock issued during period, value, new issues | $																	$ 10,000,000
Dividends, preferred stock																¥ 100	$ 25,000,000
Debt conversion, converted instrument, warrants or options issued															1,089,265
Series D-1 Convertible Redeemable Preferred Shares [Member] | Series D-1 Warrant [Member]
Number of share options exercised during the period.			1,089,265
Series D-2 Convertible Redeemable Preferred Shares [Member]
Debt conversion, converted instrument, warrants or options issued														963,139
Series D-2 Convertible Redeemable Preferred Shares [Member] | Series D-1 Warrant [Member]
Number of share options exercised during the period.			963,139
Series D-2 Convertible Redeemable Preferred Shares [Member] | Series D-2 CW Notes And Series D-2 DL Notes [Member]
Debt conversion, converted instrument, warrants or options issued				219,664
Series D-3 Convertible Redeemable Preferred Shares [Member] | Series D-3 Warrant A [Member]
Debt conversion, converted instrument, warrants or options issued													154,395
Debt instrument converted value | ¥													¥ 10,000
Series D-3 Convertible Redeemable Preferred Shares [Member] | Series D-3 Warrant B [Member]
Debt conversion, converted instrument, warrants or options issued													617,580
Debt instrument converted value | ¥													¥ 40,000
Series E Convertible Redeemable Preferred Shares [Member]
Stock issued during period						290,555	290,555	4,842,587	4,842,587		290,555	290,555
Stock issued during period, value, new issues | $							$ 3,000,000		$ 50,000,000			$ 3,000,000
Payments of stock issuance costs											¥ 100	$ 21,244
Dividends, preferred stock | ¥						¥ 400		¥ 12,000
Series E Convertible Redeemable Preferred Shares [Member] | Nanjing Xingmu [Member]
Stock issued during period, shares, acquisitions										461,513
Stock issued during period, value, acquisitions | $										$ 4,800,000
Series E Convertible Redeemable Preferred Shares [Member] | Series E Warrant [Member]
Class of warrants or rights exercise price | $ / shares					$ 10.3251
Debt conversion, converted instrument, warrants or options issued					205,767
Series A Preferred Stock [Member]
Stock issued during period																																							0	0
Dividends, preferred stock | ¥																																							¥ 0		0
Preferred stock, liquidation preference, percentage																																					180%						180%
Accretion on the Preferred Shares to redemption value | ¥																																							¥ (22,677)		59,192
Series A Preferred Stock [Member] | Maximum [Member]
Preferred stock, convertible, conversion price | $ / shares																												$ 1.4
Series A Preferred Stock [Member] | Minimum [Member]
Preferred stock, convertible, conversion price | $ / shares																												1.06
Series B Preferred Stock [Member]
Stock issued during period																																							0	0
Dividends, preferred stock | ¥																																							¥ 0		0
Preferred stock, liquidation preference, percentage																																					180%						180%
Accretion on the Preferred Shares to redemption value | ¥																																							¥ (23,345)		¥ 64,122
Series B Preferred Stock [Member] | Maximum [Member]
Preferred stock, convertible, conversion price | $ / shares																												2.22
Series B Preferred Stock [Member] | Minimum [Member]
Preferred stock, convertible, conversion price | $ / shares																												$ 2.1
Series E Preferred Stock [Member]
Stock issued during period																																							4,842,587	4,842,587	1,042,623	1,042,623
Stock issued during period, value, new issues | ¥																																							¥ 353,893		¥ 74,830
Dividends, preferred stock | ¥																																							12,039		401
Preferred stock, liquidation preference, percentage																																					110%						110%
Accretion on the Preferred Shares to redemption value | ¥																																							¥ 11,495		¥ 3,322
Series A And B Preferred Shares [Member]
Preferred stock, liquidation preference, percentage																																					180%						180%

Redeemable non-controlling in_2

Redeemable non-controlling interests - Additional Information (Detail) - CNY (¥) ¥ in Thousands		12 Months Ended
	Oct. 31, 2020	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2020
Equity, shares issued	120,000
Redeemable preferred shares issued amount			¥ 413,377
Accretion of redemption value of the redeemable non-controlling interest		¥ (575)	(138)
Redeemable non controlling interest equity carrying amount total		¥ 6,500	¥ 5,900
Yoken Holding Limited [Member]
Redeemable preferred shares issued amount	¥ 6,000
Percentage of preferred shares redeemable at redemption price measured by Interest per year Since Issuance of shares	10%

Borrowings, other debts and d_3

Borrowings, other debts and derivative liabilities - Summary of Short-term Debt (Detail) ¥ in Thousands, $ in Thousands	Mar. 31, 2022 CNY (¥)	Mar. 31, 2022 USD ($)	Mar. 31, 2021 CNY (¥)
Debt Disclosure [Abstract]
Bank borrowings	¥ 134,540		¥ 85,566
Current portion of long-term bank borrowings	26,586
Total	¥ 161,126	$ 25,417	¥ 85,566

Borrowings, other debts and d_4

Borrowings, other debts and derivative liabilities - Summary of Long-term Debt Instruments (Detail) - CNY (¥) ¥ in Thousands	Mar. 31, 2022	Mar. 31, 2021
Debt Disclosure [Abstract]
Bank borrowings	¥ 0	¥ 68,075
Total	¥ 0	¥ 68,075

Borrowings, other debts and d_5

Borrowings, other debts and derivative liabilities - Additional Information (Detail)

1 Months Ended

12 Months Ended

24 Months Ended

Mar. 31, 2022 USD ($)

Mar. 31, 2021 CNY (¥)

Oct. 23, 2020 CNY (¥) shares

Oct. 23, 2020 USD ($) $ / shares shares

Oct. 01, 2020 USD ($)

Mar. 31, 2020 CNY (¥) shares

Mar. 31, 2020 USD ($) shares

Mar. 23, 2020 shares

Dec. 27, 2019 CNY (¥)

Dec. 27, 2019 USD ($)

Dec. 03, 2019 CNY (¥)

Dec. 03, 2019 USD ($)

Jun. 16, 2019 CNY (¥) shares

Jan. 16, 2019 USD ($)

Jun. 30, 2020 CNY (¥)

Mar. 31, 2022 CNY (¥)

Mar. 31, 2022 USD ($)

Mar. 31, 2021 CNY (¥)

Mar. 31, 2020 CNY (¥)

Dec. 16, 2021 CNY (¥)

Dec. 16, 2021 USD ($)

Mar. 31, 2022 USD ($)

Mar. 08, 2021 CNY (¥)

Mar. 31, 2020 USD ($)

Mar. 06, 2020 CNY (¥) shares

Mar. 06, 2020 $ / shares

Mar. 01, 2020 CNY (¥)

Jan. 31, 2020 CNY (¥)

Jun. 16, 2019 $ / shares

May 27, 2019 USD ($)

Jan. 16, 2019 CNY (¥) shares

Jan. 16, 2019 USD ($) $ / shares shares

Aug. 03, 2018 CNY (¥) shares

Aug. 03, 2018 USD ($) shares

Borrowings Other Debts And Other Liabilities [Line Items]

Short term bank borrowings outstanding

¥ 85,566,000

¥ 161,126,000

¥ 85,566,000

$ 25,417,000

Long term bank borrowings

68,075,000

¥ 0

68,075,000

Gain loss on extinguishment of debt

6,846,000

¥ 10,095,000

Debt Conversion, Converted Instrument, Rate

7%

7%

Repayments Of Debt

¥ 176,897,000

$ 27,905,000

74,000,000

43,533,000

Proceeds from Issuance of Debt

185,614,000

29,280,000

87,846,000

162,501,000

Interest expense

20,884,000

$ 3,294,000

27,650,000

59,268,000

New Foreign Exchange Swap Contract [Member]

Borrowings Other Debts And Other Liabilities [Line Items]

Payment towards advance settlement of foreign exchange swaps | $

$ 11,000,000

Currency Swap [Member]

Borrowings Other Debts And Other Liabilities [Line Items]

Derivative, Notional Amount

¥ 26,500,000

Foreign Currency Exchange Rate

6.628

Gain (Loss) on Derivative, Net

190,000

Currency Swap [Member] | New Foreign Exchange Swap Contract [Member]

Borrowings Other Debts And Other Liabilities [Line Items]

Gain (Loss) on Derivative, Net

1,200,000

Deferred fair value gain loss on foreign swap contract one

900,000

Derivative assets current

700,000

Currency Swap [Member] | New Foreign Exchange Swap Contract [Member] | New Foreign Exchange Swap Contract One [Member]

Borrowings Other Debts And Other Liabilities [Line Items]

Currency to be exchanged

¥ 8,000

Derivative forward exchange rate

6.5452

6.5452

Currency to be received

¥ 52,400

Currency Swap [Member] | New Foreign Exchange Swap Contract [Member] | New Foreign Exchange Swap Contract Two [Member]

Borrowings Other Debts And Other Liabilities [Line Items]

Currency to be exchanged

¥ 4,000

Derivative forward exchange rate

6.5128

6.5128

Currency to be received

¥ 26,100

Currency Swap [Member] | New Foreign Exchange Swap Contract [Member] | New Foreign Exchange Swap Contract Three [Member]

Borrowings Other Debts And Other Liabilities [Line Items]

Currency to be exchanged

¥ 5,000

Derivative forward exchange rate

6.42

6.42

Currency to be received

¥ 32,100

Series D2 DL Notes [Member]

Borrowings Other Debts And Other Liabilities [Line Items]

Payment of debt issuance costs

¥ 200,000

$ 30,000

Debt instrument converted value | $

$ 1,000,000

Debt instrument conversion price per share | $ / shares

$ 9.34

Debt Conversion, Converted Instrument, Amount | $

$ 1,000,000

Debt Conversion, Converted Instrument, Rate

8%

Debt Instrument, Convertible, Renewal Maturity Days

30 months

30 months

Series D2 Preferred Shares [Member]

Borrowings Other Debts And Other Liabilities [Line Items]

Debt instrument converted shares issued | shares

107,016

Series D3 Warrant A [Member]

Borrowings Other Debts And Other Liabilities [Line Items]

Debt Instrument, Periodic Payment, Principal

¥ 10,000,000

Debt Instrument, Periodic Payment, Interest

700,000

Series D3 Warrant B [Member]

Borrowings Other Debts And Other Liabilities [Line Items]

Debt Instrument, Periodic Payment, Principal

40,000,000

Debt Instrument, Periodic Payment, Interest

¥ 1,500,000

Series D One Preferred Shares [Member]

Borrowings Other Debts And Other Liabilities [Line Items]

Fair value of temporary equity issued

¥ 82,000,000

Gain loss on extinguishment of debt

10,000,000

Series D Two Preferred Shares [Member]

Borrowings Other Debts And Other Liabilities [Line Items]

Fair value of temporary equity issued

¥ 73,000,000

Series D3 Preferred Shares [Member]

Borrowings Other Debts And Other Liabilities [Line Items]

Debt Conversion, Converted Instrument, Rate

10%

Debt Instrument, Interest Rate During Period

10%

Class Of Warrants Or Rights Extension Period

45 days

Series D3 Preferred Shares [Member] | Series D3 Warrant A [Member]

Borrowings Other Debts And Other Liabilities [Line Items]

Class of warrants or rights exercise price | $ / shares

$ 9.65

Debt Conversion, Converted Instrument, Warrants or Options Issued | shares

154,395

Series D3 Preferred Shares [Member] | Series D3 Warrant B [Member]

Borrowings Other Debts And Other Liabilities [Line Items]

Class of warrants or rights exercise price | $ / shares

$ 9.65

Debt Conversion, Converted Instrument, Warrants or Options Issued | shares

617,580

Superb Origin International Limited [Member] | Series D One Preferred Shares [Member]

Borrowings Other Debts And Other Liabilities [Line Items]

Debt instrument converted shares issued | shares

1,089,265

1,089,265

Debt instrument converted value | $

$ 10,000,000

Debt Conversion, Converted Instrument, Amount | $

$ 10,000,000

Superb Origin International Limited [Member] | Series D Two Preferred Shares [Member]

Borrowings Other Debts And Other Liabilities [Line Items]

Debt instrument converted shares issued | shares

963,139

963,139

Debt instrument converted value | $

$ 9,000,000

Debt Conversion, Converted Instrument, Amount | $

$ 9,000,000

Series D One Warrant [Member]

Borrowings Other Debts And Other Liabilities [Line Items]

Class of warrants or rights number of securities called by the warrants or rights | shares

1,089,265

1,089,265

Debt instrument convertible carrying value at the time of conversion

11,000,000

Debt Conversion, Original Debt, Amount

11,000,000

Series D Two Warrant [Member]

Borrowings Other Debts And Other Liabilities [Line Items]

Debt instrument convertible carrying value at the time of conversion

9,000,000

Debt Conversion, Original Debt, Amount

9,000,000

Yoken Series A One Warrant [Member]

Borrowings Other Debts And Other Liabilities [Line Items]

Class of warrants or rights exercise price | $ / shares

$ 7.14

Class of warrants or rights outstanding value

19,900,000

23,200,000

19,900,000

Series E Warrant [Member]

Borrowings Other Debts And Other Liabilities [Line Items]

Class of warrants or rights number of securities called by the warrants or rights | shares

205,767

Class of warrants or rights exercise price | $ / shares

$ 10.3251

Class of warrants or rights outstanding value

¥ 2,500,000

Guangcheng [Member] | Series D Two Warrant [Member]

Borrowings Other Debts And Other Liabilities [Line Items]

Class of warrants or rights number of securities called by the warrants or rights | shares

963,139

963,139

Chong Li [Member]

Borrowings Other Debts And Other Liabilities [Line Items]

Debt instrument face value

¥ 128,000,000

¥ 128,000,000

Long-term Debt, Term

5 years

5 years

5 years

Long term loan due to the related party non current

¥ 95,000,000

Chong Li [Member] | Superb Origin International Limited [Member]

Borrowings Other Debts And Other Liabilities [Line Items]

Equity method investment ownership interest

100%

100%

100%

Investor One [Member] | Yoken Series A One Warrant [Member]

Borrowings Other Debts And Other Liabilities [Line Items]

Class of warrants or rights number of securities called by the warrants or rights | shares

360,000

Debt instrument convertible carrying value at the time of conversion

¥ 18,000,000

$ 2,500,000

Debt Conversion, Original Debt, Amount

18,000,000

$ 2,500,000

Investor Two [Member] | Yoken Series A One Warrant [Member]

Borrowings Other Debts And Other Liabilities [Line Items]

Class of warrants or rights number of securities called by the warrants or rights | shares

200,000

Debt instrument convertible carrying value at the time of conversion

10,000,000

$ 1,400,000

Debt Conversion, Original Debt, Amount

¥ 10,000,000

$ 1,400,000

Long Term Bank Loan [Member]

Borrowings Other Debts And Other Liabilities [Line Items]

Collateralized by short-term investments

¥ 68,100,000

¥ 68,100,000

Long term borrowings weighted average interest rate at a point in time

4.15%

4.15%

Loan For Series D One Warrant [Member]

Borrowings Other Debts And Other Liabilities [Line Items]

Debt instrument convertible carrying value at the time of conversion

¥ 79,000,000

Debt Conversion, Original Debt, Amount

79,000,000

Loan For Series D One Warrant [Member] | Guangcheng [Member]

Borrowings Other Debts And Other Liabilities [Line Items]

Debt instrument face value

¥ 61,960

$ 9,000

¥ 66,500,000

$ 10,000,000

Long-term Debt, Term

18 months

18 months

Payment of debt issuance costs

¥ 100,000

$ 30,000

Loan For Series D One Warrant [Member] | Guangcheng [Member] | Amendment To The Maturity Date [Member]

Borrowings Other Debts And Other Liabilities [Line Items]

Long-term Debt, Term

36 months

36 months

Loan For Series D Two Warrant [Member]

Borrowings Other Debts And Other Liabilities [Line Items]

Debt instrument convertible carrying value at the time of conversion

67,000,000

Debt Conversion, Original Debt, Amount

¥ 67,000,000

Loan For Series D Two Warrant [Member] | Guangcheng [Member]

Borrowings Other Debts And Other Liabilities [Line Items]

Long term borrowings fixed rate of interest rate percentage

10%

10%

Long-term Debt, Term

36 months

36 months

18 months

18 months

Payment of debt issuance costs

¥ 2,000,000

$ 300,000

Long term debt stated rate of interest

10%

10%

Class of warrants or rights exercise price | $ / shares

$ 9.34

Loan For Series D Two Warrant [Member] | Chong Li [Member] | Series D Two Warrant [Member]

Borrowings Other Debts And Other Liabilities [Line Items]

Receivable for the issuance of temporary equity

¥ 0

¥ 0

$ 35,900,000

Interest expense

5,100,000

6,100,000

Series D Two CW Notes [Member]

Borrowings Other Debts And Other Liabilities [Line Items]

Debt instrument face value | $

$ 1,000,000

Debt instrument conversion price per share | $ / shares

$ 8.88

Series D Two CW Notes [Member] | Debt Instrument Converted Into Redeemable Preferred Stock [Member] | Series D Two Preferred Shares [Member]

Borrowings Other Debts And Other Liabilities [Line Items]

Debt instrument converted shares issued | shares

112,648

Loan For Series D3 Warrant A [Member] | Guangcheng [Member] | Series D3 Preferred Shares [Member] | Series D3 Warrant A [Member]

Borrowings Other Debts And Other Liabilities [Line Items]

Debt instrument convertible carrying value at the time of conversion

¥ 10,000,000

Debt Conversion, Original Debt, Amount

10,000,000

Loan For Series D3 Warrant B [Member]

Borrowings Other Debts And Other Liabilities [Line Items]

other gain (losses),Net

4,900,000

Loan For Series D3 Warrant B [Member] | Guangcheng [Member] | Series D3 Preferred Shares [Member] | Series D3 Warrant B [Member]

Borrowings Other Debts And Other Liabilities [Line Items]

Debt instrument convertible carrying value at the time of conversion

40,000,000

Debt Conversion, Original Debt, Amount

¥ 40,000,000

Series D Two DL Notes [Member]

Borrowings Other Debts And Other Liabilities [Line Items]

Long term borrowings fixed rate of interest rate percentage

14%

Debt instrument face value | $

$ 10

Long term debt stated rate of interest

14%

Series D Three PICC Notes [Member]

Borrowings Other Debts And Other Liabilities [Line Items]

Gain loss on extinguishment of debt

600,000

Repayments Of Debt | $

$ 10,000,000

Payments Of Interest On Debt | $

$ 1,100,000

Loan for Yoken Series A-1 Warrant [Member]

Borrowings Other Debts And Other Liabilities [Line Items]

Long term borrowings fixed rate of interest rate percentage

10%

10%

10%

Long term debt stated rate of interest

10%

10%

10%

Debt instrument converted shares issued | shares

120,000

120,000

Proceeds from Issuance of Debt

¥ 18,000,000

Loan for Yoken Series A-1 Warrant [Member] | Yoken Series A One Warrant [Member]

Borrowings Other Debts And Other Liabilities [Line Items]

Class of warrants or rights outstanding value

9,400,000

¥ 9,100,000

9,400,000

Interest Expense Reversed

1,400,000

Short-term Investments [Member] | Long Term Bank Loan [Member]

Borrowings Other Debts And Other Liabilities [Line Items]

Debt instrument unused borrowing capacity

¥ 14,000,000

¥ 14,000,000

Short Term Bank Loan [Member]

Borrowings Other Debts And Other Liabilities [Line Items]

Short term borrowings weighted average interest rate at a point in time

4.52%

2.63%

4.52%

2.63%

Debt instrument unused borrowing capacity

¥ 222,300,000

¥ 170,300,000

¥ 222,300,000

Short Term Bank Loan [Member] | Short-term Investments [Member]

Borrowings Other Debts And Other Liabilities [Line Items]

Collateralized by short-term investments

¥ 37,800,000

¥ 110,500,000

¥ 37,800,000

Borrowings, other debts and d_6

Borrowings, other debts and derivative liabilities - Summary of Maturities of Long-term Debt (Detail) - CNY (¥) ¥ in Thousands	Mar. 31, 2022	Mar. 31, 2021
Debt Disclosure [Abstract]
Within 1 year	¥ 161,126	¥ 85,566
Between 1 and 2 years	0	68,075
Total	¥ 161,126	¥ 153,641

Borrowings, other debts and d_7

Borrowings, other debts and derivative liabilities - Summary of Other Long Term Debt (Detail) ¥ in Thousands, $ in Thousands	Mar. 31, 2022 CNY (¥)	Mar. 31, 2022 USD ($)	Mar. 31, 2021 CNY (¥)
Debt Instrument [Line Items]
Other debts, non-current	¥ 181,062	$ 28,562	¥ 433,292
Payable for investment	1,500
Loan For Series C Plus Warrant [Member]
Debt Instrument [Line Items]
Other debts, non-current	86,373		312,535
Loan From Chong Li [Member]
Debt Instrument [Line Items]
Other debts, non-current	70,001		100,842
Loan For Yoken Series A One Warrant [Member]
Debt Instrument [Line Items]
Other debts, non-current	¥ 23,188		¥ 19,915

Borrowings, other debts and d_8

Borrowings, other debts and derivative liabilities - Summary of Fair Value of Derivative Liabilities (Detail) - CNY (¥) ¥ in Thousands	Mar. 31, 2022	Mar. 31, 2021
Schedule Of Derivative Liabilities At Fair Value [Line Items]
Derivative Liability	¥ 9,086	¥ 9,996
Conversion feature of Yoken Series A-1 Warrant
Schedule Of Derivative Liabilities At Fair Value [Line Items]
Derivative Liability	¥ 9,086	9,362
Series E Warrant
Schedule Of Derivative Liabilities At Fair Value [Line Items]
Derivative Liability		444
Forward exchange swap [Member]
Schedule Of Derivative Liabilities At Fair Value [Line Items]
Derivative Liability		¥ 190

Receivable for issuance of or_2

Receivable for issuance of ordinary shares - Additional Information (Detail) ¥ in Thousands, $ in Thousands	1 Months Ended		12 Months Ended
	Aug. 31, 2020 CNY (¥)	Mar. 31, 2020 CNY (¥)	Mar. 31, 2022 CNY (¥)	Mar. 31, 2021 CNY (¥)	Mar. 31, 2022 USD ($)
Receivable For The Issuance Of Ordinary Shares [Line Items]
Proceeds from contributed capital			¥ 262,900	¥ 0
Interest income on subscription receivable from shareholders			14,200	15,400
Receivable for the issuance of ordinary shares			¥ 164,700	¥ 413,377	$ 25,988
Series C+ Preferred Shares [Member]
Receivable For The Issuance Of Ordinary Shares [Line Items]
Receivables for the issuance of temporary equity	¥ 303,000
Series D-1 Preferred Shares and Series D-2 Preferred Shares [Member]
Receivable For The Issuance Of Ordinary Shares [Line Items]
Receivables for the issuance of temporary equity		¥ 95,000

Share-based compensation - Summ

Share-based compensation - Summary of Stock Option Activity (Detail) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2020
Share-based Payment Arrangement, Disclosure [Abstract]
Number of shares, Outstanding, beginning	5,512,222	4,856,972
Number of shares, Granted	1,282,500	998,000
Number of shares, Exercised	(1,204,483)
Number of shares, Forfeited	(358,348)	(342,750)
Number of shares, Outstanding, ending	5,231,891	5,512,222	4,856,972
Weighted average exercise price, Outstanding, beginning	$ 3.36	$ 2.26
Weighted average exercise price, Granted	2.86	4.13
Weighted average exercise price, Exercised	1.09
Weighted average exercise price, Forfeited	2.86	3.49
Weighted average exercise price, Outstanding, ending	$ 2.86	$ 3.36	$ 2.26
Weighted average remaining contractual term, Outstanding	5 years 3 months	6 years 3 months 25 days	6 years 8 months 1 day
Aggregate intrinsic value, Outstanding, beginning	$ 29,360	$ 39,472
Aggregate intrinsic value, Outstanding, ending	$ 404	$ 29,360	$ 39,472
Weighted average fair value, Outstanding, beginning	$ 3.28	$ 2.72
Weighted average fair value, Granted	2.27	2.49
Weighted average fair value, Exercised	0.73
Weighted average fair value, Forfeited	3.83	4
Weighted average fair value, Outstanding, ending	$ 2.36	$ 3.28	$ 2.72

Share-based compensation - Su_2

Share-based compensation - Summary of Options Measured At Fair Value, Valuation Assumptions (Detail) - Share-based Payment Arrangement, Option [Member] - $ / shares	12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility		44.41%
Risk-free interest rate		0.94%
Expected dividend yield	0%	0%
Contractual term (in years)	10 years	10 years
Expected volatility , Minimum	42.22%
Expected volatility , Maximum	43.71%
Risk-free rate , Minimum	1.64%
Risk-free rate , Maximum	1.87%
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise multiple	$ 2.8	$ 2.8
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise multiple	$ 2.2	$ 2.2

Share-based compensation - Addi

Share-based compensation - Additional Information (Detail) ¥ in Millions	12 Months Ended
	Mar. 31, 2022 USD ($) shares	Mar. 31, 2022 CNY (¥) shares	Mar. 31, 2021 USD ($) shares	Mar. 31, 2021 CNY (¥) shares	Mar. 31, 2020 USD ($)	Sep. 01, 2020 shares	Aug. 01, 2018 shares	Sep. 27, 2012 shares
Share Based Payment Arrangement [Line Items]
Percentage of entitlement to vest earn by employees	25%	25%
Share based compensation arrangement by share based payment award options granted	1,282,500	1,282,500	998,000	998,000
Share based compensation arrangement by share based payment award options outstanding intrinsic value | $	$ 404,409,000		$ 29,359,582,000		$ 39,471,589,000
Unrecognised share based compensation expenses | $	$ 2,298,328,000		$ 3,212,747,000
Weighted average vesting period	5 years 3 months 18 days	5 years 3 months 18 days	6 years 3 months 18 days	6 years 3 months 18 days
Share based compensation expense recognized until the completion of a qualified IPO | $	$ 0
Share based compensation expense		¥ 14.4		¥ 55	$ 0
Employees and Non Employees [Member]
Share Based Payment Arrangement [Line Items]
Share based compensation arrangement by share based payment award options granted	1,282,500	1,282,500	998,000	998,000
Fair value of options granted amount | $	$ 2,900,000		$ 2,500,000
2012 Global Share Plan [Member]
Share Based Payment Arrangement [Line Items]
Shares reserved for future issuances								1,061,500
2018 Global Share Plan [Member]
Share Based Payment Arrangement [Line Items]
Shares reserved for future issuances						5,987,836	5,987,836
Amended 2018 Global Share Plan [Member]
Share Based Payment Arrangement [Line Items]
Shares reserved for future issuances						8,987,836

Employee benefits - Additional

Employee benefits - Additional Information (Detail) - CNY (¥) ¥ in Millions	12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2020
Compensation Related Costs [Abstract]
Employee benefits costs	¥ 7	¥ 6	¥ 7

Fair value measurements - Summa

Fair value measurements - Summary of Company's Financial Assets and Liabilities (Detail) - CNY (¥) ¥ in Thousands	Mar. 31, 2022	Mar. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt investments	¥ 74,866	¥ 71,357
Equity securities with readily determinable fair values	670
Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	128,084	168,546
Available-for-sale debt investments	74,866	71,357
Equity securities with readily determinable fair values	670
Total assets	203,620	239,903
Derivative liabilities	9,086	9,996
Fair Value, Recurring [Member] | Significant unobservable Inputs (Level 1) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity securities with readily determinable fair values	670
Total assets	670
Fair Value, Recurring [Member] | Significant other observable Inputs (Level 2) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	128,084	168,546
Total assets	128,084	168,546
Derivative liabilities	0	190
Fair Value, Recurring [Member] | Significant unobservable Inputs (Level 3) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt investments	74,866	71,357
Total assets	74,866	71,357
Derivative liabilities	¥ 9,086	¥ 9,806

Fair value measurements - Sum_2

Fair value measurements - Summary of Roll Forward of Major Level 3 Investments (Detail) - CNY (¥) ¥ in Thousands	12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2020
Available-for-sale Securities [Member]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair value of Level 3 investments , Beginning Balance	¥ 71,357	¥ 70,328	¥ 16,050
New addition	16,000	0	50,000
Unrealized fair value change of the available-for-sale debt investments	(12,491)	1,029	4,278
Fair value of Level 3 investments , Ending Balance	74,866	71,357	70,328
Derivative Financial Instruments, Liabilities [Member]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair value of Level 3 investments, Beginning Balance	9,996	14,351	35,524
New addition	0	9,581	13,487
Unrealized fair value change of the derivative liabilities	(1,656)	(11,559)	(13,345)
Disposal of Series D-3 Notes (Note 20)		(2,377)
Conversion of Series D-1 Notes (Note 20)			(10,701)
Conversion of Series D-2 Notes (Note 20)			(10,614)
Reclassification of forward exchange contracts	746
Fair value of Level 3 investments , Ending Balance	¥ 9,086	¥ 9,996	¥ 14,351

Fair value measurements - Sum_3

Fair value measurements - Summary of Significant Unobservable Inputs (Detail) - Available-for-sale Securities [Member]	Mar. 31, 2022	Mar. 31, 2021
Weighted Average Cost Of Capital [Member] | Minimum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt Securities, Available-for-sale, Measurement Input	15	15
Weighted Average Cost Of Capital [Member] | Median [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt Securities, Available-for-sale, Measurement Input	16.5
Weighted Average Cost Of Capital [Member] | Maximum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt Securities, Available-for-sale, Measurement Input	18	16.5
Lack of marketability discount [Member] | Minimum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt Securities, Available-for-sale, Measurement Input	17	17
Lack of marketability discount [Member] | Median [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt Securities, Available-for-sale, Measurement Input	23
Lack of marketability discount [Member] | Maximum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt Securities, Available-for-sale, Measurement Input	29	23
Risk-free rate [Member] | Minimum One [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt Securities, Available-for-sale, Measurement Input	2.23
Risk-free rate [Member] | Minimum Two [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt Securities, Available-for-sale, Measurement Input	2.34
Risk-free rate [Member] | Minimum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt Securities, Available-for-sale, Measurement Input	1.95	2.88
Risk-free rate [Member] | Maximum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt Securities, Available-for-sale, Measurement Input	2.36	2.87
Expected volatility [Member] | Minimum One [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt Securities, Available-for-sale, Measurement Input	42.17
Expected volatility [Member] | Minimum Two [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt Securities, Available-for-sale, Measurement Input	42.48
Expected volatility [Member] | Minimum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt Securities, Available-for-sale, Measurement Input	39.88	41.79
Expected volatility [Member] | Maximum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt Securities, Available-for-sale, Measurement Input	47.34	42.26
Probability Liquidation Scenario [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt Securities, Available-for-sale, Measurement Input	20	40
Probability Redemption Scenario [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt Securities, Available-for-sale, Measurement Input	40	40
Probability IPO Scenario [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt Securities, Available-for-sale, Measurement Input	40	20

Fair value measurements - Sched

Fair value measurements - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Detail) - Derivative Financial Instruments, Liabilities [Member] - $ / shares	12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Risk-free rate , Minimum	1.25%	0%
Risk-free rate , Maximum	2.50%	0.90%
Expected volatility , Minimum	57.95%	41.05%
Expected volatility , Maximum	48.15%	52.33%
Minimum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Share Price	$ 0.44	$ 5.57
Expected expiry years (in years)	6 months	6 months
Maximum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Share Price	$ 6.93	$ 7.19
Expected expiry years (in years)	3 years 6 months 21 days	4 years 6 months 21 days

Net Loss per share - Schedule o

Net Loss per share - Schedule of Earnings Per Share, Basic and Diluted (Detail) - CNY (¥) ¥ / shares in Units, ¥ in Thousands		12 Months Ended
		Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2020
Numerator:
Net loss attributable to Boqii Holding Limited		¥ (128,390)	¥ (194,444)	¥ (179,024)
Accretion on convertible redeemable preferred shares			120,873	(204,796)
Accretion on the Redeemable non-controlling interests to redemption value (Note 21)		(575)	(138)
Deemed dividend to preferred shareholders			(12,547)	(1,142)
Net loss attributable to ordinary shareholders		¥ (128,965)	¥ (86,256)	¥ (384,962)
Denominator:
Weighted average number of ordinary shares used in computing net loss per share, Basic and diluted	[1]	68,006,172	66,953,610	22,238,454
Net loss per share attributable to ordinary shareholders:
Basic and diluted		¥ (1.9)	¥ (1.29)	¥ (17.31)
[1]Options exercisable for a minimal exercise price (the “Penny Stock”) are included in the denominator of basic loss per share calculation once there are no further vesting conditions or contingencies associated with them, as they are considered issuable shares. Basic net loss per share is computed using the weighted average number of ordinary shares outstanding and the Penny Stock during the reporting periods. Diluted net loss per share is computed using the weighted average number of ordinary shares and dilutive potential ordinary shares outstanding and the Penny Stock during the reporting periods.

Net Loss per share - Schedule_2

Net Loss per share - Schedule of Antidilutive Securities Excluded From Computation of Earnings Per Share (Detail) - shares	12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2020
Preferred Shares Weighted Average [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount	0	0	26,072,893
Employee Stock Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount	719,437	2,585,103	0

Related party transactions - Su

Related party transactions - Summary of Major Related Parties and Their Relationships With The Company (Detail)	12 Months Ended
	Mar. 31, 2022
Nanjing Xingmu [Member]
Schedule Of Transactions Between Related Parties [Line Items]
Name of related parties	Nanjing Xingmu
Relationship with the company	An equity investee of the Company before November 1, 2019
Nanjing Animal Pharmaceutical [Member]
Schedule Of Transactions Between Related Parties [Line Items]
Name of related parties	Nanjing Animal Pharmaceutical
Relationship with the company	An equity investee of the Company
Wuhan Chunzhijin [Member]
Schedule Of Transactions Between Related Parties [Line Items]
Name of related parties	Wuhan Chunzhijin
Relationship with the company	An equity investee of the Company
Weishi Network [Member]
Schedule Of Transactions Between Related Parties [Line Items]
Name of related parties	Weishi Network
Relationship with the company	An equity investee of the Company
Beijing Petdog [Member]
Schedule Of Transactions Between Related Parties [Line Items]
Name of related parties	Beijing Petdog
Relationship with the company	An available-for-sale debt investee that the Company has significant influence
Shanghai Guangcheng Information Technology (limited partnership) (Shanghai Guangcheng Information) [Member]
Schedule Of Transactions Between Related Parties [Line Items]
Name of related parties	Shanghai Guangcheng Information Technology (limited partnership) (“Shanghai Guangcheng Information”)
Relationship with the company	A company with a common director of the Company
Yingzhi (Lisa) Tang [Member]
Schedule Of Transactions Between Related Parties [Line Items]
Name of related parties	Yingzhi (Lisa) Tang
Relationship with the company	Senior management of the Company
Lijun Zhou [Member]
Schedule Of Transactions Between Related Parties [Line Items]
Name of related parties	Lijun Zhou
Relationship with the company	Senior management of the Company until April, 2022
Di (Jackie) Chen [Member]
Schedule Of Transactions Between Related Parties [Line Items]
Name of related parties	Di (Jackie) Chen
Relationship with the company	Senior management of the Company until July, 2021
Ying (Christina) Zhang [Member]
Schedule Of Transactions Between Related Parties [Line Items]
Name of related parties	Ying (Christina) Zhang
Relationship with the company	Senior management of the Company until February, 2022
Fei Wang [Member]
Schedule Of Transactions Between Related Parties [Line Items]
Name of related parties	Fei Wang
Relationship with the company	Senior management of the Company until April, 2022
Yan Jiang [Member]
Schedule Of Transactions Between Related Parties [Line Items]
Name of related parties	Yan Jiang
Relationship with the company	Senior management of the Company

Related party transactions - _2

Related party transactions - Summary of Related Party Transactions And Balances (Detail) - CNY (¥) ¥ in Thousands	12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2020	May 31, 2021
Related Party Transaction [Line Items]
Online marketing and information services	¥ 19	¥ 410	¥ 315
Purchase of merchandise	2,602	250	796
Loans granted to related parties	38,115	6,890	1,937
Beijing Petdog [Member]
Related Party Transaction [Line Items]
Sales of goods			2,316
Online marketing and information services		410	315
Nanjing Xingmu [Member]
Related Party Transaction [Line Items]
Purchase of merchandise			751
Nanjing Animal Pharmaceutical [Member]
Related Party Transaction [Line Items]
Purchase of merchandise	1,020	250	45
Loans granted to related parties		500	1,000
Wuhan Chunzhijin [Member]
Related Party Transaction [Line Items]
Loans granted to related parties	2,600	5,690
Yan Jiang [Member]
Related Party Transaction [Line Items]
Loans granted to related parties	70	200
Ying (Christina) Zhang [Member]
Related Party Transaction [Line Items]
Loans granted to related parties			152
Di (Jackie) Chen [Member]
Related Party Transaction [Line Items]
Loans granted to related parties			785
Fei Wang [Member]
Related Party Transaction [Line Items]
Loans granted to related parties		500
Weishi Network [Member]
Related Party Transaction [Line Items]
Online marketing and information services	19
Purchase of merchandise	1,582
Shanghai Guangcheng Information [Member]
Related Party Transaction [Line Items]
Loans granted to related parties	33,395
Yingzhi Lisa Tang [Member]
Related Party Transaction [Line Items]
Loans granted to related parties	1,750
Lijun Zhou [Member]
Related Party Transaction [Line Items]
Loans granted to related parties	¥ 300

Related party transactions - _3

Related party transactions - Summary of Related Party Transactions And Balances (Parenthetical) (Detail) ¥ in Thousands, $ in Thousands	Mar. 31, 2022 CNY (¥)	Mar. 31, 2022 USD ($)	Apr. 01, 2021 CNY (¥)	Apr. 01, 2021 USD ($)	Mar. 31, 2021 CNY (¥)	Jan. 31, 2021 CNY (¥)	Jun. 30, 2020 CNY (¥)	Dec. 31, 2019 CNY (¥)
Related Party Transaction [Line Items]
Short-term borrowings	¥ 161,126	$ 25,417			¥ 85,566
Nanjing Agricultural Pharmaceutical [Member] | Twelve Month Interest Free Loan Agreement [Member]
Related Party Transaction [Line Items]
Debt Instrument, Face Amount							¥ 500	¥ 1,000
Short-term borrowings					¥ 500
Wuhan Chunzhijin [Member]
Related Party Transaction [Line Items]
Debt Instrument, Face Amount						¥ 5,700
Shanghai Guangcheng Information [Member]
Related Party Transaction [Line Items]
Debt Instrument, Face Amount | $				$ 5,000
Debt Instrument, Interest Rate, Stated Percentage	3.50%	3.50%
Loan Agreement [Member] | Shanghai Guangcheng Information [Member]
Related Party Transaction [Line Items]
Debt Instrument, Face Amount			¥ 33,400	$ 5,000
Debt Instrument, Interest Rate, Stated Percentage			3.50%	3.50%

Related party transactions - _4

Related party transactions - Summary of Related Party Transaction (Detail) - CNY (¥) ¥ in Thousands	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2020
Related Party Transaction [Line Items]
Staff advances		¥ 10	¥ 6
Advances provided to related parties		2,073	3,350
Loans granted from related parties	9,961		11,700
Yingzhi (Lisa) Tang [Member]
Related Party Transaction [Line Items]
Staff advances		10
Loans granted from related parties			1,450
Di (Jackie) Chen [Member]
Related Party Transaction [Line Items]
Staff advances			6
Loans granted from related parties			1,250
Nanjing Animal Pharmaceutical [Member]
Related Party Transaction [Line Items]
Advances provided to related parties		2,073
Wuhan Chunzhijin [Member]
Related Party Transaction [Line Items]
Advances provided to related parties			3,350
Yan Jiang [Member]
Related Party Transaction [Line Items]
Loans granted from related parties			9,000
Shanghai Guangcheng Information [Member]
Related Party Transaction [Line Items]
Loans granted from related parties	¥ 9,961

Related party transactions - _5

Related party transactions - Summary of Related Party Transaction (Parenthetical) (Detail) ¥ in Thousands, $ in Thousands	12 Months Ended
	Mar. 31, 2022 CNY (¥)	Mar. 31, 2022 USD ($)	Apr. 01, 2021 USD ($)	Mar. 31, 2021 CNY (¥)	Mar. 31, 2020 CNY (¥)	Dec. 31, 2019 CNY (¥)	Oct. 31, 2019 CNY (¥)	Sep. 30, 2019 CNY (¥)	Jul. 31, 2018 CNY (¥)	Jul. 31, 2018 USD ($)
Shanghai Guangcheng Information [Member]
Related Party Transaction [Line Items]
Debt Instrument, Face Amount | $			$ 5,000
Debt Instrument, Interest Rate, Stated Percentage	3.50%
Loan amount obtained from related party	¥ 10,000	$ 1,500
Yingzhi (Lisa) Tang [Member]
Related Party Transaction [Line Items]
Debt Instrument, Face Amount								¥ 1,500
Due from Related Parties					¥ 2,521
Yingzhi (Lisa) Tang [Member] | Two Year Loan Agreement [Member]
Related Party Transaction [Line Items]
Debt Instrument, Face Amount								¥ 1,500
Debt Instrument, Interest Rate, Stated Percentage								9%
Yingzhi (Lisa) Tang [Member] | Forty Month Loan Agreement [Member]
Related Party Transaction [Line Items]
Debt Instrument, Face Amount									¥ 1,000	$ 150
Debt Instrument, Interest Rate, Stated Percentage									6%	6%
Di (Jackie) Chen [Member] | Forty Month Loan Agreement [Member]
Related Party Transaction [Line Items]
Due from Related Parties							¥ 1,250
Yan Jiang [Member]
Related Party Transaction [Line Items]
Due from Related Parties					¥ 9,000
Yan Jiang [Member] | Two Year Loan Agreement [Member]
Related Party Transaction [Line Items]
Debt Instrument, Face Amount						¥ 9,000		¥ 9,000
Debt Instrument, Interest Rate, Stated Percentage						9%		9%

Related party transactions - _6

Related party transactions - Summary of Transactions Due From Related Parties (Detail) - CNY (¥) ¥ in Thousands	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2020
Schedule Of Transactions Due From Related Parties [Line Items]
Prepayments to related parties	¥ 3,232	¥ 2,023
Loans to related parties	900	2,147	1,937
Beijing Petdog [Member]
Schedule Of Transactions Due From Related Parties [Line Items]
Trade receivables from related parties			1,564
Nanjing Animal Pharmaceutical [Member]
Schedule Of Transactions Due From Related Parties [Line Items]
Prepayments to related parties	1,650	2,023
Loans to related parties		500	1,000
Wuhan Chunzhijin [Member]
Schedule Of Transactions Due From Related Parties [Line Items]
Other receivables from related parties	7,594	7,295	2,481
Yingzhi (Lisa) Tang [Member]
Schedule Of Transactions Due From Related Parties [Line Items]
Loans to related parties		10
Yan Jiang [Member]
Schedule Of Transactions Due From Related Parties [Line Items]
Loans to related parties	200	200
Di (Jackie) Chen [Member]
Schedule Of Transactions Due From Related Parties [Line Items]
Loans to related parties		785	785
Ying (Christina) Zhang [Member]
Schedule Of Transactions Due From Related Parties [Line Items]
Loans to related parties		152	152
Fei Wang [Member]
Schedule Of Transactions Due From Related Parties [Line Items]
Loans to related parties	500	500
Lijun Zhou [Member]
Schedule Of Transactions Due From Related Parties [Line Items]
Loans to related parties	200
Weishi Network [Member]
Schedule Of Transactions Due From Related Parties [Line Items]
Prepayments to related parties	¥ 1,582

Related party transactions - _7

Related party transactions - Summary of Transactions Due From Related Parties (Parenthetical) (Detail) - CNY (¥) ¥ in Millions	Jan. 31, 2021	Dec. 31, 2019
Fei Wang [Member] | One Year Loan Agreement [Member]
Schedule Of Transactions Due From Related Parties [Line Items]
Debt Instrument, Face Amount	¥ 0.5
Debt Instrument, Interest Rate, Stated Percentage	4%
Debt Instrument, Number of Stock Options Collateralized	515,000
Di (Jackie) Chen [Member] | Twelve Month Interest Free Loan Agreement [Member]
Schedule Of Transactions Due From Related Parties [Line Items]
Debt Instrument, Face Amount		¥ 0.7

Related party transactions - _8

Related party transactions - Summary of Transactions Due To Related Parties (Detail) - CNY (¥) ¥ in Thousands	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2020
Schedule Of Transactions Due To Related Parties [Line Items]
Advances from related parties			¥ 11,521
Nanjing Animal Pharmaceutical [Member]
Schedule Of Transactions Due To Related Parties [Line Items]
Trade payables to related parties	219	874	45
Beijing Petdog [Member]
Schedule Of Transactions Due To Related Parties [Line Items]
Advances from related parties		36
Yingzhi (Lisa) Tang [Member]
Schedule Of Transactions Due To Related Parties [Line Items]
Long-term loan from related parties			2,521
Yan Jiang [Member]
Schedule Of Transactions Due To Related Parties [Line Items]
Long-term loan from related parties			¥ 9,000

Related party transactions - _9

Related party transactions - Summary of Transactions Due To Related Parties (Parenthetical) (Detail) $ in Thousands, ¥ in Millions	Dec. 31, 2019 CNY (¥)	Sep. 30, 2019 CNY (¥)	Jul. 31, 2018 CNY (¥)	Jul. 31, 2018 USD ($)
Yingzhi (Lisa) Tang [Member]
Schedule Of Transactions Due To Related Parties [Line Items]
Debt Instrument, Face Amount		¥ 1.5
Yingzhi (Lisa) Tang [Member] | Two Year Loan Agreement [Member]
Schedule Of Transactions Due To Related Parties [Line Items]
Debt Instrument, Face Amount		¥ 1.5
Debt Instrument, Interest Rate, Stated Percentage		9%
Yingzhi (Lisa) Tang [Member] | Forty Month Loan Agreement [Member]
Schedule Of Transactions Due To Related Parties [Line Items]
Debt Instrument, Face Amount			¥ 1	$ 150
Debt Instrument, Interest Rate, Stated Percentage			6%	6%
Yan Jiang [Member] | Two Year Loan Agreement [Member]
Schedule Of Transactions Due To Related Parties [Line Items]
Debt Instrument, Face Amount	¥ 9	¥ 9
Debt Instrument, Interest Rate, Stated Percentage	9%	9%

Commitments and contingencies -

Commitments and contingencies - Additional Information (Detail) - CNY (¥) ¥ in Thousands	12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Capital commitment amount	¥ 0	¥ 0

Subsequent events - Additional

Subsequent events - Additional Information (Detail)	Jun. 03, 2022	May 20, 2022
ADR [Member] | Subsequent Event [Member]
Subsequent Events [Line Items]
Number of shares for each depository receipt	4.5	0.75

Restricted net assets - Additio

Restricted net assets - Additional Information (Detail) ¥ in Thousands	12 Months Ended
	Mar. 31, 2022 CNY (¥)
Restricted net assets of the Company's subsidiaries and the VIEs.	¥ 0
Threshold maximum percentage of restricted net assets of consolidated and unconsolidated subsidiaries to the consolidated net assets	25%
Threshold maximum percentage of restricted net assets not met by the consolidated subsidiaries to disclose the financial statements for the parent company	25%
PRC [Member]
Required minimum percentage of annual appropriations to general reserve fund or statutory surplus fund	10
PRC [Member] | Statutory Surplus Reserve [Member] | Domestic Enterprise [Member]
Required minimum percentage of annual appropriations to general reserve fund	10
Maximum percentage of statutory surplus reserve related to entity's registered capital	50